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ABSTRACT 
 
Stato-Acoustic Ganglion (SAG) neurons originate from the floor of the otic 
vesicle during a brief developmental window. They subsequently leave the otic vesicle 
and undergo a phase of migration and proliferation (transit-amplification). Neuroblasts 
finally differentiate into mature SAG neurons and extend processes to connect sensory 
cells of the inner ear to the information processing centers in the brain.  The goal of this 
dissertation has been to elucidate mechanisms controlling these diverse events, which 
have heretofore been only poorly understood. 
 First we showed that a threshold level of Fgf signaling initially sets the 
neurogenic domain in the otic epithelium. However, the level of Fgf signaling increases 
during development and becomes inhibitory to otic neurogenesis. Specfically, fgf5 is 
expressed by accumulating SAG neurons, which serves to terminate specification of new 
neuroblasts and delay differentiation of transit-amplifying cells.  
Second, we tested the role of transcription factor tfap2a, which we found is 
expressed in the neurogenic domain in both zebrafish and chick. Gain and loss-of-
function studies revealed that Tfap2a activates expression of bmp7a, which in turn 
partially inhibits Fgf and Notch signaling. By modulating the inhibitory functions of Fgf 
and Notch, Tfap2a regulates the duration, amount and speed of SAG development.  
Third, we investigated the mechanism by which SAG neuroblasts leave the otic 
epithelium. We showed that Goosecoid (Gsc) regulates epithelial-mesenchymal 
transition of the otic neuroblasts. Fgf signaling regulates expression of gsc in a region 
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partially overlapping with the neurogenic otic domain. The medial marker Pax2a acts in 
opposition to Gsc and stabilizes otic epithelia in non-neurogenic parts of the otic vesicle.  
Lastly, we conducted a mutagenesis screen in zebrafish to identify ENU-induced 
mutations that affect SAG development. We recovered a SAG deficient mutation, 
termed sagd1 that strongly reduces a subset of SAG neurons required for vestibular 
(balance) functions. Whole genome sequencing revealed that sagd1 affects the glycolytic 
enzyme, Phosphoglycerate kinase-1 (Pgk1). Further analysis revealed that Pgk1 acts 
nonautonomously to augment Fgf signaling during early stages of otic neurogenesis.  
Together, these studies have uncovered a number of previously unknown 
mechanisms for dynamic regulation of Fgf to control specification, delamination, and 
maturation of SAG neurons.   
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
CRANIAL PLACODES 
In all vertebrates, cranial placodes originate from the preplacodal ectoderm (PPE) 
that forms at the interface between the epidermis and neural ectoderm. Distinct placodes 
arise from the stereotypical positions along the anterior-posterior axis of the PPE region 
and subsequently undergo morphological changes to form the paired sensory organs and 
cranial neural networks of the head (1-3).   Fate maps for the cranial placodes are shown 
to include adenohypophyseal, olfactory, lens, trigeminal, otic, lateral line and 
epibranchial placodes in an anteroposterior order.  The adenohypophyseal placode gives 
rise to the neuroendocrine cells of the pituitary gland. The olfactory placode forms the 
olfactory receptor cells and their afferent neurons. The lens placode forms the non-neural 
parts of the eye, such as the crystalline-containing cells in the lens. The trigeminal 
placode forms the somatosensory neurons that transmit touch, pain and temperature 
related information from the skin of the face, jaw and teeth.  Further posteriorly, the otic 
placode forms alongside the hindbrain and gives rise to the morphologically complex 
inner ear apparatus and the associated sensory cells such as hair cells and neurons.  An 
additional placode called the lateral line forms both anteriorly and posteriorly to the otic 
placode in fish and amphibian embryos and is responsible for detecting changes in the 
surrounding water. Epibranchial placode forms in close association to the endodermal 
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pharyngeal pouches and gives rise to neuroblasts that migrate and subsequently 
innervate heart and other visceral organs to transmit information related to, for example, 
heart rate and blood pressure (1-3).    Distinct set of transcriptional factor families such 
as Eya (Eyes absent), Six (Sine oculis) and Dlx (Distal-less) mark the earliest stages of 
the PPE development (4-6). Some of the important signals that regulate PPE formation 
include BMP-antagonists, Wnt antagonists and Fgf signaling (7-9). In zebrafish the 
transcription factors Gata3, Foxi1 and Tfap2a/c are shown to function redundantly and 
provide competence throughout the non-neural ectoderm to enable placodal development 
(9). Formation of the distinct placodes is governed by locally acting signals emanating 
from the surrounding tissues (2). For example, Fgf signals originating from the adjacent 
hindbrain regions are shown to be an important regulator of otic placode induction (10-
12).  Pax family of paired domain homeobox genes are shown to mark the earliest stages 
of the placodal identity. For example, pax6 marks the early lens placode progenitors, 
pax8 is the earliest marker of the otic placode (13), and later, pax2a and pax8 marks both 
otic and epibranchial placode progenitors.  
 
DEVELOPMENT OF THE INNER EAR 
In anamniotes, soon after the formation of the otic placode, otic cells began to 
condense as they excrete fluid to form a lumen and subsequently give rise to a fluid 
filled oval luminal structure, called the otic vesicle (14, 15).   The otic vesicle develops 
by a different mechanism in mammalian and avian embryos such that otic cells 
invaginate to form an otic cup and subsequently break off from the surface ectoderm to 
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generate a vesicle (16). In all vertebrates, the otic vesicle gives rise to the interconnected 
semicircular canals and chambers (utricle, saccule and lagena) that provide housing for a 
sensory epithelium called cristae in the canals and macula in the chambers  (17). Sensory 
epithelia detect and transmit vestibular (balance) and auditory (hearing) information.  In 
most vertebrates, semicircular canals and the utricular macula constitutes the vestibular 
apparatus of the inner ear whereas saccule and lagena of the anamniotes serve as the 
functional homolog of the mammalian cochlea and mediate auditory information (15, 
18). Sensory epithelia of the inner ear consist of ciliated sensory hair cells and support 
cells. Each chamber has an associated otolith, an aggregate of calcium carbonate 
molecules that is attached to the long cilia of the hair cells and vibrate in response to 
sensory stimulus. On the contrary, otoliths are lacking in the semicircular canals, hence 
the hair cells in the cristae sense the angular rotation and movement via their long cilium 
embedded in the flowing otic fluid. Support cells provide trophic support for the survival 
and maintenance of the hair cells. In zebrafish, lost hair cells could be replaced by 
transdifferentiation or proliferation of the support cells (19, 20). This ability is lost in the 
mammalian inner ear, possibly due to the inability of the highly differentiated support 
cells to reenter the cell cycle or change cell fate (20-22).  Hair cells are innervated by 
Stato-Acoustic Ganglion (SAG) neurons that carry hearing or balance related 
information to the processing centers in the hindbrain (14, 15, 18). The structure of the 
vestibular apparatus is highly conserved among vertebrates, however, auditory structures 
have undergone extensive changes in shape (15).  Despite the changes in the 
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morphology, the overall functionality of the auditory structures is highly homologous 
among the vertebrates, as explained below.  
 
MECHANOTRANSDUCTION OF AUDITORY AND VESTIBULAR SIGNALS 
Hair cells contain hair-like protrusions called stereocilia in numbers ranging from 
thirty to a few hundred and one long kinocilium on their apical surface. The kinocilium 
is a true ciliary structure with two central tubules circled with nine doublet tubules 
whereas stereocilia are composed of actin filaments. On the apical surface of the hair 
cells, stereocilia are arranged in parallel rows that progressively increase in height 
towards the kinocilium.  Cadherin23 and Protocadherin 15 form extracellular tip-links 
that connects the parallel rows of stereocilia and link the highest row of stereocilia to the 
kinocilium (23). These links are crucial for the mechanotransduction of auditory and 
vestibular stimuli (23). In mammalia and birds, kinocilium is lost from the auditory hair 
cells soon after birth but it is retained in the vestibular hair cells albeit its function is not 
known(24, 25).  During development, the kinocilium forms first and it becomes 
progressively linked to the newly forming stereocilium. In zebrafish, the kinocilium of 
the earliest forming hair cells, called tether cells, enables the attachment of the otolith 
particles over the developing macula (26). The kinocilium also plays a role in 
mechanosensation of the nascent hair cells prior to the onset of tip-link mediated 
mechanotransduction, but starts to regress afterwards (27).   
Displacement of the hair cell cilia towards the kinocilium stretches the tip links 
and opens the cation selective transduction channels (28). The composition of the otic 
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fluid (endolymph) that contacts the apical surface of the hair cells and support cells is 
unique in the presence of high concentration of potassium ions (29). The flow of the 
potassium ions into the hair cell body causes depolarization and opens the voltage gated 
calcium channels in the cell membrane (29). The influx of the calcium ions into the hair 
cell leads to the release of the neurotransmitter glutamate at the basal side and also opens 
potassium channels to allow the exit of the potassium ions and repolarization.  In 
contrast to the endolymph, basal side of the sensory cells is embedded in a low 
potassium containing fluid (perilymph) that allows passive flow of the potassium ions.  
One of the functions of the support cells is to recycle potassium ions back to endolymph 
via use of the sodium-potassium-chloride cotransporter channels and gap junctions (30).  
Unlike a conventional synapse that is governed by action potential driven 
neurotransmitter release, hair cell synapses are specialized in responding to a gradient of 
changes in membrane potential to allow detection of the stimuli with extremely varying 
intensities. Moreover, hair cell afferent synapses are specialized to encode long-lasting, 
sustained stimuli from the environment which require extensive synaptic vesicle 
recycling ability. To meet the requirements of the high rate and sustained 
neurotransmitter release, hair cells form ribbon synapses composed of an electron dense 
ribbon surrounded with tightly clustered synaptic vesicles (31).  Ribbon synapses are 
thought to improve the synchronous release of several synaptic vesicles to encode 
precise timing and intensity of the stimulus. Ribbon synapses are also capable of 
immense, continuous transmission, due to the calcium dependent mechanisms that 
resupply synaptic vesicles (32). The location and the number of ribbon synapses vary 
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greatly among the hair cells, however, each ribbon lines up with a single post synaptic 
terminal (33).   
 
PROPERTIES OF SAG NEURONS 
Exocytosis of the synaptic vesicles releases glutamate which binds and activates 
receptors clustered in the post-synaptic terminal of the SAG neurons. SAG neurons are 
defined as bipolar and pseudomonopolar as their spindle shape displays 2 main 
projections stemming from the opposite poles of the soma, connecting hair cells to 
information processing centers in the brain. This configuration renders SAG neurons 
uniquely different compared to a central neuron where the information that is received 
by the dendrites and processed in the soma, subsequently invokes an action potential at 
the axon hillock. Instead, in the SAG neurons, action potential is initiated proximal to 
hair cells and carried along the axonal segment which is interrupted by the somatic 
membrane (34). The involvement of the soma in the conductor pathway of SAG neurons 
is likely to be important for regulation and modification of action potentials.  
It is important to note that most studies that characterize the properties of the auditory 
SAG neurons are conducted in mammalian systems and accordingly 2 different classes 
of auditory neurons have been described, based on projection patterns and morphology. 
The first class of the auditory SAG neurons (type 1) is myelinated, constitute 95% of the 
overall auditory neuron population. Each type 1 SAG neuron is shown to synapse with 
one hair cell, however, each inner hair cell is innervated by many SAG neurons (35).  
The remaining 5% of the auditory neurons are classified as type 2 auditory neurons and 
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differ from the rest of the population as they lack myelin and synapse with the outer hair 
cells of the mammalian cochlea (36). Outer hair cells are an innovation of the 
mammalian cochlea and do not exist in other vertebrates. Even though these kinds of 
hair cells do not play a role in mechanotransduction of sound waves, they amplify the 
auditory stimulus and enhance the frequency sensing ability of the cochlea (37). 
Deflections in the stereocilia of the outer hair cells opens the mechanically gated 
transduction channels, however, the resulting change in the membrane potential creates a 
mechanical force that sends vibrations to increase the sensitivity of the cochlea (37). 
Interestingly, each type two auditory SAG neuron make synapses with multiple outer 
hair cells.  Very little is known about the in vivo responses of type 2 auditory neurons to 
sound stimuli, however, some of the proposed mechanisms describe them a role in the 
integration of sensory signals and pain perception (38, 39).  It is currently unknown if 
SAG neurons has similar functional diversity in other vertebrates. 
It is important to note that sound waves, based on their frequency, reach their 
maximum amplitude at different locations along the longitudinal axis of the cochlea. 
Thus, different frequencies of sound are analyzed by different locations in the cochlea, 
such as, high frequency sounds are encoded in the base and low frequency sounds are 
detected at the apex of cochlea (40). A similar tonotopic map also exists in the fish 
auditory chamber saccule, for instance, high frequency stimulus is encoded by the 
anterior region and low frequency stimulus is detected by the posterior area (41). Each 
SAG neuron innervates one hair cell, hence transmits information related to a very 
narrow range of sound frequency. SAG neurons are shown to display an extensive 
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heterogeneity in firing patterns and respond to a different range of intensity thresholds. 
Thus, innervation of the hair cells by 10-30 SAG neurons, each subtly differ from 
another, enables a hair cell to encode a variety of sound intensities regardless of the 
frequency (42, 43).  The number of synapses on the hair cells also varies by the 
tonotopical location in the cochlea; the hair cells are innervated by 10 SAG neurons in 
the apex of the cochlea whereas in the 15-30 synapses are present in the mid cochlear 
regions. Synaptic density correlates with greater hearing acuity, as increased synaptic 
density shown to correspond to frequencies of increased behavioral sensitivity (44).  
Many morphological, anatomical and physical properties of auditory SAG 
neurons show heterogeneity and display a different response phenotype based on the 
tonotopic position (45). For example, SAG neurons are arranged along the longitudinal 
axis of the cochlea such that the size of the soma increases from the apex through mid-
base and then increases extremely towards the basal end of the cochlea (46).  Hence, 
SAG neurons likely have somatic specializations towards transmission of high, mid or 
low sound frequencies. Furthermore, electrophysiological properties of SAG neurons, 
such as resting membrane potential, action potential latency and duration also show 
extensive heterogeneity and display a frequency-based tonotopical distribution (47). 
SAG neurons are also graded according to their responsiveness to the intensity of the 
sound such that the neurons that are capable of responding to the lowest detectable 
intensity of the sound are located in the apex while those that require a much higher 
stimulus to produce a response are located towards the basal end of the cochlea (47). 
Moreover, the properties that show a clear tonotopic distribution from the apex to the 
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base of the cochlea also present a marked variation locally, within each of these regions 
(47).   These pronounced differences in excitability and neural firing patterns of SAG 
neurons are partially accounted by the variation in the abundance and diversity of the 
potassium and calcium channels present in each SAG auditory neuron. Differential 
expression of electrophysiologically relevant proteins such as synaptic vesicle-associated 
proteins, neurofilament proteins and calcium ion binding proteins also contribute to the 
heterogeneity of SAG neurons (47). 
  Many of the distinct characteristics of the auditory SAG neurons are partially 
regulated and maintained by the neutrophic factors BDNF and NT3. Both factors are 
expressed in the sensory epithelium and important for the survival and synaptic strength 
of SAG neurons (48-50). Furthermore, BDNF and NT3 regulate expression of the ion 
channels and synaptic proteins that are known to affect response kinetics of SAG 
neurons (51). Interestingly, BDNF and NT3 act in opposition such that BDNF 
overexpression enhances basal SAG characteristics and expression profiles whereas 
overexpression of NT3 introduces apical SAG neuron properties (50).  Accordingly, 
BDNF is strongly expressed in the basal sensory epithelium and neurons whereas NT3 is 
highly concentrated in apical hair cells and neurons (50). However, these factors are 
unlikely to be the sole regulators of variation among SAG population. Yet, very little is 
known about the other regulators   of SAG development and maintenance.   
Vestibular system of the inner ear transmits information to the brainstem and 
cerebellum and drive powerful reflexes that control gaze, direction and balance.  Hair 
cells in the semicircular canals detect rotational acceleration and hair cells in the otolith 
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organ utricle are responsible for detecting linear acceleration and give information 
related to head position. Saccular macula detects auditory information in fish, however, 
in mammals and birds it serves as a vestibular endorgan.  Vestibular neurons display a 
resting discharge, possibly to allow detection of bidirectional information towards 
increasing or decreasing stimulus.  Very little is known about the mechanisms that 
regulate functional segregation and differential targeting of auditory versus vestibular 
neurons. Nevertheless, similar to the auditory SAG neurons, vestibular neurons also 
display heterogeneity in morphology and response dynamics (52, 53). Some vestibular 
neurons have regularly spaced action potentials with high rates and more precision 
whereas other vestibular neurons show huge variation in firing rates and display 
irregularly spaced action potentials (52). Irregular vestibular neurons are more sensitive 
and have been shown adapt easier to the changing stimulus whereas regular neurons 
detect a better range of thresholds and temporal information.  These two populations are 
shown to differ in their location in the sensory epithelium, synaptic endings, size and 
axonal diameter and presence of structural or calcium binding proteins (52). How these 
two different types of vestibular neurons generated during development are is largely 
unknown.    
 
DEVELOPMENT OF SAG NEURONS 
In all vertebrates, SAG neurons originate from the otic epithelium.  A long 
history of studies explored the possibility of the neural crest or neural tube origin of 
SAG neurons. However, recent experiments using Cre-recombinase to activate 
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expression of fluorescent proteins under the control of ear specific markers such as pax2, 
pax8 and foxg1 ruled out these possibilities by showing most, if not all, SAG neurons 
derive from the otic floor (54-56).  Furthermore, similar fate mapping studies using 
neural epithelium markers such as wnt1 and pax3 did not reveal any neural crest 
contribution to the SAG neurons (57). However, neural crest cells do give rise to the 
Schwann cells that are important for the myelination of the inner ear neurons. Neural 
crest derived glial cells also likely to play a role in growth and guidance of the central 
projections of SAG (58). Studies in chick show that axonal processes of SAG neurons 
follow the corridor of the migratory neural crest cells in perfect concordance (58). 
Furthermore, removal of hindbrain rhombomere 4 from chick embryos eliminates the 
migratory neural crest from this region and severely disrupts central and peripheral 
outgrowth of SAG projections (59). However, these experiments need to be confirmed 
by genetic ablation of the neural crest since the observed phenotypes could also stem 
from the lack of signals from the removed hindbrain segment. 
In birds and mammals neurogenesis precedes the development of the hair cells 
and the sensory epithelium, however, in zebrafish both tissues are produced concurrently 
in adjacent regions.  Mouse and chick are estimated to have 8000-9000 SAG neurons in 
adulthood and humans are estimated to have 30.000 SAG neurons. However, there are 
only a few hundred of SAG neurons in fish species. The discrepancy for the low number 
of SAG neurons is very poorly understood. SAG neuroblasts mainly originate from the 
anteroventral part of the otic vesicle and marked by expression of the basic helix-loop-
helix (bHLH) transcription factor neurogenin1 (ngn1).  All cranial neurons fail to form 
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in ngn1 mutants (60, 61) and overexpression of ngn1 leads to formation of ectopic 
cranial neurons (62, 63). Specified neuroblasts subsequently undergo epithelial-
mesencyhmal transition and leave the otic epithelium by a process called delamination.  
Soon after delamination, neuroblasts turn off ngn1 and upregulate a related proneural 
bHLH factor called neurod (64, 65).  Neurod expressing neuroblasts migrate towards the 
hindbrain as they proliferate, and upon reaching their final destination differentiate into 
mature neurons (66). Mature SAG neurons are marked by the expression of neuronal 
markers, such as Islet-1(Isl1) or Islet-2b (Isl2b) (67, 68). 
 
PATTERNING OF THE NEUROGENIC OTIC DOMAIN 
Neuroblasts originate from mostly the anteroventral quadrant of the otic vesicle. 
This part of the otic vesicle is shown to produce SAG neurons when dissected and 
isolated in culture. However, anteroposterior patterning of the otic vesicle is initially 
determined by environmental signals that originate from the tissues surrounding the ear. 
In chick, removal of the otic vesicle from a donor embryo at the otic cup stage and 
transplanting into a host embryo with a reverse anterior-posterior (AP) orientation leads 
to formation of an otic vesicle with the axial plan of the host (69). However, a similar 
manipulation at later stages causes a reverse AP orientation in transplanted otic vesicles 
(70). This result indicates that the factors that determine the AP polarity of the otic 
vesicle are not intrinsic at early stages but the axis becomes fixed at later stages.  
Further studies show that, underlying mesoderm and ectodermal tissues express 
retinoic acid (RA) which confers posterior identity in the otic vesicle (71).  
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Administration of high levels of RA expands the expression of posterior marker tbx1 in 
the expense of the neurogenic tissue (71). Similarly, inhibition of the RA signaling in the 
posterior half of the otic vesicle expands expression of the neurogenic markers to the 
posterior region (71).  However, complete inhibition of RA signaling is also detrimental 
to expression of ngn1 (71). It is likely that RA signaling is graded along the AP axis of 
the otic vesicle where a low level is required for the patterning of the neural region, 
whereas, high levels are inhibitory to the neurogenesis. 
Fgf signaling is important for many aspects of otic development. In zebrafish, 
fgf3 and fgf8 are expressed in the hindbrain and act redundantly to establish the otic 
placode and loss of both factors impairs otic development (72).  Fgf signaling is also 
crucial for AP patterning during otic vesicle development. In zebrafish valentine (val) 
mutants, fgf3 expression which is normally restricted to the hindbrain rhombomere 4, 
expands into the rhombomeres 5 and 6 and results in expansion of the anterior otic 
vesicle markers(73).Furthermore, conditional inhibition of Fgf signaling during otic 
development using pharmacological inhibitors leads to loss of anterior otic vesicle 
characteristics, indicating that Fgf signaling is necessary for the formation of anterior 
otic fates (74). Fgf signaling has been shown to have neural-inducing potential in many 
tissues. Loss of Fgf3 and Fgf8 function has also been shown to impair neurogenesis of 
SAG neurons in zebrafish (75).Correspondingly, pharmacological  inhibition of Fgf 
signaling also impairs SAG neuroblast formation and overexpression of fgf3 expands 
anterior otic markers and leads to formation of additional neurod positive SAG 
neuroblasts in zebrafish embryos (74). In chick, electroporation of an fgf8 construct 
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expands neurod expression in a similar fashion (76). Moreover, overexpression of fgf10 
increases the neurogenic domain whereas inhibition of the Fgf signaling reduces neurod 
expression (77). Another Fgf ligand, fgf19 is also expressed in delaminating SAG 
neuroblasts in chick, albeit its function is unknown (78). In mouse, Fgf3 from the 
hindbrain and Fgf10 from the subjacent tissues underlying the otic vesicle regulate otic 
induction and patterning. Mouse fgf3 mutants display morphological defects in produce 
fewer SAG neurons (79). On the contrary, loss of fgf10 and fgf3 function is shown to 
induce ectopic and expanded neurod expression in the otic vesicle (80).  Similarly, 
mouse Kreisler mutants which display lower fgf3 and fgf10 expression levels due to a 
patterning defect in rhombomeres 4 and 5 show an expansion in neurogenic domain and 
produce neurod positive cells in ectopic locations (80). Thus, the role of Fgf signaling on 
otic neurogenesis remains unclear, partially resulting from the lack of detailed analysis 
on the varying levels and timing of Fgf signals.    
There are four Fgf receptors in vertebrates with many alternative splicing 
isoforms. Fgf receptors vary in their responsiveness due to their different affinities to the 
present Fgf ligands.  All Fgf receptors are expressed in the otic vesicle, although they 
display a complex spatial and temporal pattern (81).  Accordingly fgfr3 mutation in mice 
leads to hearing loss and fgfr2 mutation leads to severe morphological defects in ear 
development (82, 83).  The importance of the differential expression and levels of many 
Fgf ligands and their receptors during SAG neurogenesis also remains ambiguous. 
Moreover Fgf signaling is likely involved in many aspects of SAG development, 
including proliferation and differentiation. For example, Fgf2 has been shown to induce 
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migration and differentiation of otic neuroblasts (84). Furthermore, addition of Fgf10 
reduces proliferation of SAG neuroblasts whereas inhibition of Fgf signaling enhances 
this process.  Despite that, loss of function of other Fgf ligands, such as Fgf9, is shown 
to induce a contrasting proliferation phenotype in the inner ear. It is currently unknown 
why Fgf antagonizes neurogenesis in some contexts but induces neurogenesis in others.  
In zebrafish, the prosensory domain forms the support cells and hair cells of the 
sensory epithelia and the proneural domain that produces SAG neuroblasts develop 
concurrently, in adjacent regions.  Prosensory precursors are marked by the expression 
of the proneural gene atoh1a.  Development of the prosensory and proneural domain is 
temporally segregated in mouse and chick embryos, and common progenitors of the 
sensory and neural domains have been observed in these species (85, 86). Binary cell 
fate decisions and the pace of neurogenesis are partially regulated by Notch signaling in 
both progenitor pools. Initially described in Drosophila, Notch receptors interact with the 
Delta transmembrane ligands in the neighboring cells and induce lateral inhibition to 
promote acquisition of distinct cell fates within a progenitor pool. Proneural factors such 
as atoh1a, ngn1 and neurod induces the expression of the Delta ligands.  Binding of the 
Delta ligand induces the cleavage of the Notch intracellular fragment (ICD). Notch-ICD 
acts as a transcription factor and activates expression of the target genes within the 
nucleus. These target genes include basic helix-loop-helix proneural factors such as 
Hairy enhancer of split (Hes) and Hairy related (Her) genes known to act as 
transcriptional repressors of proneural genes including atoh1a and ngn1. As a result, 
activation of Notch pathway leads to repression of the neural fate in the receiving cell 
  
16 
 
which consequently adopts an alternate fate, for instance, to become a support cell 
versus a hair cell. Accordingly, inhibition of Notch signaling leads to excess production 
of both hair cells and SAG neurons in the zebrafish inner ear (87-89). However, the role 
of Notch signaling during SAG neurogenesis is very poorly described. Many Delta 
ligands and Notch receptors are expressed by the early otic neuroblasts, yet there is no 
secondary cell fate is described for the neurogenic pool. Possibly, neuroblasts that 
receive lateral inhibition remain in the otic epithelium and contribute to the non-
neurogenic parts of the otic vesicle. Alternatively, Notch signaling could have a role in 
regulation of the overall pace of otic neurogenesis.  
As mentioned earlier, prosensory and neural domains develop in adjacent regions 
in zebrafish.  Since ngn1 and atoh1a are required for SAG neuron and hair cell 
formation, it is suggested that these two transcription factors engage in mutually 
antagonistic interactions within the anterior otic vesicle domain to sharpen domain 
boundaries.  Accordingly, in mouse atoh1a mutants produce more neural precursors 
whereas loss of ngn1 function leads to excess number of hair cells precursors (86).  
However, induction of different proneural genes within these sensory domains is very 
poorly described. Expression of proper dose of Fgf signaling increases the number of 
hair cells, despite the effects of this regimen on SAG neurogenesis is very poorly 
described.  Many Fgf ligands are expressed in the developing macula, exposing the 
prosensory domain to a higher level of Fgf signaling. Possibly, requirements for Fgf 
signaling or other signaling molecules differ for the induction of ngn1 versus atoh1a.  
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During my doctoral studies, I aimed to recover novel genes that regulate 
development of SAG neurons and unreveal the genetic mechanisms and signaling 
pathways that modulate timing and size growth of SAG neurons. First we investigated 
the role of Fgf signaling pathway during specification and maturation of SAG 
neuroblasts (Chapter II). Next, we took candidate approaches to characterize the role of 
transcription factors Tfap2a and Gsc in SAG development (Chapter III & IV). I have 
also recovered a novel mutation through an ENU mutagenesis screen. Whole genome 
sequencing revealed the affected locus as the glycolytic enzyme Pgk1. Further analysis 
revealed a novel role for glycolysis during SAG development (Chapter V). Future work 
will focus on studying the remarkable interactions between these identified transcription 
factors and signaling pathways during SAG development (Chapter VI).     
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CHAPTER II 
 
 
 
 
A SPATIAL AND TEMPORAL GRADIENT OF FGF DIFFERENTIALLY 
REGULATES DISTINCT STAGES OF NEURAL DEVELOPMENT IN THE 
ZEBRAFISH INNER EAR
1
 
 
 
 
 
INTRODUCTION  
Neurons of the VIIIth cranial ganglion, or the statoacoustic ganglion (SAG), 
innervate sensory hair cells in the inner ear.  These bipolar neurons relay auditory and 
vestibular information to the hindbrain.  During development, SAG precursors 
(neuroblasts) originate in the floor of the otic vesicle during a relatively brief window of 
time.  Newly specified neuroblasts soon delaminate from the floor of the otic vesicle 
before continuing development outside the ear.  
Neuroblast specification requires the bHLH transcription factor neurogenin1 
(neurog1) (60, 61).  Expression of neurog1 is transient and is followed by strong 
upregulation of neurod, which encodes a related bHLH transcription factor required for 
completing neuronal differentiation (61, 90).  After delamination, neuroblasts migrate a 
short distance to become situated between the hindbrain and otic vesicle and undergo a 
                                                 
1Reprinted with permission from “A spatial and temporal gradient of Fgf differentially regulates distinct 
stages of neural development in the zebrafish inner ear.” by Vemaraju S., Kantarci H., Padanad M.S., & 
Riley B.B., 2012, PLoS genetics, 8, 11,:e1003068. Copyright [2012] by Vemataju et al. 
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transient phase of proliferation to expand the precursor population (66, 77, 91, 92).  This 
phase, termed transit-amplification, is characterized by co-expression of neurod and 
proliferation markers (93).  Neuroblasts eventually exit the cell cycle and differentiate 
into mature neurons. 
 Numerous studies suggest a role for Fgf in otic neurogenesis.  In chick, Fgf10 is 
expressed in the neurosensory domain of the otic placode and promotes neuroblast 
specification (77).  Elevating Fgf2 or Fgf8 increases the number of SAG neurons (84, 
94), though the mechanism of action in these cases has not been determined.  In mouse, 
Fgf3 is also expressed in the neurosensory domain, and SAG development is impaired in 
Fgf3 null mutants .  In zebrafish, fgf3 and fgf8 are prominently expressed in the 
developing utricular macula adjacent to the neurogenic domain (75, 95), and impairment 
of fgf8 causes a reduction in SAG markers (75, 96). Also in zebrafish, mutations that 
expand the domain of fgf3 expression in the hindbrain cause a corresponding expansion 
of anterior markers in the otic vesicle, including markers of the utricular macula and 
neurogenic domain (73, 97).  Unfortunately, interpretation of these mutant phenotypes in 
mouse and zebrafish is clouded because morphogenesis of the inner ear is significantly 
altered.  Additionally, previous studies have not been able to clearly distinguish effects 
of changing Fgf levels on different stages of SAG development. 
 Here we study the development of SAG and its regulation by Fgf by 
conditionally manipulating Fgf signaling levels.  We show that Fgf signaling 
differentially controls distinct stages of otic neurogenesis.  A moderate level of Fgf is 
necessary for the initial specification of neuroblasts in the floor of the otic vesicle, 
  
20 
 
whereas high levels of Fgf inhibit specification.  During later stages of SAG 
development, Fgf5 expressed by mature SAG neurons serves two roles.  First, upon 
accumulation of sufficient mature neurons the phase of specification is terminated.  
Second, ongoing Fgf signaling delays the differentiation of SAG precursor cells.  This 
ensures maintenance of progenitors and steady production of an appropriate number of 
mature neurons.  
 
MATERIALS AND METHODS 
 
Fish strains, misexpression and inhibitor treatment 
Wild-type zebrafish strains were derived from the AB line (Eugene OR).  The 
following transgenic lines were used in this study: Tg(hsp70:fgf8)
x17 
 (19), 
Tg(hsp70I:dnfgfr1-EGFP)
pd1
  (98) and Tg(-17.6isl2b:GFP)
zc7
 (99).  Embryos were 
maintained at 28
o
C, unless otherwise stated, and staged according to standard protocol 
(100).  Heat shock-inducible transgenes were activated by incubating embryos for 30 
minutes at elevated temperatures as indicated in the Results.  In some experiments, Fgf 
signaling was blocked by treating wild-type embryos in their chorions with SU5402 
(Tocris Bioscience) diluted from a 20mM stock in DMSO to a final concentration of 100 
µM SU5402.  PTU (1-phenyl 2-thiourea, 0.3mg/ml, Sigma) was added to fish water to 
prevent melanin formation.  
 
 
 
  
21 
 
Morpholino injection and RT-PCR 
To block fgf5 translation, we used fgf5tb-MO”  5’-
CATTCTTTCCAGAGAGCGCTAGGCC-3’.  To block splicing of fgf5 transcript, we 
used fgf5i1e2-MO: 5’ -GCTCCAGCACACCTAGATAGAGAAA- 3’.  Approximately 
5ng morpholino was injected per embryo at one-cell stage.  Both morpholinos gave 
identical phenotypes.  The efficacy of the splice blocker was assessed at 24 hpf by RT-
PCR with primers P1 (forward), 5’-TCGATGGAAGAGTCAACGGGAGC-3’ and P2 
(reverse) 5’-GCCTTCCCCTCTTGTTCATGGC-3’ (see Fig. 2.4 D, E).  Expression of 
ornithine decarboxylase (odc) was measured as a constitutive control.  Uninjected 
embryos from the same genetic background were used to measure control transcript 
levels.  
 
In situ hybridization 
Whole-mount in situ hybridization was carried out with methods described 
previously (72, 101).  A shorter riboprobe was synthesized for neurog1 using T7 RNA 
polymerase to avoid binding to shared vector sequences encoded by the Tg(-
17.6isl2b:GFP)
zc7
 transgene.  To improve signal and reduce background staining during 
in situ hybridization for fgf5, pre-hybridization and hybridization were performed at 
70
o
C for 12 hours and 24 hours, respectively.   
 
 
 
  
22 
 
Immunostaining  
Antibody staining was performed as described previously (102).  Primary 
antibodies were as follows: anti-Islet1/2 (Developmental Studies Hybridoma Bank 
39.4D5, 1:100 for whole-mount, 1:250 for cryosections) and anti-BrdU (Beckton-
Dickinson, 1:300).  Secondary antibodies were as follows: HRP-conjugated goat anti-
mouse IgG (Vector Labs PI-2000, 1:200) and Alexa 546 goat anti-mouse IgG 
(Invitrogen A-11003, 1: 250).  
 
Cryosectioning and BrdU labeling 
Fixed embryos were washed three times for 5 min each in 1x PBS and then 
soaked in 20% sucrose solution made in PBS followed by 30% sucrose until sinking to 
the bottom of a microcentrifuge tube.  Embryos were embedded in tissue freezing 
medium (Triangle Biomedical Sciences, TFM-C) and transverse sections were cut at 
10m thickness using a cryostat and immunostained.  Finally, slides were washed twice 
in 1x PBS and mounted in ProLong Gold (Invitrogen) with a coverslip.  For double 
labeling, whole-mount in situ hybridization was performed first followed by 
immunostaining on cryosections.  For BrdU labeling, dechorionated embryos were 
incubated in fish water containing 10mM BrdU in 1% DMSO for the indicated duration.  
Embryos were rinsed twice for 5 minutes each in fish water prior to fixation.  For older 
stages (96 hpf) 2nl of 10mM BrdU/1% DMSO solution with 3% filtered green food 
coloring was injected into the brain ventricle of larvae anesthetized in Tricaine (Sigma).  
Embryos were first processed by whole-mount in situ hybridization for neurod and then 
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cryosectioned.  Slides were washed thrice for 5 minutes each in PBT (with 0.1% Triton) 
and incubated in 2N HCl for 45 minutes at 37
o
C.  Slides were rinsed in PBT again, 
incubated in blocking solution (with 1% Triton for 36 hpf and 3% Triton for 102 hpf) for 
2 hours and stained for BrdU.  
 
Laser ablation 
Maturing SAG neurons were ablated using a MicroPoint laser, under 40x 
objective, in isl2b:GFP transgenic line that labels this population of cells.  Anesthetized 
embryos were mounted in a dorsolateral orientation beneath a #1 coverslip on a bridge 
slide made by stacking two #1 coverslips on either side of the embryo.  
 
RESULTS 
 
Development of the statoacoustic ganglion (SAG)  
The paradigm for otic neurogenesis, as formalized in several recent reviews (103, 
104), involves a sequential process of specification, delamination, proliferative 
expansion and differentiation of precursor cells to form the mature SAG.  The general 
features of this process appear to be conserved in zebrafish, shown schematically in Fig. 
2.1A.  In zebrafish, SAG neuroblasts are initially specified in the floor of the late 
placode/nascent vesicle as early as 16 hpf (14 somites) and express neurog1 (61, 105).  
Neuroblasts begin to delaminate and accumulate outside the otic vesicle by 17 hpf.  The 
reiterative process of specification and delamination peaks at 24 hpf, continues at a more 
moderate pace through 30 hpf (Fig. 2.1D), then declines sharply and stops entirely by 42 
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hpf  (14).  Expression of neurog1 is only transient.  As neuroblasts delaminate they lose 
expression of neurog1 and initiate expression of neurod (61, 106).  At this point SAG 
precursors enter a phase of transit-amplification, as shown by co-labeling with neurod 
expression and BrdU incorporation (Fig. 2.1E, F).  neurod
+
 cells continue to proliferate 
through at least 4 days post fertilization (dpf), the latest stage examined (Fig. 2.1F).  
Surprisingly, staining with anti-phospho histone H3 shows that there are typically only 
1-2 mitotic cells in the SAG at any time between 24 and 50 hpf (Fig. 2.1G, and data not 
shown), indicating that transit-amplifying cells cycle relatively slowly.  Summing 
neurod
+
 cells in serial sections revealed that the number of transit-amplifying cells 
remains relatively constant after 30 hpf, with a transient peak at 48 hpf followed by a 
return to steady state of 180-200 cells through 78 hpf (Fig. 2.1B).  As precursor cells 
begin to differentiate they exit the cell cycle and lose expression of neurod (Fig. 2.1E, F) 
and initiate expression of isl1/2 genes (Fig. 2.1H, I) (90).  The first mature Isl1
+
 neurons 
appear by 20 hpf and almost immediately begin to extend processes to peripheral and 
central targets (data not shown).  Co-staining for BrdU and Gfp in isl2b:Gfp transgenic 
embryos (99) confirms that relatively few mature neurons incorporate BrdU (Fig. 2.1H).  
The number of Isl1
+
 neurons increases linearly at a rate of 2-2.5 neurons per hour 
through at least 72 hpf, despite the cessation of specification and delamination at 42 hpf 
(Fig. 2.1C).  The steady increase in mature neurons after 42 hpf presumably reflects 
ongoing differentiation from the slowly cycling pool of transit-amplifying cells.  The 
slow mitotic rate amongst precursors presumably counterbalances production of new 
neurons, thereby maintaining a relatively stable transit-amplifying pool.To clarify the 
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spatial relationship between transit-amplifying and mature SAG cells, we examined 
sections co-stained for neurod and Isl1 (Fig. 2.1I-M).  The most mature neurons 
accumulate in immediate contact with the ventromedial surface of the ear, while neurod
+
 
cells undergoing transit-amplification reside more distally (Fig. 2.1L, M).  By 36 hpf the 
SAG also develops a more complex spatial distribution, forming three distinct regions 
along the anterior-posterior axis: The anterior-most region abuts the front end of the otic 
vesicle and contains only neurod
+
 precursors (Fig. 2.1K), although mature neurons 
accumulate in this region at later stages (see below).  The middle region forms a broad 
mass spreading mediolaterally beneath the utricular region and contains complementary 
domains of neurod
+
 cells and Isl1
+
 cells (Fig. 2.1L). The posterior-most region forms as 
a narrow finger of Islet
+
 cells and abutting neurod
+
 cells extending along the medial 
surface of the otic vesicle to the level of the saccular macula (Fig. 2.1M).  Segregation of 
neurons into these three AP domains reflects emergence of the topological pattern of 
innervation of the inner ear: Specifically, Sapède and Pujades (107) reported that 
anteroventral SAG neurons (corresponding to the anterior and middle regions reported 
here) predominantly innervate the utricular macula and to a lesser degree anterior and 
lateral cristae, whereas posterior-medial SAG neurons (corresponding to the posterior 
region reported here) predominantly innervate the saccular macula and to a lesser degree 
the posterior crista.  
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A general model of SAG regulation and manipulation of Fgf signaling 
The data presented in subsequent sections support a model in which changing 
levels of Fgf differentially affect SAG development:  Initially, moderate Fgf from nearby  
 
 
Figure 2.1.  Development of Statoacoustic Ganglion (SAG). (A) Illustration showing the various stages 
of SAG development. Neuronal precursors (neuroblasts) are specified (1) and delaminate from (2) the 
floor of the otic vesicle.  Neuroblasts undergo a phase of transit-amplification (3) wherein they migrate to 
a position between the otic vesicle and hindbrain as they continue to proliferate.  Neuroblasts finally 
differentiate into mature neurons (4).  (B) Total number of delaminated neurod
+
 cells within the SAG 
counted from serial sections at the indicated times (mean ± standard deviation, n=2 or greater for each 
time point).  (C) total number of Islet-1-positive SAG neurons at the indicated times (mean of total number 
± standard deviation, n=20 for each time point).  (D) neurog1 expression at 30 hpf.  (E, F) Co-staining for 
neurod (blue) and BrdU (red) in embryos exposed to BrdU for 6 hours starting at 26 hpf (E) and 96 hpf 
(F), and then fixed at 32 hpf and 102 hpf, respectively.  (G) Co-staining for isl2b:Gfp (green) and 
phospho-histone H3 (PH3, red) at 32 hpf.  Only one mitotic cell (arrow) is seen in the vicinity of the SAG.  
(H) Co-staining for Islet1 (green) and BrdU (red) at 36 hpf.  Only one double-stained cell is visible 
(arrow).  (I-M) Expression of neurod (blue) and Islet-1 (red) at 36 hpf.  Mature neurons are labeled with 
Islet-1 (I) and delaminated progenitor cells express neurod (J).  Positions of section-planes in K-M are 
indicated in (J). (K-L) Transverse sections passing through the anterior (K), middle (L) and posterior (M) 
regions of the SAG show mostly complementary patterns of neurod and Islet-1.  The outer edge of the otic 
vesicle is outlined in all panels.  SAG cells in stages 1-4 of development are indicated in sections, and the 
position of the utricular macula (u) is indicated.  Images of whole-mount specimens (G, I, J) show 
dorsolateral (G, I) and dorsal (J) views with anterior to the left.  Images of transverse sections (C-F, H, K-
M) show dorsal to the top and lateral to the left.  Scale bar, 25 µm.  
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cells promotes neuroblast specification in the otic vesicle.  Subsequently, Fgf levels rise 
in part because mature SAG neurons specifically express Fgf5 and accumulate just 
outside the otic vesicle (Fig. 2.2). 
Elevated Fgf then terminates further specification/delamination and also inhibits 
maturation of transit-amplifying precursors.  Manipulation of Fgf to test this model was 
achieved by specifically knocking down fgf5 (described below) and more generally by 
using two heat shock inducible transgenic lines, hs:fgf8 and hs:dnfgfr1 (dominant- 
   
 
Figure 2.2.  Mature SAG neurons express fgf5. 
(A-C) Wholemount embryos showing lateral views of fgf5 expression at 24 hpf (A) and 27 hpf (B) and a 
dorsal view at 30 hpf (C).  During these stages, fgf5 expression marks the trigeminal ganglion (tg), anterior 
lateral line ganglion (all) and SAG, and there is also weak diffuse expression in the developing hindbrain 
(hb).  There is no detectable staining in the otic vesicle (ov).  (D-F) Transverse sections (dorsal to the top 
and lateral to the left) of specimens co-stained for fgf5 (blue) and Islet-1 (red) at 24 hpf (D), 30 hpf (E) and 
48 hpf (F).  Sections pass through the middle portion of the SAG at the level of the utricular macula (u).  
The inner and outer surfaces of the otic vesicle are outlined.  Co-labeling confirms that fgf5 expression in 
the SAG is restricted to mature neurons.  Scale bar, 25 µm.  During mid-somitogenesis stages fgf5 is 
diffusely expressed throughout the neural tube and strongly marks the developing trigeminal ganglion (not 
shown).  
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negative Fgf receptor), to increase or decrease Fgf signaling, respectively (19, 98).  
 To document the efficacy of these transgenic lines, we examined expression of the Fgf-
feedback gene etv5b (previously erm) (108, 109) following activation of the transgenes.  
Strong activation of hs:fgf8 by heat shocking embryos at 24 hpf (30 minutes at 39°C) led 
to a detectable increase in etv5b levels by the end of the heat shock period (not shown), 
with maximal etv5b seen throughout the embryo by 26 hpf (Fig. 2.3B, E).  etv5b levels 
remained elevated through 30 hpf (Fig. 2.3H) and subsequently returned to normal.  In 
contrast, strong activation of hs:dnfgfr1 at 24 hpf (30 minutes at 38°C) led to marked 
reduction of etv5b expression throughout the embryo by 25 hpf (not shown), and 
complete loss by 26 hpf (Fig. 2.3C, F).  Expression first began to return by 36 hpf, 
though levels were still well below normal at that time (Fig. 2.3I).  These transgenes 
were subsequently used to assess the effects of changing Fgf signaling levels at different 
stages of SAG development. 
 
Fgf regulates SAG specification in a dose-dependent manner 
Several Fgfs expressed in tissues near the developing SAG have been implicated 
in establishing a neurogenic domain in the ear (79).  In zebrafish, fgf3 is expressed in the 
adjacent hindbrain through placodal stages and later helps initiate expression of fgf3 and 
fgf8 in the nascent utricular macula by 18 hpf (73).  We have hypothesized that sensory-
neural patterning is spatially coordinated by a lateral gradient of Fgf, with high levels 
initiating sensory development in the medial half of the otic placode – e.g. closest to the 
Fgf source (95), and lower levels specifying the neurogenic domain in laterally adjacent 
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otic epithelium.  We previously documented a stringent requirement for Fgf in sensory 
development (95) and here we focused on the requirement for Fgf in neurogenic 
specification.  To bypass the early requirements of Fgf during otic induction we used the 
chemical inhibitor, SU5402, to block Fgf signaling at later stages of otic development.   
 
 
Figure 2.3. Effects of transgene activation on expression of the Fgf reporter etv5b.  
All embryos were heat shocked for 30 minutes beginning at 24 hpf.   Wild-type and hs:fgf8 embryos were 
heat shocked at 39°C and hs:dnfgfr1 embryos were heat shocked at 38°C.(A-C) Cross sections showing 
etv5b expression in wild-type (A) , hs:fgf (B) and hs:dnfgfr1 (C) embryos at 26 hpf.  (D-I) Dorsal views 
(anterior up) of wholemounts showing etv5b expression in wild-type (D, G), hs:fgf8 (E, H) and hs:dnfgfr1 
(F, I) embryos at the indicated times.  The otic vesicle (ov) is marked.  Expression of etv5b remains 
elevated in hs:fgf8 embryos for at least 6 hours after heat shock, whereas etv5b expression is 
downregulated in hs:dnfgfr1 for at least 12 hours after heat shock.  Scale bar, 25 µm. 
 
Embryos treated with 100M SU5402 from 14 hpf -18 hpf showed a strong reduction in 
neurog1 expression (Fig. 2.4A, B).  Likewise, impairment of Fgf signaling by strongly 
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activating hs:dnfgfr1 (98) (38
o
C for 30 minutes) showed similar results (Fig. 2.4C).  
Blocking Fgf from this early stage caused widespread cell death at later stages, 
precluding analysis of SAG maturation.  Nevertheless, these data confirm that normal 
specification of the neurogenic domain requires Fgf signaling.  To test the hypothesis 
that SAG neuroblasts are specified by a specific lower level of Fgf in a signaling 
gradient, we manipulated Fgf levels using hs:fgf8 (98).  The level of hs:fgf8 activity can 
be adjusted by heat shocking at different temperatures (110).  To provide a broad shelf 
of low Fgf signaling, embryos were incubated at 35
o
C from 18 hpf to 24 hpf.  This 
caused a marked upregulation and expansion of neurog1 expression (Fig. 2.4D, E).  
Additionally, there was a notable increase in the number of delaminating neuroblasts as 
seen by hmx3 expressing cells leaving the vesicle (Fig. 2.4F, G).  By 42 hpf, the number 
of Isl1
+
 cells in the mature SAG had increased by 37% over the control (Fig. 2.4H, 63 ± 
6.0 Isl1
+
 cells in control embryos compared to 86 ± 3.6 in hs:fgf8 transgenic embryos, 
n=15).  To evaluate the effects of a higher level of Fgf, hs:fgf8 embryos were maximally 
induced by heat shocking them at 39
o
C for 30 minutes beginning at 18 hpf.  Under these 
conditions, neurog1 expression was reduced for several hours following heat shock but 
recovered to near normal by 24 hpf  (data not shown).  However, the number of mature 
Isl1
+
 neurons at 42 hpf was reduced by 20% (51 ± 4.2 Isl1
+
 cells, n=15; Fig. 2.4H).  As 
summarized in Table 1, these data support the idea that Fgf acts in a concentration-
specific manner, with lower levels promoting neuroblast specification and higher levels 
inhibiting specification.  
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Because the rate of neuroblast specification and delamination peaks at 24 hpf, we 
examined the effects of Fgf misexpression during this stage.  As before, maximal 
activation of hs:fgf8 (39°C) at 24 hpf reduced expression of neurog1 in the ear by 30 hpf 
(Fig. 2.4I, J).  However, in contrast to earlier stages, low level activation of hs:fgf8 
(35°C) at 24 hpf reduced neurog1 expression by 30 hpf (data not shown).  Fully 
blocking Fgf by strong activation of hs:dnfgfr1 (38°C) at 24 hpf also diminished 
neurog1 expression by 30 hpf (data not shown), in keeping with the requirement for Fgf 
in neuroblast specification.  However, weak attenuation of Fgf signaling by activating 
hs:dnfgfr1 at a low level (35
o
C for 2 hours followed by incubation at 33
o
C) expanded the 
neurog1 expression domain at 30 hpf (Fig. 2.4K).  Overall these data (summarized in 
Table 1) support the hypothesis that a specific low-to-moderate level of Fgf promotes 
neuroblast specification at both early and later stages, and either a high level of Fgf 
signaling or complete blockage of Fgf signaling impairs this process.  At later stages, 
however, the process of specification becomes increasingly sensitive to inhibition by 
elevated Fgf.  This likely reflects the finding that the level of Fgf increases during 
development, as described in the next section. 
 
fgf5 from mature neurons inhibits neuroblast specification 
Because SAG specification becomes increasingly sensitive to inhibition by 
elevated Fgf, we hypothesized that the process of neuroblast specification is normally 
terminated by a developmental increase in local Fgf signaling.  To explore this 
possibility, we surveyed expression of all known fgf genes in zebrafish and identified  
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Figure 2.4.  Fgf regulates neuroblast specification. The icon at the top of the figure indicates that 
analysis focuses on initial stages of neuroblast formation, as normally marked by neurog1 expression.  
Experimental manipulations in groups I, II and III are briefly summarized at the tops of the corresponding 
data panels.  (A-C) Experiment I, neurog1 expression at 18 hpf in a control (A), SU5402 inhibitor treated 
(B) and hs:dnfgfr1/+ transgenic embryo heat shocked for 30 minutes at 38°C beginning at 14 hpf.  
Blocking Fgf strongly reduces expression of neurog1.  (D-G) Experiment II, expression of neurog1 (D-E) 
and hmx3 (F-G) in control and hs:fgf8/+ embryos heat shocked at 35
o
C for 6 hours, from 18 hpf until 24 
hpf.  This regimen results in weak overexpression of Fgf8, which at this stage enhances expression of 
neurog1.  (H) Experiment II, total number of Islet1-positive cells in the SAG (mean and standard 
deviation, n=15) at 42 hpf following heat shock activation of hs:fgf8 at 18 hpf at indicated temperatures.  
Weak misexpression of Fgf8 (35°C) increases production of SAG neurons whereas strong misexpression 
of Fgf8 (39°C) reduces production of SAG neurons.  *p < 0.001 in comparison to the control, analyzed 
with Student’s t test.  (I-K) Group III, neurog1 expression at 30 hpf following heat shock at 24 hpf in 
control embryos (I), hs:fgf8/+ embryos heat shocked at 39
o
C for 30 minutes to strongly over-express Fgf 
(J) and hs:dnfgfr1/+ embryos heat shocked for 2 hours at 35
o
C and then shifted to 33
o
C to maintain low 
level inhibition of Fgf signaling (K).  At this stage, weak impairment of Fgf enhances neurog1 expression, 
consistent with the idea that Fgf levels normally increase during development and become inhibitory for 
neuroblast specification.  All images show dorsolateral views with anterior to the left, and the otic vesicle 
is outlined. 
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fgf5 as a strong candidate for a feedback regulator of SAG development.  During mid-
somitogenesis stages fgf5 is diffusely expressed throughout the neural tube and strongly 
marks the developing trigeminal ganglion (not shown).  As mentioned above, fgf5 shows 
relatively specific expression in mature SAG neurons, and several other cranial ganglia, 
by 24 hpf and this pattern is maintained through at least 48 hpf (Fig. 2.2).  No expression 
is detected in the otic vesicle or other nearby tissues.  We tested the role of Fgf5 by 
injecting morpholino oligomers to block translation (fgf5tb-MO) or to disrupt splicing at 
the intron1-exon2 splice junction (fgf5i1e2-MO).  Injection of either MO yielded 
identical phenotypes: Morphants showed highly specific and fully penetrant 
enhancement of SAG specification and maturation, as described below, but otherwise 
there were no other detectable changes in embryo morphology nor was there a detectable 
increase in cell death.  For most experiments reported here, we show results obtained 
with fgf5i1e2-MO, which proved to be highly effective in reducing mature fgf5 transcript 
levels (Fig. 2.5A, B).  
 
 
Figure 2.5.  Efficacy of fgf5 splice-blocking MO. 
 (A) Schematic of fgf5 mRNA showing intron-exon structure (not to scale).  Binding sites for splice-
blocking morpholino at intron1-exon2 junction (I1E2-MO) and PCR primers for RT-PCR (forward P1, 
reverse P2) are shown.  (B) RT-PCR results showing the efficacy of I1E2-MO.  fgf5 transcript levels are 
severely reduced in fgf5 morphants at 24 hpf.  odc transcript level was used as a constitutive control.  
 
To address the role of fgf5 in neuroblast specification we examined neurog1 
expression at various stages in fgf5 morphants.  At 24 hpf no obvious difference was 
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observed between fgf5 morphants and control embryos (not shown).  By 30 hpf, 
however, neurog1 expression was dramatically expanded in fgf5 morphants (Fig. 2.6A, 
B, E, F), including a pronounced mediolateral expansion of neurog1 in the floor of the 
otic vesicle (Fig. 2.6B, F).  Normally, neuroblast specification declines dramatically 
after 30 hpf [1,20] (Fig. 2.6C).  However, fgf5 morphants continued to show abundant 
neurog1-positive cells at 36 hpf, indicating a prolonged phase of robust specification and 
delamination (Fig. 2.6G).  Neuroblast specification/delamination finally ceased by 48 
hpf in fgf5 morphants (not shown).  Knockdown of fgf5 appeared to affect SAG 
development in a highly specific manner, as other regional markers in the otic vesicle 
were expressed normally and development of sensory hair cells was also normal at 32 
hpf (Fig. 2.7).  Additionally, the fgf5 morphant phenotype was rescued by strong 
activation of hs:fgf8 (39°C) at 24 hpf such that neuroblast specification returned to 
normal (Fig. 2.6D, H).  Such rescue supports the idea that neuroblast specification relies 
on a proper balance of Fgf signaling, with the morpholino and transgene counter-
balancing each other.  Overall, these data (summarized in Table 1) support the 
hypothesis that mature SAG cells become a source of elevated Fgf, which eventually 
exceeds a signaling threshold that serves to terminate neuroblast specification in a timely 
manner.   
To test this model in another way, mature neurons marked by isl2b:gfp transgene 
expression (99) were killed by serial laser-ablation at 22 hpf and 25 hpf (Fig. 2.6I, J) and 
neurog1 expression was examined at 30 hpf.  Expression of neurog1 was expanded on 
the ablated side relative to the unablated (contralateral) side (Fig. 2.6K, L, Table 1).  
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Together, these data support the notion that as mature neurons expressing fgf5 
accumulate within the SAG, overall levels of Fgf signaling increase and as a result 
neuroblast specification is terminated.  This also explains the increased susceptibility to 
misexpression of Fgf8 after 24 hpf, as described above.    
 
Fgf regulates the balance between transit-amplification and differentiation 
We next examined the effects of Fgf on post-delamination stages of SAG 
development.  In these experiments heat shock transgenes were activated at high levels 
(38-39°C) at 24 
 
Table 2.1. Effects of altering Fgf on neuroblast specification. 
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hpf and the effects on neurod
+
 (transit-amplifying) and Isl1
+
 (mature) populations were 
examined at 36 hpf and 48 hpf.  Summing neurod
+
 cells in serial sections of control 
embryos indicated that there are approximately 200-250 transit-amplifying cells in the  
 
 
Figure 2.6.  fgf5 from mature neurons terminates the phase of neuroblast specification. 
The icon at the top of the figure indicates that analysis focuses on initial formation of neuroblasts.  
Experimental manipulations in groups IV and V are briefly summarized at the tops of the corresponding 
data panels.  (A-H) Expression of neurog1 in control embryos (A-C), a hs:fgf8 embryo (D),  fgf5 
morphants (E-G), and a hs:fgf8 embryo injected with fgf5-MO (H) at the indicated stages.  Transgenic 
embryos (D, H) were heat shocked for 30 minutes at 39°C beginning at 24 hpf.  Vertical lines in (A, C-E, 
G, H) indicate the plane of transverse sections in (B, F, and insets in C, D, G and H).  (I-L) Expression of 
isl2b:Gfp at 22 hpf (I, J) and neurog1 at 30 hpf (K, L) in a specimen in which mature (fgf5-expressing) 
neurons were laser-ablated.  The same specimen is shown in all panels.  Mature SAG neurons expressing 
isl2b:Gfp were serially ablated on the left side at 22 hpf (J) and 25 hpf (not shown), and the embryo was 
fixed and sectioned at 30 hpf to examine neurog1 expression (L).  Images of the unablated right side (I, K) 
were inverted to facilitate comparison.  The surface of the otic vesicle is outlined in all panels.  Arrows in 
sections indicate the edges of neurog1 domain in the otic floor.  Note that the amount and duration of 
delamination of neurog1
+
 neuroblasts is strongly enhanced by knockdown of fgf5 (F, G) or ablation of 
mature neurons (L).  Activation of hs:fgf8 reverses the effects of fgf5-MO (H).  Scale bar, 25 µm.  
Transverse sections are shown with lateral to the left and dorsal up.  Wholemount images show 
dorsolateral views with anterior to the left.   
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Figure 2.7.  Normal axial patterning in fgf5 morphants. (A-H) Expression of regional patterning 
markers in control embryos (A-D) and fgf5 morphants (E-H).  Expression of pax5 (A, E) and pou3f3b (B, 
F) labels anterior and posterior regions,  respectively.  Expression of otx1a (C, G) and dlx3b (D, H) labels 
ventromedial and dorsolateral regions, respectively.  The otic vesicle is outlined.  Images show 
dorsolateral views with anterior to the left.  (I) The total number of hair cells in the utricular (ut) and 
saccular (sac) maculae of control embryos and fgf5 morphants at 32 hpf.  Data were obtained by counting 
GFP-positive hair cells (mean of total number ± standard deviation) in the sensory epithelia of brn3c:Gfp 
transgenic embryos.  Data show means and standard deviations from 20 specimens each.  Differences 
between control and experimental specimens were not statistically significant (p=0.16 for the utricle, 
p=0.67 for the saccule) based on Student’s t tests. 
 
SAG at these stages (Fig. 2.1B).  Because this approach proved laborious and was prone 
to occasional loss of tissue sections, changes in the neurod domain were assessed by 
measuring mean cross-sectional areas in the three AP regions of the SAG in transgenic 
and control embryos.  Strong activation of hs:fgf8 at 24 hpf (39°C for 30 minutes) 
increased the neurod
+
 precursor domain by 31% in the largest, middle region of the SAG 
at 36 hpf (Fig. 2.8A, B, I).  A similar trend was observed in the anterior region, although 
the difference was not statistically significant (Fig. 2.8I).  Under these conditions, the 
smallest, posterior part of the SAG was truncated in hs:fgf8 embryos and therefore 
wasnearly devoid of neurod
+
 cells in most specimens (Fig. 2.8I).  This is possibly 
because the posterior SAG forms later and elevated Fgf prematurely terminates 
specification of neuroblasts that might otherwise contribute to this region.  Despite, the 
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increased population of transit-amplifying cells in the middle region, the total number of 
Isl1
+
 neurons in the SAG was reduced in hs:fgf8 embryos by 30% at 36 hpf (Fig. 2.8E, 
F, J) and the hourly rate of neuron production between 24 hpf and 36 hpf was reduced by 
half (Fig. 2.8K).  For loss of function studies, hs:dnfgfr1 was activated at 24 hpf (38
°
C 
for 30 minutes) to impose a strong block to Fgf signaling.  This resulted in a decrease of 
26% in the neurod
+
 domain in the middle region at 36 hpf, and a decrease of 50% in the 
posterior region (Fig. 2.8C, I).  Again, the anterior region showed a similar but non-
significant trend.  Under the same conditions, there was a 30% increase in the total 
number of mature Isl1
+
 SAG neurons (Fig. 2.8G, J).  The relative effects of hs:fgf8 and 
hs:dnfgfr1 on the transit-amplifying population persisted through at least 48 hpf (Fig. 
2.8L).  Differences in the total number of mature neurons also persisted at 48 hpf (Fig. 
2.8M).  However, most of the differences seen at 48 hpf appeared to reflect changes 
occurring before 36 hpf because the rate of production of new Isl1
+
 neurons after 36 hpf 
was nearly normal in hs:fgf8 and hs:dnfgfr1 embryos (compare Fig. 2.8K, N).  This 
presumably reflects the transient nature of transgene activity and gradual reestablishment 
of normal SAG regulation.  Note that under the conditions used here, we detected little 
or no cell death in the transit-amplifying or mature regions of the SAG as shown by 
staining with Acridine Orange or anti-Caspase 3 antibody (not shown).  Likewise, we 
detected no changes in the number of mitotic cells in the SAG, nor in the proportion of 
cells incorporating BrdU (data not shown), indicating that Fgf does not directly affect 
cell cycle dynamics.  Instead, the data (summarized in Table 2.2) suggest that Fgf slows  
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Figure 2.8.  Fgf regulates the balance between transit-amplification and differentiation.The icon at 
the top of the figure indicates that neuronal maturation (neurod
+
 transit-amplifying cells and Isl1
+
 mature 
neurons) is the focus of analysis.  Manipulations in these experiments (Neuronal maturation group I) are 
briefly summarized at the top.  Embryos were heat shocked for 30 minutes at 39°C (wild-type controls, 
hs:fgf8/+ embryos, and fgf5-morphants) or 38°C (hs:dnfgfr1/+ embryos) beginning at 24 hpf.  (A-H) 
Transverse sections (lateral to the left, dorsal up) showing neurod expression (A-D) or Isl1 staining (E-H) 
at 36 hpf in control embryo (A, E), hs:fgf8/+ embryos (B, F), hs:dnfgfr1/+ embryos (C, G) and fgf5 
morphants (D, H).  All sections shown pass through the middle  region of the SAG at the level of the 
utricular macula (u).  The otic vesicle is outlined.  Scale bar, 25 µm.  (I-N) Quantitation of transit-
amplifying and mature neuronal populations at 36 hpf (I-K) and at 48 hpf (L-N).  Panel I shows a color 
key to facilitate comparison between treatments: White bars, control; gray bars, hs:fgf8; black bars, 
hs:dnfgfr1; brown bars, fgf5 morphants; red bars, activation of hs:fgf8 in fgf5 morphants.  Analysis of 
transverse sections was used to measure the mean area of neurod
+
 precursor cells (I, L) in the anterior, 
middle and posterior regions of SAG.  The total number of Isl1+ neurons (J, M) and the mean hourly rate 
of neuron production from 24 hpf to 36 hpf (K) and from 36 to 48 hpf (N) was measured by counting 
neurons in stained wholemount specimens.  Error bars in I, J, L, M indicate standard deviations (n=3 or 
greater for sectional areas; n=15 for Isl1
+
 cell counts).  *p < 0.05 in comparison to control, analyzed with 
Student’s t test.  Error bars in K, N indicate standard errors. 
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the rate at which transit amplifying cells differentiate into mature SAG neurons, whereas 
blocking Fgf accelerates differentiation.  
We next assessed the role of Fgf5 in restraining maturation of precursor cells.  In 
fgf5 morphants, the size of neurod
+
 domain was increased in both the middle and 
posterior regions of SAG in the embryos at 36 and 48 hpf (Fig. 2.8D, I, L).  Note that the 
increase in the transit-amplifying region seen in fgf5 morphants was different from what 
was observed following activation of hs:dnfgfr1.  This is presumably because the 
prolonged phase of robust specification seen in fgf5 morphants (Fig. 2.6G, H) continues 
to replenish the transit-amplifying population.  Additionally, fgf5 morphants also 
produced more Isl1
+ 
neurons than normal (Fig. 2.8H, J, K, M, N).  However, despite the 
enlargedpool of precursors fgf5 morphants did not produce more mature neurons than 
did hs:dnfgfr1 embryos (Fig. 2.8J, M).  This is possibly because redundant factors 
(possibly macular Fgfs) continue to restrain the enlarged pool of progenitors in fgf5 
morphants.  Finally, we observed that strong activation of hs:fgf8 (39°C) at 24 hpf in 
fgf5-morphants restored neuron production to normal (Fig. 2.8J, K, M, N).  Thus, as 
during neuroblast specification, the rate of neuronal maturation is also regulated by a 
proper balance of Fgf signaling.  Moreover, these data (summarized in Table 2.2) 
support a role for Fgf5 as a feedback inhibitor released by mature SAG neurons to 
restrict the rate of neuronal differentiation. 
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Table 2.2. Effects of altering Fgf on SAG maturation. 
* rate of  mature neuron production during the indicated interval. 
 
Neuronal maturation following ablation of mature SAG neurons  
To further explore regulation of SAG maturation, we assessed whether laser-
ablation of mature SAG neurons affects the rate of new neuron production.  This 
analysis was conducted after 30 hpf to minimize the impact of neuroblast specification 
on overall cell number.  Using the isl2b:Gfp line, mature SAG neurons on one side of 
the head were targeted for serial ablation at 30 hpf and 32 hpf, with the contralateral side 
serving as a non-ablated control.  We observed that a single round of ablation was 
inefficient, allowing a substantial fraction of neurons to survive.  However, serial 
ablation successfully eliminated over 90% of mature neurons, as confirmed by anti-Isl1 
staining just after the second ablation (not shown).   Analysis of the transit-amplifying 
population revealed that the number of neurod
+
 cells declined by 10-20% on the ablated 
side during the first 12 hours following neuronal ablation, probably reflecting collateral 
damage, but the number returned to normal by 56 hpf (24 hours post-ablation) (data not 
shown).  Despite the initial decrease in transit-amplifying cells, new Isl1
+
 neurons 
accumulated at a rate comparable to the non-ablated contralateral side for the first 12 
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hours after ablation, (Fig. 2.9A).  The rate of neuron production briefly declined during 
the next 12-hour period, but then increased to a rate 60% greater than normal through at 
least 80 hpf (Fig. 2.9A, Table 2).  Co-ablation of both mature and transit-amplifying 
cells (the latter were targeted based on position and morphology) nearly eliminated 
production of new Isl1
+
 cells through at least 56 hpf (Fig. 2.9A), confirming the vital 
importance of transit-amplifying cells for producing new mature SAG neurons.  
Together these data suggest that loss of feedback inhibition from mature neurons leads to 
accelerated differentiation of cells from a pool of self-renewing progenitors.  
We next examined whether altering Fgf signaling influences neuron production 
after 30 hpf, with and without laser-ablation of mature neurons.  Ablations were 
conducted in transgenic embryos carrying both isl2b:Gfp and either hs:fgf8 or 
hs:dnfgfr1.  Again, isl2b:Gfp
+
 cells were serially ablated on one side at 30 hpf and 32 
hpf, and embryos were then heat shocked at 38°C or 39°C (strong activation) at 34 hpf.  
The contralateral side served as a non-ablated control.  On the non-ablated side, the 
effects of activating hs:fgf8 or hs:dnfgfr1 at 34 hpf were similar the effects of activating 
these transgenes at 24 hpf: Specifically, strongly elevating Fgf impaired production of 
new neurons whereas blocking Fgf accelerated production of new neurons (Fig. 2.9B, 
Table 2).  On the ablated side, activation of hs:dnfgfr1 (38°C) accelerated production of 
new neurons to more than twice the normal rate through 44 hpf, after which the rate 
flattened out as in non-transgenic ablations (Fig. 2.9B).  Moreover, the rate of neuron 
production in ablated hs:dnfgfr1 embryos was 50% greater than in non-ablated 
hs:dnfgfr1 embryos.  Surprisingly, strong activation of hs:fgf8 (39°C) resulted in a rate 
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of neuronal accumulation on the ablated side that was nearly normal (comparable to the 
non-ablated control).  Thus, misexpressing Fgf8 counterbalances the effects of 
eliminating mature neurons (and hence Fgf5) such that there is no net change in the rate 
of neuron production.  This is similar to the ability of hs:fgf8 to counterbalance the 
effects of fgf5-MO on neuroblast specification (Fig. 2.6H) and maturation of SAG 
neurons (Fig. 2.8J, K, M, N).  Analysis of the neurod
+
 domains showed that transgene 
activity had no significant effect on the size of the transit-amplifying pool at these stages 
(Table 2.2).  Thus, blocking Fgf accelerates production of new neurons and enhances the 
effects of neuronal ablation whereas misexpressing Fgf8 offsets the effects of neuronal 
ablation (summarized in Table 2.2).  These data further support the hypothesis that Fgf5 
from mature neurons acts as a feedback inhibitor to slow the rate of maturation of new 
SAG neurons. 
 
DISCUSSION 
The data presented here support a model in which changing levels of Fgf 
differentially regulates distinct stages of SAG development (Fig. 2.10).  Initially a 
moderate level of Fgf in a spatial gradient specifies the neurogenic domain within the 
otic vesicle.  Subsequently, Fgf levels gradually rise as differentiating SAG neurons 
accumulate and express Fgf5, eventually terminating neurogenesis in the otic vesicle.  It 
is likely that the expanding macular source of Fgf also contributes to termination of 
neurogenesis.  Terminal differentiation of SAG neurons initially occurs rapidly 
following delamination from the otic vesicle.  However, the developmental increase in 
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Fgf delays neuronal differentiation, maintaining the transit-amplifying phase.  This 
allows the developing SAG to achieve a steady state in which the rate of progenitor 
growth just matches the rate of neuronal differentiation.  This property of the SAG is 
presumably necessary to provide sufficient neurons to innervate growing sensory 
epithelia, which continue to expand throughout larval and early adult stages in zebrafish 
(111).  Knockdown of fgf5 prolongs the phase of neuroblast specification and also 
accelerates the rate of neuronal differentiation.  Neuroblast specification eventually 
ceases in fgf5 morphants, possibly in response to elevated Fgf from the growing utricular 
macula.  We cannot assess the long-term effects of fgf5 knockdown because morpholino 
efficacy dissipates after 3-5 days.  However, once specification/delamination ceases, 
accelerated neural differentiation in the absence of fgf5 function would be expected to 
deplete the transit-amplifying pool, leading to a neural deficiency in the long-run. Cell 
cycle dynamics are likely to be rather complex in the transit-amplifying population.  
With a steady state of 180-200 progenitors producing 50-60 neurons per day, the average 
cell cycle length could be unusually long assuming that most progenitors 
continue to cycle.  However, patterns of BrdU incorporation suggest cell cycle dynamics 
are not uniform amongst progenitors.  A 6-hour incorporation period labels roughly 40% 
of neurod
+
 progenitors, with labeling being especially prominent in distal regions of the 
SAG (Fig. 2.1E, F, and data not shown).  It is therefore possible that a substantial 
fraction of progenitors enter a quiescent state.  We detected no overt effect of Fgf 
signaling on the pattern of BrdU incorporation or the incidence of mitotic cells (not 
shown), although we cannot exclude the possibility that our heat shock lines act too  
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Figure 2.9.  Regeneration following SAG ablation. The icon at the top of the figure indicates that 
neuronal maturation is the focus of analysis.  Manipulations in these experiments (Neuronal maturation 
group II) are briefly summarized at the top.  (A) Accumulation of Isl1
+
 SAG neurons in isl2b:Gfp/+ 
embryos after serial ablation of Gfp-positive neurons (mature) or ablation of Gfp-positive neurons and 
transit-amplifying cells (t.a. + mature) at 30 hpf and 32 hpf.  Neuronal accumulation on the contralateral 
(non-ablated) side served as a control.  (B) Effects of modulating Fgf after serial ablations at 30 hpf and 32 
hpf on the total number of Isl1
+
 neurons.  Embryos were heat shocked for 30 minutes at 39°C (+/+ and 
hs:fgf8/+ embryos) or 38°C (hs:dnfgfr1/+ embryos) beginning at 34 hpf.  Data show means and standard 
deviations of 2-5 specimens per time point.  
 
transiently to detectably alter cell cycle dynamics.  Nevertheless, modulating Fgf clearly 
had a rapid effect on the rate of production of mature neurons (Figs. 2.8 and 2.9),thereby 
indirectly affecting the progenitor pool.  Interestingly, activating hs:fgf8 or hs:dnfgfr1 at 
24 hpf caused lasting changes in the size of the progenitor pool (Fig. 2.8), whereas no 
such change was seen when the transgenes were activated at 34 hpf (data not shown).  
This difference likely reflects the greater relative impact of changing the rate of neuronal 
differentiation at early stages when the progenitor pool is still small.  In contrast, with 
nearly 200 progenitors at 32 hpf, it is not surprising that altering the rate of neuronal 
differentiation by 1-2 cells per hour for several hours had little impact on the progenitor 
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pool.  Although the model in Figure 2.10 depicts the influence of macular Fgfs on SAG 
specification in the otic vesicle, it must be emphasized that a lateral gradient of Fgf from 
the hindbrain acts much earlier to coordinate formation of sensory and neural 
progenitors in adjacent domains during placodal stages.  The prosensory gene atoh1b is 
induced at 10.5 hpf in the nascent otic placode in medial cells closest to the  
 
 
Figure 2.10.  Model for regulation of SAG development by Fgf. 
(A) Neuroblast specification at early stages.  A moderate level of Fgf3 and Fgf8 in a gradient generated by 
the utricular macula specifies neuroblasts in the floor of the otic vesicle (step 1), and nascent neuroblasts 
quickly delaminate from the otic vesicle (step 2).  (B) As development proceeds, neuroblasts establish a 
pool of transit-amplifying (TA) progenitors (step 3), which eventually differentiate into mature neurons 
and express Fgf5 (step 4).  Rising levels of neuronal Fgf5, combined with Fgf3 and Fgf8 from the growing 
utricular macula, exceeds an upper threshold that serves to terminate specification of new neuroblasts 
within the otic vesicle.  Neuronal Fgf5 also slows differentiation of progenitors into mature neurons.  (C, 
D) At stages immediately following establishment of the transit-amplifying pool, experimental attenuation 
of Fgf signaling promotes maturation of neurons at the expense of progenitors (C) whereas elevating Fgf 
inhibits maturation, expanding the size of the transit-amplifying pool (D).  
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Fgf-source (95), and elevating Fgf expands this domain laterally (our unpublished 
observations).  Expression of neurog1 begins in more lateral tissue by 16 hpf (14 
somites) and is initially influenced by the same hindbrain source of Fgf (73, 97).  We 
have confirmedhere that neuroblast specification requires Fgf whereas excess Fgf 
inhibits neurog1 expression, consistent with the notion that the neurogenic domain is 
established by intermediate levels of Fgf in a diffusion gradient.  After formation of the 
otic vesicle, the utricular macula provides the strongest source of Fgf in the otic vesicle 
and the neurogenic domain forms an arc wrapping around the lateral and posterior edges 
of this source (14).  Later the saccular macula begins to expand and expresses more Fgf 
(95, 112), with a corresponding posterior extension of the neurogenic domain to form a 
narrow band just lateral to the saccule (14).  Soon thereafter Fgf levels exceed the upper 
threshold and terminate neuroblast specification.   
 In zebrafish, it is currently unclear whether the spatial distribution of neuroblasts 
within the otic vesicle is directly tied to later distribution of mature neurons in the SAG.  
However, fate mapping studies in chick and mouse reveal that the spatial-temporal 
progression of neuroblast formation in the otic vesicle presages the spatial-temporal 
accumulation of vestibular and auditory neurons outside the ear (113, 114).  It is likely 
that a similar progression occurs in zebrafish, though fate mapping studies have yet to 
confirm this relationship.  Mechanism of SAG subtype specification has not been well 
characterized in any species, though several studies in zebrafish suggests that Shh is 
involved.  Disruption of Hedgehog signaling ablates posterior fates in the otic vesicle, 
including the saccule and posterior (presumptive auditory) neurons (19, 107).  Fgf 
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signaling acts in opposition to Shh by promoting anterior fates in the otic vesicle (73, 74, 
97), though altering Fgf does not appear to cause wholesale redistribution of SAG 
neurons.  However, we found that activating hs:fgf8 at 24 hpf caused premature 
termination of neuroblast specification and also blocked later production of 
posterior/auditory neurons, supporting a link between spatial/temporal cues and SAG 
subtype-specification. 
 
Are the distinct roles of Fgf conserved in amniotes?  
Numerous studies support a role for Fgf in SAG neuroblast specification in the 
chick and mouse.  In chick, misexpression of Fgf8 or Fgf10 during placodal stages 
causes expansion of the neurogenic domain in the otic vesicle, whereas blocking Fgf 
signaling dramatically reduces the neurogenic domain (76, 77).  In mouse, knockout of 
Fgf3 or receptor isoform Fgfr-2 (IIIb) causes severe deficiencies of delaminating 
neuroblasts and neurons (82, 115).  Explant cultures of chick or mouse otocysts treated 
with exogenous Fgf2 produce 5- to 10-fold more delaminated neuroblasts compared to 
controls, whereas blocking Fgf2 with a neutralizing antibody severely reduces the 
number of neuroblasts (84, 116).  Thus the requirement for Fgf in neuroblast 
specification appears broadly conserved.  However, the spatial gradient of Fgf that we 
propose coordinates sensory and neural development in zebrafish is unlikely to operate 
in mammals.  Unlike the situation in zebrafish, in mouse the neurogenic and sensory 
domains overlap spatially but are specified at slightly different times.  Neuroblast 
specification occurs first, but as the phase of neuroblast specification/delamination 
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begins to wane sensory epithelia begin to form in the same region.  The transition from 
neural to sensory development partly reflects mutual repression between Neurog1 and 
Atoh1, the principal initiators the proneural and prosensory pathways, respectively (86).  
Whether Fgf also influences this transition is not known. 
Despite the above studies showing a requirement for Fgf, it is not clear whether 
high levels of Fgf are inhibitory in birds and mammals as we have shown here, nor 
whether Fgf delays maturation of cells in the transit-amplifying pool.  In explants of 
chick or mouse otocysts, exposure to Fgf accelerates the appearance of mature neurons 
compared to cultures lacking exogenous Fgf (84, 116).  At first glance, these results 
appear to contradict our findings that Fgf delays differentiation.  However, Fgf levels 
used in the above explant studies were based on dose-response curves and were selected 
to optimize growth of the explant.  Hence potential inhibitory effects of higher doses of 
Fgf were not evaluated.  Furthermore, neuroblasts in culture disperse after delamination 
rather than accumulating against the otocyst wall where they might facilitate feedback 
inhibition.  This possibly explains why otic explants continue to produce neuroblasts for 
many days, far longer than during normal embryonic development.  In rodent embryos, 
differentiating auditory neurons express Fgf1, Fgf2, Fgf5 and Fgf10 (82, 117-120), 
which could help mediate feedback inhibition.  Unfortunately, relevant functional 
studies are lacking.  In adult rodents, neuronal Fgf is thought to play a role in 
maintenance of the spiral ganglion.  Augmenting Fgf mitigates neural degeneration 
following nerve injury or noise-induced trauma (121, 122).  Additionally, conditional 
knockout of Fgf receptor genes Fgfr1 and Fgfr2 in glial cells in the spiral ganglion leads 
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to progressive loss of auditory neurons beginning around 2 months of age, suggesting a 
role in promoting trophic support from glia (123).  In cultures of spiral ganglion from 
adult mouse, exogenous Fgf2 can promote neuronal survival and neurite outgrowth 
(124).  Unexpectedly, such cultures were also found to contain quiescent progenitors that 
could be induced to reenter the cell cycle by incubation with EGF and Fgf2, with some 
cells differentiating into neurons after removal of EGF and Fgf2 (124).  These latter data 
are consistent with the possibility that Fgf maintains progenitors and inhibits neural 
differentiation, though it remains to be seen whether such a mechanism operates in vivo. 
 The developing SAG can be compared to the developing olfactory epithelium 
(OE).  Fgf8 expression around the rim of the olfactory pit stimulates proliferation of OE 
progenitors, which differentiate into mature neurons deeper inside the pit away from the 
Fgf8 source (125).  Conditional knockout of Fgf8 results in severe deficiency of neurons 
due to failure of progenitors to expand.  Development of the OE neurons is also 
regulated by feedback inhibition from mature neurons, though the mechanism differs 
from the SAG.  Specifically, mature OE neurons secrete the TGFβ factor GDF11, which 
inhibits further proliferation of progenitors by antagonizing Fgf8 (126).  In the eye, too, 
GDF11 acts as a feedback inhibitor of retinal ganglion cells, though in this case GDF11 
blocks further differentiation of progenitors rather than restricting proliferation (127). 
In numerous other settings, Fgf regulates the balance between growth and differentiation 
of neural progenitors.  In cultures of human or rat cortical progenitors, high levels of Fgf 
stimulate proliferation and block neuronal differentiation (128, 129). In the developing 
midbrain-hindbrain region in mouse, conditional knockdown of Fgf receptors results in 
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an increase in differentiated neurons and a concomitant loss of progenitor cells in the 
ventricular zone (130).  During earlier stages of mouse development, Fgf induces 
embryonic stem (ES) cells to form epiblast, which begin to express Fgf5.  Subsequently, 
Fgf maintains the epiblast as a stable intermediate by preventing reversion back to the 
ES ground state and blocking further differentiation into neural ectoderm (131).  Thus, 
maintenance of stable progenitor pools by Fgf appears to be a broadly conserved 
mechanism utilized in many aspects of neural development.  A relatively novel aspect of 
SAG development is that Fgf coordinates the entire process, initially specifying 
neuroblasts and, at a higher level, also mediates feedback from mature neurons to inhibit 
further differentiation.  How changing levels of Fgf achieve this balance remains an 
important unresolved question. 
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CHAPTER III 
 
 
 
 
TFAP2A PROMOTES SPECIFICATION AND MATURATION OF NEURONS IN 
THE INNER EAR THROUGH MODULATION OF BMP, FGF AND NOTCH 
SIGNALING
2
 
 
 
 
INTRODUCTION 
Vestibular and auditory information is transmitted from the inner ear to the 
hindbrain via neurons of VIII.th cranial ganglion, also known as the stato-acoustic 
ganglion (SAG).  SAG neurons are formed by a complex but poorly understood multi-
step process that begins in the otic vesicle, the precursor of the inner ear.  In the first 
step, SAG neuroblasts are specified in the floor of the otic vesicle and are marked by the 
expression of proneural gene neurogenin1 (ngn1) (60, 61).  After specification, 
neuroblasts delaminate from the otic epithelium via epithelial-mesenchymal transition 
and migrate to a region between the otic vesicle and hindbrain.  In zebrafish, markers of 
later stages of differentiation are usually not expressed within the otic epithelium.  Upon 
delamination, however, neuroblasts quickly lose expression of ngn1 and upregulate the 
related factor neurod (61, 90).  neurod-expressing cells form a population of migrating 
                                                 
2Reprinted with permission from “Tfap2a promotes specification and maturation of neurons in the inner 
ear through modulation of Bmp, Fgf and notch signaling.”  by  Kantarci H., Edlund R.K., Groves A.K., & 
Riley B.B., 2015, PLoS genetics 11, 3:e1005037. Copyright [2015] by  Kantarci et al.  
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and proliferating precursors called the transit-amplifying (TA) pool (93).  As cells in the 
TA pool differentiate into mature neurons they lose expression of neurod and upregulate 
early neuronal markers islet1 and islet2b (132).  Newly formed neurons extend processes 
bi-directionally to connect sensory epithelia with central targets in the hindbrain.  SAG 
development in chick and mouse embryos follows a similar course except that transit-
amplification and expression of NeuroD and Isl1/2 begin while neuroblasts still reside 
within the otic epithelium (60, 77, 133). 
We previously showed that Fgf signaling regulates each step in SAG 
development in zebrafish (132).  Specification of SAG neuroblasts is initiated by a low 
level of Fgf signaling.  As SAG neurons mature they begin to express fgf5 such that 
rising levels of Fgf eventually become inhibitory to ngn1 expression in the otic vesicle.  
Consequently, neuroblast specification starts to decline after 24 hpf and ceases entirely 
by 42 hpf (14, 132). Elevated Fgf also delays terminal differentiation of cells in the TA 
pool.  The TA pool is thereby maintained as a relatively stable population in which the 
rate of proliferation closely matches the rate of terminal differentiation. 
The otic vesicle originates from an ectodermal thickening called the otic placode.  The 
otic placode, along with all other cranial placodes, emerges from a contiguous region of 
pre-placodal ectoderm (PPE) that forms around the anterior neural plate by the end of 
gastrulation (9, 134). In zebrafish competence to form PPE is regulated by four 
transcription factors: Tfap2a, Tfap2c, Gata3 and Foxi1 (9, 135).  These transcription 
factors are also essential for later development of a subset of cranial placodes, including 
the otic placode.  For example, in response to inductive Fgf signaling foxi1 expression 
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upregulates in nascent otic/epibranchial placodes; and disruption of foxi1 leads to severe 
deficiencies of epibranchial and otic tissue in zebrafish (136-138). A similar role has 
been shown recently for Foxi3 in mouse and chick (139, 140). Expression of gata3 also 
regulates otic development, becoming localized to the nascent otic placode (141) and to 
discrete regions of the otic vesicle (142-144). Disruption of Gata3 in mouse causes 
severe defects in otic vesicle development (142), including deficiencies of sensory 
epithelia and improper wiring of auditory neurons (145-147).  In contrast, less is known 
about later roles of tfap2a/c.  tfap2a is best known for its role in the early differentiation 
and survival of neural crest cells (148-156) and together with tfap2c is indispensible for 
neural crest specification in zebrafish (150, 152).  However, whether tfap2a/c genes 
regulate later development in the otic placode and vesicle has not been investigated. 
Here we report that tfap2a is expressed throughout the nascent otic placode and is later 
restricted to a ventrolateral region in the otic vesicle overlapping with the neurogenic 
domain.  Misexpression of tfap2a leads to excess specification and precocious 
differentiation of SAG neurons whereas knockdown of tfap2a causes reduced 
neurogenesis and delayed differentiation of SAG precursors.  Further investigation 
revealed that tfap2a acts non-autonomously through upregulation of bmp7a, which in 
turn restricts Fgf and Notch signaling to promote specification and differentiation of 
SAG precursors. 
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MATERIAL AND METHODS 
 
Fish strains and developmental conditions 
The wild type strains were derived from AB line (Eugene, OR). Transgenic lines 
used in this study include Tg(hsp70:tfap2a)
x24 
(135), Tg(hsp70:fgf8a)
x17 
(19), 
Tg(hsp70I:dnfgfr1-EGFP)
pd1 
(98), Tg(hsp70I:gal41.5)
kca4
 (157), Tg(UAS:myc-Notch1a-
intra)
kca3 
(158) and Tg(brn3c:gap43-GFP)
s356t 
(159).  These transgenic lines are referred 
as hs:tfap2a, hs:fgf8, hs:dnfgfr1, hs:gal4/UAS-NICD  and brn3c-GFP respectively.  
Mutant line tfap2a
m819
 (160) was used for most loss of function studies.  Mutants were 
identified by characteristic phenotypes showing expected Mendelian frequencies.  
Except where noted, embryos were maintained at 28.5 °C in fish water containing 
0.008% Instant Ocean salts, methylene blue and PTU (1-phenyl 2-thiourea, 0.3 mg/ml, 
Sigma) to block melanin formation.  Embryos were staged according to standard 
protocols (100).  
 
Gene misexpression and morpholino injection  
To activate heat-shock inducible transgenic lines, heterozygous transgenic 
embryos were incubated at 39ºC for 30 minutes except where noted.  Under this 
condition, activation of hs:tfap2a at 24 hpf led to a detectable increase in tfap2a levels 
by the end of the heat-shock period.  Maximal tfap2a expression was seen at 25.5 hpf 
and the tfap2a levels remained elevated in the otic vesicle thorough at least 29 hpf (Fig. 
3.S1).  Since the complete blockage of Fgf signaling inhibits neurogenic specification in 
the otic vesicle (132), weak attenuation of Fgf signaling was achieved by activation of 
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hs:dnfgfr1 at 35 ºC for 30 minutes (Fig. 3.6) or at 36.5 ºC for 30 minutes (Fig. 3.7).  
After the heat-shock, embryos were incubated at 33 ºC until fixation.   
 
 
Figure 3.S1: Heat-shock activation of hs:tfap2a transgene leads to transient misexpression of tfap2a. 
(A-L) Whole-mount images (dorsal up, anterior left) showing tfap2a expression in wild-type and hs:tfap2a 
embryos.  Embryos were fixed and stained at indicated intervals after the end of a 30-minute heat-shock 
initiated at 24 hpf.  
 
In some loss of function experiments, tfap2a was knocked down by injecting embryos at 
the 1-cell stage with approximately 5 ng of tfap2a morpholino oligomer (MO).  The 
sequence of tfap2a MO has been tested previously for specificity and efficiency (161). 
 
Pharmacological treatments 
Notch signaling was blocked by treating embryos with LY411575 diluted from a 
10 mM stock in DMSO to a final concentration of 30 μM in fish water.  Bmp signaling 
was blocked by Dorsomorphin (Sigma, P5499) diluted from a 10 mM stock solution into 
a final concentration of 100 μM in fish water.  Treatments were carried in a 24-well plate 
with a maximum of 15 embryos per well in a volume of 500 μl each.   
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In situ hybridization and immunohistochemistry  
In situ hybridization and antibody staining was carried out as described 
previously (72, 101, 102).  In situ TUNEL assay was performed by using Promega 
terminal deoxynucleotidyl transferase (M828A) according to the manufacturer’s 
protocol.  Following primary and secondary antibodies were used in this study: anti-
Islet1/2 (Developmental Studies Hybridoma Bank 39.4D5, 1:100 for whole-mount, 
1:250 for cryo-sections), anti-BrdU (Beckton-Dickinson, 1:250) and Alexa 546 goat 
anti-mouse IgG (Invitrogen A-11003, 1:50 for whole-mount, 1:250 for cryo-sections).  
Cryo-sectioning and BrdU labeling were carried out as described previously (132).  
Whole-mount stained embryos were sectioned except for Figures 3.1, 3.7 and 3.S4 
where anti-islet1/2 staining was performed on sections using standard whole mount 
protocols.  
 
Cell transplantation 
Wild-type donor cells were injected with the lineage tracer 
(tetramethylrhodamine labeled, 10,000 MW, lysine-fixable dextran in 0.2 M KCl) and 
transplanted into non-labeled hs:tfap2a embryos at blastula stage.   
 
Chick experiments 
Embryonic day 3 (E3) and E4 chick embryos were fixed and embedded in gelatin 
(7.5% gelatin, 15% sucrose in PBS). 14m thick sections were collected on Superfrost 
Plus slides.  For AP2a and Jagged-1 co-detection, slides were boiled in 10mM citric acid 
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for 10 minutes prior to antibody application and then incubated in 0.012% hydrogen 
peroxide for 15 minutes at room temperature.  The 3B5 AP2α monoclonal antibody 
developed by Trevor Williams was obtained from the Developmental Studies 
Hybridoma Bank developed under the auspices of the NICHD and maintained by the 
University of Iowa, Department of Biology, Iowa City, IA 52242.  AP2α antibody was 
diluted 1:100 and Jagged-1 polyclonal antibody (Santa Cruz Biotechnology H-114) was 
diluted 1:200 in blocking buffer (PBS with 0.02% Tween-20, 0.1% Triton X-100, and 
10% goat serum).  Staining was detected with biotinylated mouse secondary antibody 
(Mouse Vectastain ABC kit) in conjunction with PerkinElmer TSA Plus Cyanine-3 
System and AlexaFluor 488 conjugated rabbit secondary antibody diluted 1:500 in A+B 
substrate solution (AlexaFluor goat anti-rabbit, Invitrogen).  All slides were mounted in 
Fluoromount G (Southern Biotech). 
 
Statistics 
For pairwise comparisons, student’s t-tests were used to evaluate significance.  
For experiments involving more than two groups significance was evaluated using one-
way ANOVA and Tukey post-hoc HSD tests 
 
 
RESULTS 
 
Expression of tfap2a during otic development 
To begin to assess potential functions of tfap2a in otic development, we 
examined expression of tfap2a in the otic placode and early otic vesicle in zebrafish.  At 
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14 hpf (10 somites) when otic cells first form a morphological placode, tfap2a is 
expressed broadly throughout the placode as shown by co-staining for the early otic 
marker pax2a (Fig. 3.1A-B).  The level of tfap2a expression varies, with higher levels in 
dorsal and lateral otic cells.  Otic expression in general appears much weaker than in 
surrounding neural crest cells.  By 24 hpf, expression of tfap2a in the otic vesicle is 
restricted to ventrolateral cells.  This domain partially overlaps with the neurogenic 
domain of the otic vesicle, marked by the proneural gene ngn1 (Fig. 3.1C-D).  
Neurogenesis declines sharply by 30hpf and ceases entirely by 42 hpf (14, 132).  
Similarly, the level of tfap2a gradually declines in the neurogenic domain after 30 hpf 
and is no longer detectable by 48 hpf (Fig. 3.1E-I).  Despite initial expression of tfap2a 
in at least some neuroblasts in the otic vesicle, expression is lost in most neural 
precursors as they delaminate from the otic vesicle.  Mature neurons of the statoacoustic 
ganglion (SAG), marked by expression of Isl1, show no detectable expression of tfap2a 
(Fig. 3.1J).  These data are consistent with the possibility that tfap2a is involved in at 
least some aspects of neurogenesis in the otic vesicle. Expression patterns of tfap2a, 
ngn1, and other key genes involved in SAG development are summarized in Fig. 3.1K.  
To examine the possibility that expression is conserved in amniote vertebrates, we 
examined expression of Tfap2a in chick embryos.  In agreement with the patterns 
observed in zebrafish, chick embryos also show expression in ventrolateral regions of 
the otic vesicle (Fig. 3.1L-Q). Moreover, in chick as in zebrafish, the domain of Tfap2a 
expression abuts the sensory domain with little or no overlap.  The similar expression  
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Figure 3.1: Conserved expression of tfap2a during otic neurogenesis.  All images show cross-sections 
of the otic placode or vesicle in wild type zebrafish embryos (A-J) or chick embryos (L-Q) with a dorsal 
up and medial to the left.  (A, B) At 14 hpf (10 somites) pax2a (red) marks the precursor cells in the 
emerging otic placode that are co-labeled with tfap2a (blue).  (C-H) Cross-sections through the widest part 
of the neurogenic domain of the otic vesicle, just posterior to the utricular macula.  The outer and inner 
edges of the otic vesicle are outlined.  Patterns of ngn1 or tfap2a are shown at the indicated times.  tfap2a 
is expressed in the ventrolateral part of the otic vesicle, which partially overlaps the domain of ngn1 
expression.  (I-J) Cross-sections passing through the utricular macula of specimens co-stained for Isl1 
(red) and tfap2a (blue) at 48 hpf.  Expression of tfap2a is not detected in the floor of the otic vesicle or in 
the mature SAG neurons at this time.  (K) Schematic summary of SAG development in zebrafish, 
including regional markers. Neuroblasts are specified and delaminate from the otic vesicle (light purple) 
adjacent to nascent sensory epithelia (green).  Recently delaminated neuroblasts migrate towards hindbrain 
and continue to proliferate, forming the transit-amplifying pool (blue).  Neuroblasts then stop dividing and 
differentiate into mature neurons (red).  Relevant genes expressed in each domain are indicated.  
Expression of tfap2a (dark purple) overlaps the neurogenic domain, as well as the domain of bmp7a 
expression.  Note that all of the tissues indicated express Fgf-target genes (etv5b and spry4) and 
transducers of Bmp (smad1 and smad5), but transit amplifying SAG precursors show specific upregulation 
of smad1 and smad5 (162).  (L-Q) Cross-sections through the otic vesicle of chick embryos at days 3 and 
4 (E3 and E4). The sensory region is labeled with Jagged-1 (green).  Tfap2a (red) is expressed in the 
ventrolateral otic domain in chick embryos similar to the pattern observed in zebrafish.  
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patterns seen in zebrafish and chick potentially reflect a broadly conserved role in early 
otic development. 
 
Effects of Tfap2a on neurogenesis in the otic vesicle 
To explore the role of tfap2a, we characterized the effects of tfap2a loss of 
function or misexpression on neurogenesis in the otic vesicle in zebrafish.  Disruption of 
tfap2a causes no overt defects in morphogenesis of the otic vesicle (151).  However, 
tfap2a
-/-
 (lockjaw) mutants produced only half the normal number of ngn1-positive 
neuroblasts in the otic epithelium at 24 hpf, the stage when neurogenesis normally peaks 
in wild-type embryos (Fig. 3.2A, C).  At later stages, too, tfap2a
-/-
 mutants continued to 
show significant deficiencies in neuroblast specification (Fig. 3.2D, F, M).  Similar 
results were seen in tfap2a morphants (tfap2a-MO, Fig. 2M).  We next used a heat-
shock inducible transgenic line, hs:tfap2a, to misexpress tfap2a at various 
developmental stages.  Activation of hs:tfap2a at 20 hpf increased the peak number of 
neuroblasts in the otic vesicle at 24 hpf by 30% (58.33±3.21 ngn1+ cells in hs:tfap2a 
embryos vs. 44.5±2.65 cells in controls, Fig. 3.2B).  Activation of hs:tfap2a at 24 hpf 
prolonged the phase of peak neurogenesis, resulting in twice the normal number of 
neuroblasts at 28 hpf (Fig. 3.2D, E, M).  Despite the initial surge, however, the number 
of ngn1+ neuroblasts subsequently declined sharply in transgenic embryos, dropping 
below the level seen in control embryos at 30 hpf and thereafter (Fig. 3.2G, H, M).  
Because transgene activity decays 5 hours after heat shock (Fig. 3.S1), we tested the 
effects of serial heat shocks at 24 hpf and 29 hpf.  This resulted in elevated neurogenesis 
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through at least 32 hpf, when transgenic embryos had twice as many ngn1+ cells in the 
otic epithelium as in control embryos (Fig. 3.2G, I, N).  Neurogenesis in the ear 
normally ceases by 42 hpf (14, 132), prompting us to investigate whether termination of  
 
                             
Figure 3.2: Tfap2a enhances otic neurogenesis.  (A-L) Cross-sections (medial left, dorsal up) through 
the otic region just posterior to the utricular macula showing ngn1 expression in +/+ control embryos, 
hs:tfap2a embryos and tfap2a
-/-
 mutants at the indicated times.  Wild-type and hs:tfap2a embryos were 
heat shocked as indicated in each panel.  Overexpression of tfap2a increases the number of neuroblasts in 
the otic vesicle whereas loss of tfap2a slows down and decreases otic neurogenesis.  The outer and inner 
edges of the otic vesicle are outlined in each image.  (M, N) Mean and standard deviation of the total 
number of ngn1 positive cells in the otic epithelium from 24 to 32 hpf for the genotypes indicated in the 
color key (counted from serial sections, n=3-7 ears per time point).  Asterisks (*) indicate statistically 
significant differences between groups indicated by brackets (N) or compared to control embryos (M). 
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neurogenesis could be altered by later misexpression of tfap2a.  Indeed, activation of 
hs:tfap2a at 38 hpf prolonged specification of neural precursors, as ngn1+ neuroblasts 
were still present in the otic vesicle through at least 43 hpf (Fig. 3.2J, K).  In contrast, 
activation of hs:tfap2a at 40 hpf was not sufficient to prevent or delay the cessation of 
neurogenesis in the otic vesicle (Fig. 3.2L).  Overall these results indicate that tfap2a 
enhances neurogenesis in the ear but cannot induce ectopic neurogenesis beyond the 
floor of the otic vesicle nor reactivate neurogenesis after it has stopped. 
 
Effects of Tfap2a on later stages of SAG development 
We next examined whether altered levels of neuroblast specification caused by 
manipulating tfap2a function were followed by changes in later stages of neuronal 
differentiation.  Normally, newly specified neuroblasts delaminate from the otic vesicle, 
lose expression of ngn1 and initiate expression of neurod, a marker of the “transit- 
amplifying” (TA) stage of development (61, 132) (Fig. 3.1K).  Surprisingly, despite 
reduced neurogenesis in tfap2a
-/-
 mutants and tfap2a morphants, the number of neurod+ 
TA cells was greater than normal at every time point examined (Fig. 3.3B, E, H, J).  
Conversely, despite the large increase in neurogenic specification caused by 
overexpression of tfap2a at 24 hpf, the number of neurod-expressing TA cells was 
reduced at all time points through 48 hpf (Fig. 3.3C, F, I, J).  We hypothesized that 
changes in the size of the TA pool reflect changes in the overall pace of neuronal 
differentiation.  To test this we examined expression of Isl1, a marker of mature SAG 
neurons.  We observed that tfap2a
-/-
 mutants and tfap2a morphants produced fewer than 
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normal neurons despite the increased number of neurod+ cells (Fig. 3.4E-H, T).  The 
deficiency in neuronal maturation persisted in tfap2a
-/-
 mutants through at least 72 hpf 
(Fig. 3.S2) In contrast, activation of hs:tfap2a had the opposite effect.  Activation of 
hs:tfap2a during placodal stages elevated accumulation of Isl1+ neurons at 30 hpf, and  
 
 
Figure 3.3: Tfap2a regulates the number of transit-amplifying SAG precursors.  (A-I) Cross-sections 
(medial left, dorsal up) at the level of the utricular macula showing neurod expression in +/+ control, 
tfap2a mutants and hs:tfap2a embryos.  Wild-type and hs:tfap2a embryos were heat shocked at 24 hpf.  
Disruption of tfap2a leads to accumulation of excess TA cells whereas tfap2a overexpression decreases 
the number of the TA cells.  The outer and inner edges of the otic vesicle are outlined in each image.  (J) 
Mean and standard deviation of the total number of neurod positive SAG precursors for the genotypes and 
conditions indicated in the color key (counted from serial sections, n=3-6 ears per time point). Asterisks 
(*) indicate significant differences from control specimens.  
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the fold-stimulation was progressively increased with successively later stages of 
activation (Fig. 3.4M).  Activation of hs:tfap2a at 24 hpf led to maximal accumulation of 
neurons, with nearly twice the normal number of Isl1+ neurons observed in transgenic 
embryos at 30 hpf and 37 hpf (Figure 3.4I-L, M, T).  Interestingly, transgene activation 
at these early stages enhanced accumulation of anterior (vestibular) SAG neurons but not 
posterior (auditory) neurons (Fig. 3.4D, L).  However, activating hs:tfap2a expression at 
29 hpf increased accumulation of both anterior and posterior neurons (Fig. 3.4N-P), 
consistent with our previous findings that auditory neurons are specified at later stages 
than vestibular neurons (132).  Together these data indicate that disruption of tfap2a 
inhibits neurogenesis and slows neural maturation, whereas misexpression of tfap2a 
stimulates neuroblast specification and accelerates subsequent differentiation. 
Importantly, although activation of hs:tfap2a at 24 hpf led to elevated accumulation of 
mature neurons through 37 hpf, the number of mature neurons fell dramatically 
thereafter to roughly half normal by 48 hpf (Fig. 3.4T).  This decline was preceded by a 
marked increase in the rate of apoptosis amongst mature neurons (Fig. 3.4Q-S, U).  
Elevated cell death possibly reflects insufficient duration of earlier stages of 
differentiation and consequent misregulation of factors required for neuronal survival. 
 
Effects on patterning in the otic vesicle 
To determine whether the above changes in SAG development resulted from 
mis-patterning of the otic vesicle, we examined expression of several regional markers.  
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In tfap2a
-/-
 mutants and tfap2a morphants, domains of the dorsal marker dlx3b and the 
ventrolateral marker otx1b were slightly contracted (Fig. 3.5B, E).  Domains of pax5, an 
 
 
Figure 3.S2: Maturation of SAG neurons remains deficient in tfap2a mutants at 3 dpf. (A-F) Cross-
sections (dorsal up, medial left) pass through the anterior (A, B), middle (C, D), and posterior (E, F) parts 
of the otic vesicle and show isl1 staining in a wild-type embryo (A, C, E) and a tfap2a mutant (B, D, F) 
embryo at 72 hpf.  (G) Mean and standard deviation of the total number Isl1+ SAG neurons in wild-type 
(n=3) and tfap2a mutant (n=4) embryos at 72 hpf (counted on serial sections).  Asterisk (*) indicate 
statistically significant difference compared to wild-type embryos.  
 
anterior-ventral marker of the utricular macula, and pou3f3b, a posterior-medial marker 
of the saccular macula were not altered (Fig. 3.5H, K).  Additionally, sensory epithelia  
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Figure 3.4: Tfap2a regulates maturation of SAG neurons.  (A-L) Images of anti-Isl1 antibody staining 
in control embryos (A-D), tfap2a
-/-
 mutants (E-H) and hs:tfap2a embryos (I-L) at 37 hpf. Control and 
hs:tfap2a embryos were heat shocked at 24 hpf.  Whole-mount specimens (A, E, I) show dorsolateral 
(anterior to the left) and indicate planes of cross-section in (B-D), (F-H) and (J-L).  Cross-sections are 
oriented with dorsal up and medial to the left.  The otic vesicle is outlined in each image.  White arrows 
indicate the SAG population to help distinguish it from other Isl1+ populations present in some sections.  
(M) Total number of Isl1+ neurons in hs:tfap2a embryos at 30 hpf following heat shock at the indicated 
times (n=10-15 each).  (N-P) Cross-sections of a hs:tfap2a specimen at 37 hpf following heat shock at 29 
hpf.  Planes of section are similar to those shown in (I).  (Q-S) Cross-sections of a hs:tfap2a embryo 
stained for TUNEL positive SAG neurons at 42 hpf.  (T) Mean and standard deviation of the total number 
of Isl1+ SAG neurons at the indicated times in +/+ embryos, hs:tfap2a embryos, tfap2a
-/-
 mutants and 
tfap2a morphants (n=7-34 embryos per time point).  (U) Mean and standard deviation of the total number 
of TUNEL positive SAG neurons at the indicated times in control embryos and hs:tfap2a embryos 
(counted from serial sections, n=3-6 ears per time point).  Asterisks (*) indicate statistically significant 
differences compared to control embryos.  
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Figure 3.5: Effects of tfap2a knockdown and overexpression on otic vesicle patterning.  (A-L) Whole-
mount images (dorsal up, anterior left) showing dorsolateral views of the otic vesicle (outlined) in control 
embryos, tfap2a
-/-
 mutants and tfap2a morphants, and hs:tfap2a embryos for the indicated genes at 26 hpf.  
(M) Mean and standard deviation of the total number of hair cells in utricular and saccular maculae of 
control and hs:tfap2a embryos and tfap2a morphants at the indicated times (n=24 embryos each).  Data 
were obtained by counting GFP-positive hair cells in the sensory epithelia of brn3c:Gfp transgenic 
embryos.  Accumulation of hair cells was normal except in tfap2a morphants at 36 hpf (*), which showed 
a small but significant decrease relative to the control.   
 
appeared to develop normally and there were no obvious changes in hair cell 
development through 54 hpf (Fig. 3.5M).  Activation of hs:tfap2a at 24 hpf led to weak 
contraction otx1b but a substantial expansion of the dlx3b (Fig. 3.5C, F).  pax5 was 
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expressed in its normal domain but at a reduced level (Fig. 3.5L).  Expression of 
pou3f3b was normal (Fig. 3.5I) and there were no changes in accumulation of hair cells 
 
 
 
Figure 3.6: Tfap2a regulates the level of Fgf and Notch Signaling in the otic vesicle.  (A-V) Whole-
mount images (dorsal up, anterior left) showing dorsolateral views of the otic vesicle (outlined).  (A-R) 
Expression of the indicated genes in wild-type embryos, hs:tfap2a embryos and tfap2a
-/-
 mutants (A-I) or 
tfap2a morphants (J-R) at 26 hpf (A-L, P-R) and 28 (M-O) hpf.  (S, T) Cross-sections (dorsal up, medial 
left) passing through the utricular macula show spry4 expression at 28 hpf in a control embryo and tfap2a
-
/-
 mutant.  (U-X) Whole-mounts showing expression of etv5b at 26 hpf.  Activation of hs:tfap2a 
diminishes etv5b expression (U, V), activation of hs:fgf8 leads to global upregulation of etv5b (W), and 
co-activation of hs:fgf8 and hs:tfap2a restores etv5b to near normal (X).  (Y) Cross-sections (dorsal up, 
medial left) passing just posterior to the utricular macula showing ngn1 at 24 hpf following a 35°C heat 
shock at 23 hpf.  Reduction in the ngn1 domain caused by knockdown of tfap2a is rescued by weak 
activation of hs:dnfgfr1.  (Z) Mean and standard deviation of the total number of ngn1 positive cells in the 
otic epithelium at 24 hpf for the genotypes and knockdowns indicated in the color key (counted from serial 
sections, n=3-6 ears per time point).  Asterisks (*) indicate statistically significant differences between the 
groups indicated in brackets. 
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through 54hpf (Fig. 3.5M).  Thus, gross patterning in the otic vesicle was nearly normal 
in tfap2a
-/-
mutants and morphants, though substantial changes were seen in one marker 
 
 (dlx3b) following overexpression of tfap2a. Such changes in gene expression likely 
reflect changes in cell signaling as described below. 
 
Effects on Notch and Fgf signaling 
We next investigated whether Tfap2a activity influences Notch and Fgf 
signaling, pathways known to regulate development of SAG neurons.  For example, 
Delta-Notch signaling is normally activated by neurogenic factors Ngn1 and Neurod and 
serves as a
 
feedback inhibitor of neurogenesis (60, 86, 163).  Disruption of Delta-Notch 
signaling leads to excess neural specification and precocious differentiation (89), similar 
to the effects of misexpression of tfap2a.  Here we observed that expression of deltaA 
and deltaB was increased in tfap2a
-/-
 mutants and, conversely, delta gene expression was 
strongly impaired following overexpression of tfap2a (Fig. 3.6A-F).  Similar changes 
 
were observed for the Notch target gene her4, which increased in tfap2a
-/-
 mutants and 
decreased following activation of hs:tfap2a (Fig. 3.6G-I).  Thus Tfap2a appears to 
inhibit Notch activity during development of SAG neurons by inhibiting expression of 
Notch ligands. Fgf signaling has a more complex role in neural development in the ear.  
At early stages specification of neuroblasts requires Fgf.  As development proceeds, 
however, rising levels of Fgf5 secreted by mature SAG neurons terminates specification 
of new neuroblasts and delays differentiation of TA cells into mature neurons (132) (Fig. 
3.1K).  Weak impairment of Fgf signaling can prolong neurogenesis and accelerate 
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neural differentiation, mimicking aspects of the tfap2a overexpression phenotype.  We 
therefore examined expression of various fgf genes in the otic vesicle.  Knockdown of 
tfap2a did not appear to alter expression of fgf3, fgf8, or fgf10a (Fig. 3.6K, N, Q). 
Activation of hs:tfap2a at 24 hpf led to reduced expression of fgf3 and fgf8, but  
expression of fgf10a was not altered (Fig. 3.6L, O, R).  To look for changes in Fgf 
signaling, we examined expression of Fgf-target genes spry4 , etv4 (pea3) and etv5b 
(erm).  Although etv4 and etv5b expression appeared normal in tfap2a morphants (Fig. 
3.S3D, H), spry4 was expressed at higher levels and in a broader domain than normal in 
                                                                    
 Figure 3.S3: tfap2a inhibits Fgf signaling in the otic vesicle. (A-J): Cross-sections (dorsal up, medial 
left) passing through the otic vesicle just posterior to the utricle showing expression of etv4 (A-D), etv5b 
(E-H) and sprouty4 (I, J) in heat-shocked wild-type (A, E, I), hs:tfap2a (B, F, J), non-heat shocked wild-
type (C,G) and tfap2a morphant (D,H) embryos at indicated time points.  (K-P): Whole-mount images 
(dorsal up, anterior left) showing dorsolateral views of the otic vesicle (outlined) stained for etv5b 
expression in heat-shocked wild-type and hs:tfap2a embryos at indicated times.  
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tfap2a
-/-
 mutants, indicating that Fgf signaling was elevated (Fig. 3.6S-T).  Conversely, 
activation of hs:tfap2a at 24 hpf reduced expression of etv4, etv5b and spry4 by 26 hpf,  
 
 
Figure 3.7: Reducing Fgf and Notch levels mimics the effects of tfap2a overexpression. (A-L)  Cross-
sections (medial left, dorsal up) passing just posterior to the utricular macula and showing expression of 
ngn1 at 28 hpf (A-D), or sections passing through the utricular macula and showing neurod at 37 hpf (E-
H) or Isl1 at 37 hpf (I-L) in wild-type control (A, E, I), hs:dnfgfr1 embryos (B, F, J), LY411575 inhibitor 
treated wild-type embryos (C, G, K) and LY411575 inhibitor treated hs:dnfgfr1 embryos (D, H, L). All 
specimens were treated with 0.3% DMSO and heat-shocked at 24 hpf. The otic vesicle is outlined in each 
image. (M, N) Mean and standard deviation of the total number of ngn1 positive cells in the otic 
epithelium at 28 hpf (M) and total neurod positive SAG precursors at 37 hpf (N) for the genotypes and 
treatments indicated in the color key (counted from serial sections, n=3-6 ears per time point). Asterisks 
(*) indicate significant differences from control embryos and filled squares indicate significant differences 
relative to hs:dnfgfr1 embryos treated with LY411575. (O) Mean and standard deviation of the total 
number of Isl1 positive SAG neurons at different times for the genotypes and treatments indicated in the 
color key (n=6-15 embryos each).  In (O) differences between control and experimental specimens were 
significant at each time point. In addition, LY411575 treated hs:dnfgfr1 embryos were significantly 
different from hs:dnfgfr1 alone or LY411575 treatment alone. 
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indicating a reduced level of Fgf signaling (Fig. 3.6U-V, Fig. 3.S3A-J).  Fgf signaling 
remained reduced through 28 hpf but started to recover after 30 hpf as transgene activity 
decayed (Fig. 3.S3K-Q).  Thus, Tfap2a appears to limit Fgf signaling, in part through 
reducing expression of fgf genes. 
To test whether Tfap2a can influence Fgf signaling independently of ligand 
expression, we co-misexpressed tfap2a and fgf8.  While activation of hs:fgf8 led to 
global upregulation of etv5b, co-activation of hs:tfap2a with hs:fgf8 at 24 hpf partially 
suppressed expression of etv5b (Fig. 3.6W-X).  This indicates that tfap2a can inhibit Fgf 
signaling at a level downstream of ligand accumulation.  
To test the functional significance of elevated Fgf signaling in tfap2a morphants, 
we examined whether weakly inhibiting Fgf signaling could rescue the neurogenic 
deficiencies in tfap2a morphants.  Indeed, reducing the level of Fgf signaling via low-
level activation of hs:dnfgfr1 (dominant-negative Fgf receptor) at 35 °C restored ngn1+ 
cell counts to normal in tfap2a morphants (Fig. 3.6Y-Z).  This suggests that elevated Fgf  
signaling partially accounts for the reduced neuroblast specification in tfap2a morphants 
and mutants.   
Because Tfap2a appears to dampen both Fgf and Notch signaling, we tested 
whether weakening both pathways by other means could mimic the effects of tfap2a 
overexpression.  Low level activation of hs:dnfgfr1 at 36.5°C increased the number of 
ngn1+ neuroblasts in the ear by ~30% (Fig. 3.7B, M).  Similarly, reducing the level of 
Notch signaling by treatment with the gamma-secretase inhibitor LY411575 increased  
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Figure 3.S4: Inhibition of Notch and Fgf signaling in hs:tfap2a embryos does not enhance the effects 
of hs:tfap2a activation. (A-I): Cross-sections at the level of utricular macula (medial to the left, dorsal up) 
show bright field (A, D, G), fluorescent (B, E, H) and merged (C, F, I) images for neurod (blue) and isl1 
(red) in heat-shocked wild-type, hs:tfap2a and LY 411575 treated hs:tfap2a+ hs:dnfgfr1 embryos at 37 
hpf.  All specimens were treated with 0.3% DMSO and heat-shocked (39 °C, 30 minutes) at 24 hpf.  (J) 
Mean and standard deviation of the total number of is1+ neurons at 37 hpf under the conditions indicated 
in the color key (n=10-15 specimens each).  (K) Mean and standard deviation of the total number of nrd+ 
neuroblasts at 37 hpf under the conditions indicated in the color key (n=3-6 ears each, counted from serial 
sections).  Both experimental conditions were significantly different compared to controls.  n.s., no 
statistical difference between the groups indicated in brackets.   
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the number of ngn1+ cells in the otic vesicle by ~50% (Fig. 3.7C, M).  Combining these 
conditions to reduce both Fgf and Notch signaling further increased neuroblast 
specification, closely mimicking the effects of activating hs:tfap2a at 24 hpf (Fig. 3.7D, 
M).  Likewise, inhibiting both Fgf and Notch together reduced the number of neurod+  
cells in the TA pool and increased accumulation of Isl1+ neurons through 37 hpf in 
amanner similar to activating hs:tfap2a at 24 hpf (Fig. 3.7E-O).  Moreover, embryos 
inhibited for both Fgf and Notch signaling showed a dramatic loss of mature SAG 
neurons after 37 hpf, again mimicking the effects of hs:tfap2a activation (Fig. 3.7O).  
Interestingly, inhibition of either Fgf or Notch alone caused similar but more modest 
acceleration of neural differentiation, but such conditions did not lead to subsequent loss 
of mature neurons after 37 hpf (Fig. 3.7O).  This is possibly because differentiation, 
though accelerated relative to control embryos, is still slow enough to allow expression 
of all factors essential for survival.  Finally, activating hs:tfap2a at 24 hpf combined 
with conditions to inhibit Fgf and Notch did not further increase accumulation of Isl1+ 
neurons at 37 hpf (Fig. 3.S4).  Thus, reducing both Fgf and Notch signaling is sufficient 
to recapitulate all observed effects of tfap2a overexpression. 
 
Tfap2a regulates transit amplification independently of earlier stages 
We considered the possibility that the ability of Tfap2a to alter development of 
SAG cells outside the ear could arise secondarily from perturbation of earlier 
developmental stages within the otic vesicle.  To test whether Tfap2a can specifically 
influence cells after delamination (without altering early development within the otic  
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  Figure 3.8: Tfap2a regulates development of TA cells independent of earlier stages.  (A-L) Cross-
sections (medial left, dorsal up) at the level of utricular macula.  The otic vesicle and regions occupied by 
mature SAG neurons and TA cells are outlined in each image.  Co-staining for Isl1 (red) and neurod (blue) 
at 50 hpf (A-D) and 72 hpf (E-H) under conditions indicated across the top of the figure.  All specimens 
were treated with 0.3% DMSO and heat-shocked (39 °C) at 40 hpf.  (I-L) BrdU staining in embryos 
exposed to BrdU for 5 hours, from 40 to 45 hpf.  The region containing mature SAG neurons is indicated.  
(M-O) Mean and standard deviation for the total number of neurod+ TA cells (M), total Isl1+ mature 
neurons (N) and total BrdU+ TA cells (O) for the indicated genotypes and treatments (counted from serial 
sections, n=3-6 ears per time point).  Differences between control and experimental specimens were 
significant at all time points, except that hs:fgf8+hs:gal4/UAS-NICD embryos were not significantly 
different from control embryos at 72 hpf in (N).  (P) Percentage of neurod+ TA cells that are also BrdU 
positive (counted from serial sections, n=3-6 ears per time point).  Only hs:fgf8+hs:gal4/UAS-NICD 
embryos were significantly different from the control in (P). 
 
 
  
77 
 
vesicle), we activated hs:tfap2a at 40 hpf when neurogenesis has ceased in the otic 
vesicle.  Recall that transgene activation fails to prolong or reinitiate neuroblast 
specification at this stage (Fig. 3.2L).  Regardless, overexpression of tfap2a at 40 hpf 
still reduced the number of neurod+ cells and led to an increase in Isl1+ neurons at 50 
hpf (Fig. 3.8B, F, M, N).  Misexpression of tfap2a also reduced the total number of cells 
in the TA pool that incorporated BrdU (Fig. 3.8J, O).  However, this was proportional to 
the reduction in the total number of neurod+ cells (Fig. 3.8P), consistent with 
acceleration of the entire TA pool.  A notable difference from earlier activation is that 
activating hs:tfap2a at 40 hpf did not lead to apoptosis of SAG neurons at later stages, as 
the number of Isl1+ cells remained elevated and in fact continued to increase through at 
least 72 hpf (Fig. 3.8B, F, N).  The same effects were obtained by directly inhibiting 
both Fgf and Notch signaling after 40 hpf (Fig. 3.8C, G, K M-P).  Conversely, 
misexpressing Fgf8 and NICD (Notch intracellular domain) by heat shock activation at 
40 hpf led to accumulation of more TA cells and fewer mature neurons than normal at 
50 and 72 hpf, indicating a delay in neuronal differentiation (Fig. 3.8D, H, M, N).  
Moreover, activating Fgf and Notch together increased the percentage of neurod+ cells 
that continue to incorporate BrdU (Fig. 3.8L, O, P), suggesting that the majority of cells 
in the TA pool persist in a relatively immature stage of SAG development.  Thus, 
manipulating tfap2a, or Fgf and Notch signaling directly, can alter the rate of 
differentiation of TA cells even when earlier development within the otic vesicle has 
occurred normally.  On the other hand, survival of mature SAG neurons requires normal 
development at early stages. 
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Tfap2a acts non-autonomously  
It is noteworthy that tfap2a is not normally expressed in the TA pool or mature 
neurons, yet knockdown or misexpression of tfap2a alters the rate of differentiation and 
survival of these cells.  This raised the possibility that Tfap2a could act non-  
 
 
 
Figure 3.9: Tfap2a regulates SAG development non-autonomously.  (A-D) Whole-mounts (dorsal up, 
anterior left) and cross-sections (just posterior to utricular macula, medial to the left) showing both bright-
field and corresponding fluorescent images of +/+ host embryos (A, B) and hs:tfap2a host embryos 
stained for etv5b expression (blue) and showing transplanted wild-type donor cells (red).  Positions of 
wild-type cells that fail to express etv5b are highlighted with arrows in (C, D).  (E) Summary of mosaic 
analysis showing the number of +/+ or hs:tfap2a host embryos examined and the number of +/+ donor 
cells expressing etv5b over the total number of donor cells that populated the ventral half of the otic 
vesicle.  (F-H) Expression of etv5b at 26 hpf in a control (F), a DM-treated hs:tfap2a embryo (G) and DM-
treated wild-type embryo (H).  All specimens were treated with 1% DMSO and heat-shocked at 24 hpf.  
(I-L) Expression of bmp7a at 26 hpf in a control (I, J), tfap2a
-/-
 mutant (K) and hs:tfap2a embryo (L).  
Wild-type and hs:tfap2a embryos were heat shocked at 24 hpf.  
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autonomously on cells outside the ear.  To test directly whether tfap2a can act non-
autonomously, we generated genetic mosaics by transplanting wild-type cells into 
hs:tfap2a host embryos.   
We reasoned that if hs:tfap2a were to act non-autonomously, activating the 
transgene in host cells should be able to prevent wild-type cells from responding to Fgf  
sources in the otic vesicle.  In support, activation of hs:tfap2a at 24 hpf suppressed etv5b 
expression in the majority (73.5%) of transplanted wild-type cells by 26 hpf (Fig. 3.9C-
E), indicatingthat tfap2a acts non-autonomously to modulate the response to Fgf.  In 
contrast, all wild-type donor cells transplanted into wild-type host embryos showed 
normal expression of etv5b in the otic vesicle (Fig. 3.9A, B, E).  Thus Tfap2a non-
autonomously inhibits Fgf signaling in the otic vesicle (Fig. 3.9H).   
 
Bmp7a mediates the effects of Tfap2a 
We next surveyed expression of various bmp genes following activation of 
tfap2a and identified bmp7a as a likely candidate for mediating its effects on Fgf 
signaling.  bmp7a is normally expressed in cells at the anterior and posterior ends of the 
otic vesicle, and at a lower level in a ventrolateral domain that overlaps the tfap2a Bmp 
signaling is well known to antagonize Fgf signaling in a variety of developmental 
contexts.  Here we found that blocking Bmp signaling with the pharmacological 
inhibitor dorsomorphin (DM) (164) strongly suppressed the ability of hs:tfap2a to 
reduce Fgf signaling.  For example, etv5b expression was nearly normal in the otic 
vesicle 2 hours after the activation of hs:tfap2a when embryos were also treated with 
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DM (Fig. 3.9F, G).  DM treatment alone had negligible effects on expression of etv5b 
expression domain (162) (Fig. 3.9I-J, compare with Fig. 3.1C).  Expression of bmp7a 
was nearly abolished in tfap2a
-/-
 mutants (Fig. 3.9K).  In contrast, activation of hs:tfap2a 
strongly upregulated bmp7a expression in the otic vesicle as well as in surrounding 
tissues (Fig. 3.9L).  In contrast to bmp7a, we observed no consistent changes in 
expression of bmp2b or bmp4 following manipulation of tfap2a function (Fig. 3.S5), 
indicating that changes in bmp7a are relatively specific.  Together, these data suggest 
that tfap2a positively regulates bmp7a, which in turn restricts the level of Fgf signaling 
during otic development.  
 We next examined whether Bmp signaling mediates the effects of tfap2a on 
Notch activity.  In support, blocking Bmp with DM rescued expression of deltaB and 
her4 following activation of hs:tfap2a at 24 hpf  (Fig. 3.10A-L, M-P).  Treatment with 
DM alone caused a slight but significant increase in the number of cells expressing 
deltaB and her4 (Fig. 3.10D, H, I-L).  Thus the ability of tfap2a to restrict Notch 
signaling requires elevated Bmp signaling.  
Finally, we tested whether the effects of tfap2a on SAG development also require 
Bmp signaling.  Blocking Bmp after activating hs:tfap2a at 24 hpf restored neuroblast 
specification to normal in 6 out of 8 specimens (Fig. 3.10I-L, Q).  Similarly, 
accumulation of mature Isl1+ neurons was nearly normal in 12 out of 15 embryos at 30 
hpf (Fig. 10R) and was restored to normal in all specimens at 37 hpf (n=15) (Fig. 3.10S).  
DM treatment alone caused a slight but significant reduction in neuroblast specification 
and accumulation of mature SAG neurons (Fig. 3.10Q-S).  Together, these findings 
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support a model in which tfap2a regulates the level of bmp7a expression in the otic 
vesicle, which in turn restricts Fgf and Notch signaling to control the amount, duration 
and speed of SAG development.  
 
 
Figure 3.S5: The effects of tfap2a overexpression and knock-down on bmp2b and bmp4 expression. 
(A-H): Whole-mount images (dorsal up, anterior left) showing dorsolateral view of the otic vesicle 
(outlined) for bmp2b (A-D) and bmp4 (E-H) expression for the indicated genotypes and conditions.  
Activation of hs:tfap2a appears to reduce expression of both genes in portions of the otic vesicle, but 
bmb2b is upregulated in the hindbrain (B) and bmp4 is upregulated in the dorsal part of the otic vesicle 
(F).  Knocking down tfap2a had little or no effect on either gene (D, H). 
 
DISCUSSION 
We have shown that Tfap2a regulates development of SAG neurons by 
modulating Fgf, Notch and Bmp signaling.  Tfap2a overexpression promotes neurogenic 
specification in the otic vesicle and accelerates subsequent differentiation of TA  
precursors into mature neurons.  Conversely, disruption of tfap2a reduces the number of 
ngn1+ neuroblasts and decreases the rate of neuroblast differentiation.  The neurogenic 
effects of tfap2a overexpression result from inhibition of Notch and Fgf signaling, which 
normally serve to restrict neuroblast specification and delay differentiation.  The effects 
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of Tfap2a appear to be mediated by Bmp7a, which is upregulated in response to Tfap2a 
activity.  Bmp signaling in turn antagonizes Fgf and Notch signaling to promote 
specification and terminal differentiation of SAG precursors.  These findings are novel 
and clarify several aspects of SAG development, which are discussed further below. 
 
Coordination of Fgf and Notch 
The interplay between Fgf and Notch is complex and dynamic, and levels must 
be precisely balanced for proper development of the SAG.  A low-to-moderate level of 
Fgf is required to initiate neurogenesis by activating expression of ngn1 (76, 77, 82, 115, 
132), which in turn activates expression of Notch ligands (60, 86).  Notch activity serves 
to limit and slow neurogenesis (86, 163).  Neurogenesis is also inhibited at later stages 
by rising levels of Fgf5 derived from mature neurons (132) (Fig. 3.1K).  Without proper 
modulation by tfap2a, both Fgf and Notch signaling quickly become overactive, which 
terminates specification prematurely and impedes maturation of neuroblasts in the TA 
pool, thereby leading to under-production of mature SAG neurons.   
While too much Fgf and Notch activity clearly impairs neurogenesis, insufficient 
levels are ultimately far more damaging to SAG development.  Conditions that reduce 
Fgf and Notch signaling (e.g. overexpression of tfap2a) cause dramatic acceleration of 
differentiation and overproduction of neurons, most of which later die upon maturation.  
Neuronal death appears to arise secondarily from acceleration of early stages within the 
otic vesicle, as accelerating later stages does not lead to neuronal death.  It is likely that 
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early neuroblast differentiation is especially sensitive to acceleration due to insufficient 
buildup of factors needed for survival and function of mature neurons.  In contrast, an  
 
 
 
Figure 3.10: Bmp signaling mediates the effects of Tfap2a on SAG development.  (A-L) Cross 
sections (medial left, dorsal up) through the otic vesicle just posterior to the utricular macula showing 
expression of her4 (A-D) and deltaB (E-H) at 26 hpf and ngn1 (I-L) at 28 hpf in control embryos (A, E, I), 
hs:tfap2a embryos (B, F, J), DM-treated hs:tfap2a embryos (C, G, K) and DM-treated wild-type embryos 
(D, H, L).  All specimens were treated with 1% DMSO and heat-shocked at 24 hpf.  (M-P) Mean and 
standard deviation of the total number of deltaB or her4 expressing cells inside the otic vesicle or in the 
TA pool at 26 hpf under conditions indicated in the color key (counted from serial sections, n=3-6 ears per 
time point).  (Q-S) Mean and standard deviation of the total number of ngn1+ cells at 28 hpf (Q) and Isl1+ 
SAG neurons at 30 hpf (R) and 37 hpf (S) under the conditions indicated in the color key.  Asterisks (*) 
indicate statistical differences between the groups indicated in brackets.   
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important attribute of the TA pool is that the rate of differentiation can be regulated 
without compromising subsequent neuronal survival.  The TA pool represents a 
relatively stable population of slowly cycling progenitors that must be maintained to 
meet the needs of the growing larva or to regenerate new neurons following damage 
(132).  It is likely that tfap2a is needed only transiently in the otic vesicle to prolong 
specification and establish a healthy progenitor population.  Once neuroblast 
specification has terminated, however, downregulation of tfap2a appears necessary to 
allow Fgf and Notch signaling to rise sufficiently to balance rates of proliferation vs. 
differentiation in the TA pool. 
 
The role of Bmp 
We have shown for the first time a role for Bmp in SAG development.  
Numerous earlier studies have shown that Bmp regulates morphogenesis of semicircular 
canals (165-168) and numerous aspects of development of sensory epithelia (169-173).  
Bmp has also been found to promote SAG survival and neurite outgrowth in chick 
explant cultures (174).  However, no previous studies have detected a role in 
specification or differentiation of SAG neurons.  Abello et al. (76) reported that blocking 
Bmp signaling did not alter the size of the neurogenic domain in the chick otic vesicle; 
and mosaic misexpression of an activated form of Bmp receptor did not inhibit 
neurogenesis, though the possibility that it may have accelerated neurogenesis was not 
examined.  In comparison, we find that tfap2a activates expression of bmp7a and that 
blocking Bmp signaling reverses the effects of tfap2a overexpression.  Treating wild-
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type embryos with DM partially mimics the effects of disrupting tfap2a.  The more 
severe defects caused by tfap2a loss of function could indicate that additional factors 
help mediate the effects of Tfap2a.  Alternatively, Bmp7a could act partly through non-
canonical signaling, similar to the role of Bmp7 in establishing tonotopy in the organ of 
Corti in mouse (170). The specific requirement for Bmp7a in SAG development cannot 
be assessed by examining bmp7a mutants because development of the otic placode is 
severely compromised (175). Development of lines to conditionally disrupt or 
misexpress bmp7a could resolve many of these issues. 
 Interestingly, in zebrafish Bmp effectors Smad1 and Smad5 are specifically 
upregulated in delaminated SAG cells (112, 162) (Fig. 3.1K).  This constitutes an 
unusual form of regulation because smad1/5 genes are broadly expressed with relatively 
little variation in the level of expression.  Elevated levels of Smad1/5 accumulation 
could render SAG precursors outside the ear especially sensitive to Bmp, explaining how 
Bmp expressed within the otic vesicle could have such a profound effect on development 
of TA cells. 
 
Regulation of tfap2a 
We do not yet know how tfap2a is regulated in the otic vesicle.  We detect no 
changes in expression after manipulating levels of Fgf, Notch, Bmp, Wnt or ngn1.  It is 
possible that expression of tfap2a in the otic placode and otic vesicle reflects auto-
regulatory maintenance from earlier stages.  During gastrulation tfap2a is induced by 
Bmp in non-neural ectoderm where it functions as a competence factor for preplacodal 
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development (9).  Once induced Tfap2a acts to maintain its own expression even if Bmp 
is subsequently blocked (135).  This is an important aspect of regulation because 
dorsally expressed Bmp-antagonists are required to initiate preplacodal development 
near the end of gastrulation (7-9, 176).  Although expression of tfap2a could simply 
persist in the otic placode through self-maintenance, it is not clear how expression 
becomes restricted to ventrolateral cells in the otic vesicle.  A similar pattern is seen in 
the chick otic vesicle, possibly indicating a conserved mechanism ((177); Fig. 3.1).  
Identifying factors that regulate tfap2a in zebrafish and chick will likely shed light on 
general mechanisms of otic patterning and specific mechanisms of otic neurogenesis. 
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CHAPTER IV 
 
 
THE SPEMANN ORGANIZER GENE GOOSECOID PROMOTES DELAMINATION 
OF NEUROBLASTS FROM THE OTIC VESICLE
3
 
 
 
 
 
INTRODUCTION 
The Stato-Acoustic Ganglion (SAG) connects the inner ear to the brain and 
transmits hearing and balance information.  SAG neurons are generated by a stepwise 
program that starts in the otic vesicle, the precursor of the inner ear.  Initially, a subset of 
the cells in the otic epithelium is specified for neural fate by the upregulation of the 
proneural gene neurogenin1 (ngn1) (60, 61).  Otic expression of ngn1 is first detected by 
16 hpf, peaks at around 24 hpf and then gradually declines, ceasing entirely by 42 hpf 
(132).  Throughout this period, a subset of newly specified neuroblasts undergoes 
epithelial-mesenchymal transition (EMT) and delaminates from the otic vesicle (14) (14, 
178, 179).  In zebrafish, most neuroblasts lose ngn1 expression after leaving the otic 
vesicle and subsequently upregulate the related proneural factor neurod (64, 65, 180).  
                                                 
3
Reprinted with permission from “Spemann organizer gene Goosecoid promotes delamination of 
neuroblasts from the otic vesicle.” by Kantarci H., Gerberding A., & Riley B.B., 2016, Proceedings of the 
National Academy of Sciences of the United States of America, 113, 44:E6840-E6848. Copyright [2016] 
by National Academy of Sciences. 
  
88 
 
neurod expressing cells form a group of proliferating and migrating precursors called the 
transit-amplifying (TA) pool (66, 132).  As TA cells differentiate into mature SAG 
neurons, they lose neurod expression and upregulate mature neuronal markers such as 
Islet1 and Islet2b (67, 68).  The first mature Isl1+ SAG neurons are detected by 20 hpf 
and subsequently accumulate at a linear rate through at least 72 hpf (132).  At the same 
time, the TA pool is maintained as a stable population by proliferative renewal, assuring 
further growth of the SAG as larvae develop (132). 
 Specification of the neurogenic domain is established by a low threshold level of 
Fgf signaling (132, 181).  However, nothing is known about the mechanisms regulating 
delamination of neuroblasts from the otic vesicle.  Ngn1 is required for neuroblast fate 
specification (60, 61), but ngn1 is not sufficient to induce delamination.  In mouse, many 
cells that initially express Ngn1 ultimately remain in the otic vesicle and contribute to 
developing sensory epithelia (86).  In zebrafish, too, delamination of cells within the 
ngn1 domain appears highly restricted.  Clearly additional factors are required to initiate 
EMT in the otic epithelium during SAG development.   
 In addition to positive regulation, other factors appear to stabilize the otic 
epithelium and prevent inappropriate EMT.  In zebrafish, chick and mouse, Pax2 marks 
the nascent otic placode and is later restricted to the medial half of the otic vesicle (137, 
182-185).  Loss of Pax2 and related factor Pax8 compromises epithelial integrity, 
leading to faulty morphogenesis of the otic vesicle and cell dispersal (184, 185). 
 EMT is characterized by loss of epithelial markers and upregulation of 
mesenchymal genes, many of which confer the ability to migrate.  This process is critical 
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for establishment of the vertebrate body plan during gastrulation and is initiated by a 
unique group of cells originally described as Spemann’s organizer.  Goosecoid (gsc) is 
the most abundantly expressed homeobox gene in the vertebrate organizer (186, 187).  
Ectopic expression of Gsc is sufficient to induce organizer activity (188) and promote 
cell migration (189).  Gsc is also expressed in the tissues that undergo tissue remodeling 
at later stages, such as neural crest derived mesenchymal tissues (190).  Loss of Gsc 
function leads to craniofacial defects in mouse and humans (191-193).  It has also been 
found that many aggressive metastatic cancers show strong upregulation of Gsc, and 
experimental misexpression of Gsc strongly promotes EMT and enhances metastasis 
(194, 195).  Interestingly, Gsc expression has been reported in the developing otic 
vesicle in mouse (190, 196)  but its functional importance has never been investigated.  
Due to these widespread roles of Gsc in regulating epithelial dynamics, we examined 
whether Gsc regulates EMT during otic neurogenesis in zebrafish.  
 Here we describe a full time course for gsc expression in the zebrafish otic 
vesicle.  Disruption of gsc impairs delamination of SAG neuroblasts, whereas 
misexpression of gsc strongly promotes neuroblast delamination.  Although gsc is 
regulated by Fgf in a domain that partially overlaps with ngn1, gsc does not affect neural 
fate specification.  Thus, ngn1 and gsc act in parallel downstream of Fgf to coordinate 
neural fate specification with morphogenesis.  Further analysis revealed the transcription 
factor Pax2a functions as a strong epithelializing factor expressed in the non-neurogenic 
regions of the otic vesicle.  Moreover, Pax2a represses gsc transcription and function, 
helping to restrict EMT to the neurogenic domain of the otic vesicle.  
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MATERIALS AND METHODS 
 
Fish strains and developmental conditions 
Wild-type embryos were derived from the AB line (Eugene, OR).  Transgenic 
lines used in this study include Tg(hsp70:fgf8a)
x17
(19), Tg(hsp70I:dnfgfr1-
EGFP)
pd1
(98), TgBAC(neurod:EGFP)(197), Tg (hsp70:pax2a)
x23
(198), and lines 
produced for this report Tg(hsp70:gsc)
x58
 and Tg(hsp70:ngn1)
x28
.  Transgenic lines are 
named in the text as hs:fgf8, hs:dnfgfr1, nrd:GFP, hs:pax2a, hs:gsc and hs:ngn1, 
respectively.  Mutant lines gsc
x59 
and pax2a
 tu29a 
(199) were used for loss of function 
analysis.  Homozygous mutants were identified by characteristic morphological changes.  
Embryos were maintained at 28.5 °C (except where noted) and staged accordingly to 
standard protocols (100).   PTU (1-phenyl 2-thiourea, 0.3 mg/ml, Sigma) was added to 
block pigment formation.  
 
Gene misexpression and morpholino injections   
To activate the heat shock transgenes, heterozygous carriers were incubated in a 
water bath at 39°C for 60 minutes (except where noted).  After heat-shock embryos were 
kept at 33°C until the fixation.  At least 15 embryos were observed for each time point.  
Transgenic carriers were identified by characteristic phenotypes when available, or by 
PCR-genotyping as previously described (200).  Primer sequences are as follows (5’-3’): 
hs:gsc GCAATGAACAGACGGGCATTTA (F), GAATACACGGACACTGTTGCG 
(R) ; hs:pax2a GCAATGAACAGACGGGCATTTA (F), 
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TCTGCTTTGCAGTGAATATCCA (R).  In some experiments ngn1 or gsc were 
knocked down by injecting embryos at the one-cell stage with 5 ng of morpholino 
oligomer (MO) using previously published MO sequences (61, 201).  
 
In situ hybridization and immunohistochemistry 
Wholemount in situ hybridization and antibody labeling were performed as 
previously described (72, 102).  The primary and secondary antibodies used in this study 
are as follows: Anti-Islet1/2 (Developmental Studies Hybridoma Bank 39.4D5, 1:100), 
anti-GM130 ( BD Transduction Laboratories
TM
 610822, 1:100), anti-ZO1 
(ThermoFisher Scientific 33-9100, 1:150), anti-phospho-Paxillin pTyr118 
(ThermoFisher Scientific PA5-17828, 1:50), anti-phospho-Histone H3 (EMD 
MILLIPORE 06-570, 1:350) and Alexa 546 goat anti-mouse or anti-rabbit IgG 
(ThermoFisher Scientific A-11003/A-11010, 1:50).  TUNEL assay was performed by 
using Promega terminal deoxynucleotidyl transferase (M1871) according to 
manufacturer’s protocol.  Whole-mount stained embryos were prepared for 
cryosectioning as preciously described (132) and cut serially into 10 μm sections.  
 
Statistics   
Quantitation of cells expressing genes of interest was performed either in 
wholemounts (n=6-20 specimens each) or by counting cells in serial sections (n=2-4 
specimens each).  In experiments to test the effects of altering gene function, 
homozygous mutants and transgenic embryos were identified by characteristic 
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morphological changes or PCR-genotyping.  Student’s t-test was utilized for pairwise 
comparisons.  Comparisons between three or more samples were analyzed by one way 
ANOVA and Tukey post-hoc HSD test.  
 
RESULTS 
 
Fig. 4.1.  Expression and regulation of gsc during otic neurogenesis.  (A-L) Whole mount images 
(dorsal up, anterior left) show dorsolateral views of gsc expression in the otic vesicle (outlined) at the 
indicated times.  (M-R) Cross sections (dorsal up, medial left) passing through the widest part of the 
neurogenic domain showing expression of gsc or ngn1 at the indicated times.  The otic epithelium is 
outlined in each image.  (S) Maps of regional markers in the floor of the otic vesicle (medial up, anterior 
left) generated from serial cross sections of embryos stained for ngn1, gsc, or GM130 at 24 or 30 hpf.  The 
location and number of cells expressing individual markers (4 embryos each) was normalized and plotted 
accordingly.  
 
Expression of gsc during otic neurogenesis   
To assess the function of gsc during development of SAG neurons we examined 
expression of gsc in the otic vesicle during relevant stages.  gsc is first detected in a 
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small number of ventral otic cells at 20 hpf and becomes strongly upregulated in a 
ventrolateral domain by 22 hpf (Fig.4.1A, B).  This domain lies close to the neurogenic 
domain of the otic vesicle (61).  Ventrolateral expression of gsc is maintained in the otic 
vesicle through at least 48 hpf (Fig. 4.1C-F), beyond the stage when neurogenesis 
normally ceases (132). 
 Neurogenesis in the otic vesicle, marked by expression of ngn1, is initiated by a 
low level of Fgf signaling, whereas high-level Fgf signaling blocks expression of ngn1 
(132).  Expression of gsc shows similar regulation by Fgf.  Specifically, blocking Fgf 
signaling by activation of hs:dnfgfr1 (dominant-negative Fgf receptor) completely 
eliminated gsc expression in the otic vesicle (Fig. 4.1G, H).  Additionally, low level 
activation of hs:fgf8 at 35°C expanded the domain of gsc expression, with a more 
modest expansion seen at 37°C (Fig. 4.1I, J).  Thus, the requirement for Fgf and 
response to low-level Fgf appears highly similar for gsc and ngn1.  However, expression 
of gsc does not require ngn1: High-level activation of hs:fgf8 at 39°C represses ngn1 
expression (132) but did not abolish gsc expression (Fig. 4.1K).  Additionally, 
expression of gsc was normal in ngn1 morphants (Fig. 4.1L).  Similarly, ngn1 expression 
does not require gsc, as shown below.  Thus gsc and ngn1 are co-induced by low-level 
Fgf signaling but are not dependent on each other. 
 We next compared the spatial patterns of gsc1 and ngn1 expression in serial 
sections.  This confirmed that expression of gsc partially overlaps with ngn1 in the otic 
floor at least through 36 hpf (Fig. 4.1M-R).  gsc expression can also be detected in a 
small number of cells just ventral to the otic vesicle (Fig. 4.1M), presumably marking 
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recently delaminated neuroblasts.  After leaving the otic vesicle, these cells quickly lose 
gsc expression: Neither transit-amplifying neuroblasts (marked by neurod) nor mature 
SAG neurons (marked by Isl1) show detectable expression of gsc (Fig. 4.S1).   To 
further examine the degree of overlap between gsc and ngn1 expression domains, we 
mapped the locations of cells expressing either gsc or ngn1 in the otic floor based on 
data from serial sections.  ngn1 is expressed in the otic floor adjacent and lateral to the 
developing sensory epithelia (Fig. 4.1S).  Expression of gsc overlaps with lateral 
portions of the ngn1 domain but extends to more lateral and posterior regions of the otic 
floor (Fig. 4.1S).  Because Gsc is known to regulate epithelial-mesenchymal transition 
(EMT) (189, 195), we also examined expression of GM130, a Golgi marker that 
undergoes a dramatic basal relocalization as cells undergo EMT (202, 203).  The pattern 
of GM130-staining in the otic floor revealed that the highest rate of EMT occurs in the 
region where ngn1 and gsc are coexpressed. (Fig. 4.1S).    
 
 
Fig. 4. S1.  Expression of gsc during later stages of SAG development. (A-C) Images show expression 
of gsc (A), nrd (B) and immuno detection of Isl1 in DAPI stained (C) cross sections passing through the 
middle of the otic vesicle in wild type embryos.  The otic epithelium is outlined with black, TA cells are 
outlined with blue and mature SAG neurons are outlined in red.  Gsc expression is absent from the TA 
cells or mature SAG neurons.  gsc is also expressed in the pharyngeal endoderm (red arrows) and neural 
crest derived pigment cells (black arrows).  
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Fig. 4.S2.  Generation of gsc mutants via TALEN-targeting.  (A) A summary of the TALEN target 
sequences on the first exon of the gsc locus (marked in green) and the resulting lesions (marked in red) at 
the predicted cut site (marked in blue) are shown for the two F1 founders isolated during the screening 
process.  (B-I) Live specimens at 24 hpf were viewed at low magnification to show general morphology 
(B, E) and at higher magnifications to show cranial development (D-F) and the otic vesicle (G-I) in 
controls, gsc morphants and gsc mutants.  (J-L) Live specimens at 96 hpf viewed from lateral (J, K) or 
ventral (L, M) reveal cardiac edema and jaw hypoplasia in gsc mutants.  (N) Mean and standard deviation 
of surface area of the otic vesicles, normalized to control embryos, are indicated for gsc mutants and gsc 
morphants at 24 hpf.   
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Role of Gsc during otic neurogenesis   
We next tested the effects of disrupting or misexpressing gsc on otic 
neurogenesis.  Using TALEN-mediated targeting, we recovered two lesions predicted to 
eliminate gsc function (Fig. 4.S2A).  Disruption of gsc did not cause axial defects or any 
overt changes in the gross morphology at 24 hpf (Fig. 4.S2B, C).  However, gsc mutants 
did show a slight (~7%) reduction in the size of the otic vesicle (Fig. 4.S2G-I, N) and 
impaired neural delamination as described below.  At later stages gsc mutants also 
developed cardiac edema and a severe jaw defect (Fig. 4.S2J-M).   
Similar phenotypes were seen in gsc morphants, although gsc morphants also showed 
mild brain necrosis not observed in mutant embryos (Fig. 4.S2D-F).   
 Despite the reduced size of the otic vesicle in gsc mutants, most aspects of otic 
patterning appeared normal, including expression of various regional markers and 
accumulation of sensory hair cells (Fig. 4.S3).  In addition, gsc mutants produced a 
normal number of the ngn1+ neuroblasts in the otic epithelium (Fig. 4.2A, B, G).  
However, the number of ngn1+ neuroblasts outside the otic vesicle was reduced by more 
than 50% at all stages of neurogenesis, suggesting a reduced rate of neuroblast 
delamination.  A similar deficiency of recently delaminated ngn1+ neuroblasts was seen 
in gsc morphants (Fig. 4.2G).   
To overexpress gsc, we generated a heat-shock inducible transgenic line, hs:gsc 
(Fig. 4.S4).  Overexpression of gsc at 22 hpf led to a dramatic decrease in the number of 
ngn1+ neuroblasts in the otic epithelium within 60 minutes, with a concomitant increase 
in the number of ngn1+ cells outside the otic vesicle (Fig. 4.2C, H, I).  The number of 
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ngn1+ cells outside the ear remained elevated in hs:gsc embryos for several hours but 
then  returned to control levels by 25 hpf (Fig. 4.2I), presumably reflecting the decline in 
transgene activity (Fig. 4.S4).  Activation of hs:gsc at 30 hpf or 36 hpf gave results 
similar to those observed following activation at 22 hpf (Fig. 4.2H, I).  Otic neurogenesis 
normally ends by 42 hpf (132), so we tested whether activation of hs:gsc at this stage 
could reinitiate neuroblast specification.  Activation of hs:gsc at 42 hpf failed to 
reinitiate ngn1 expression in the otic vesicle, but nevertheless caused a substantial 
increase in the number of ngn1+ cells outside the otic vesicle (Fig. 4.2D-F, H, I).  This 
latter increase appears to result from a stage-specific effect on proliferation of transit-
amplifying neuroblasts, as shown below.   
Together, these data suggest that Gsc does not affect neuroblast specification but 
instead enhances the ability of neuroblasts to leave the otic vesicle.  The effect of Gsc on  
neuroblast delamination was highly specific, as other aspects of otic vesicle development 
appeared largely normal several hours after activating hs:gsc (Fig. 4.S3).   
We next examined the effects of Gsc on the epithelial and mesenchymal cell markers. 
Zonula Occludens (ZO)-1 is expressed apically in epithelial otic cells but is lost upon 
transition to the mesenchymal state (Fig. 4.S5A, D, G), whereas the transition is marked 
by activation of the focal adhesion protein p-Paxillin at the leading edge of migrating 
cells (Fig. 4.2K, N; Fig. 4.S5A).  Delaminating otic cells also show dramatic 
redistribution of golgi marker GM130 to the basal surface as cells transition to the 
mesenchymal state (Fig. 4.2Q, T).  gsc mutants showed more ZO-1 staining in the otic  
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Fig. 4.S3 .  Effects of altering gsc function on otic vesicle patterning.  (A-U) Whole-mount images 
(dorsal up, anterior left) show dorsolateral views of the otic vesicle (outlined) in controls, gsc mutants and 
hs:gsc embryos for the indicated genes at 24 hpf.  Patterning of the otic vesicle is not affected in gsc 
mutants.  Hs:gsc embryos show a slight decrease in the expression of ventral-lateral otic marker otx1 (F) 
but otherwise appear normal.  (V) Mean and standard deviation of the total number of hair cells in utricular 
and saccular maculae of control embryos, gsc mutants and hs:gsc embryos at the indicated times (n= 3 
embryos each).  Data were obtained by counting hair cells in the serial sections.  Accumulation of the hair 
cells was normal except that gsc mutants showed a small but significant decrease relative to the control at 
36 hpf.  There was also a slight decrease in the number of hair cells (though not statistically significant) in 
hs:gsc embryos at 78 hpf.  
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Fig. 4.S4.  Heat-shock activation of hs:gsc during gastrulation or otic development.  (A-C) Whole 
mount live images at 24 hpf (dorsal up, anterior left) show the phenotypic effects of a 30 min 39°C heat-
shock initiated at 6 hpf in control and hs:gsc embryos.  Activation of hs:gsc under these standard heat-
shock conditions dorsalized the embryos to varying degrees (B, C).  (D-I) Whole-mount images (dorsal up, 
anterior left) showing gsc expression in controls and hs:gsc embryos.  Embryos were fixed and stained at 
indicated times after the end of a 60-minute heat-shock initiated at 22 hpf.  Activation of hs:gsc at 22 hpf 
led to a strong increase in the gsc level by the end of the heat-shock period (E).  The level of gsc 
expression was maximal at 23.5 hpf (F) but declined rapidly thereafter, returning to normal by 25 and 26 
hpf (H, I). 
 
epithelium (Fig. 4.S5B, E, H) and a loss of cells with p-Paxillin staining (Fig. 4.2L, O).  
gsc mutants also showed a reduced number of cells with basal GM130 staining (Fig. 
4.2R, U).  Conversely, activation of hs:gsc reduced the ZO-1 staining in the otic 
epithelium (Fig. 4.S5C, F, I) and increased the number of cells with p-Paxillin staining 
(Fig. 4.2M, P; Fig. 4.S5C).  Activation of hs:gsc also increased the number of cells with 
basal GM130 staining (Fig. 4.2S, V).  Overall, these results suggest that gsc stimulates 
EMT of neural progenitors in the otic vesicle without affecting cell fate specification.   
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Fig. 4.2.  Gsc promotes EMT of otic neuroblasts.  (A-F) Expression of ngn1 in cross sections passing 
through the widest part of the neurogenic domain (dorsal up, medial left) just posterior to the utricular 
sensory epithelium expression in controls, gsc mutants and hs:gsc embryos at 24 hpf (A-C) or 43.5 hpf (D-
F).  Control and transgenic embryos were heat shocked at 22 hpf (A, C) or 42 hpf (D, F).  The otic 
epithelium is outlined in each image.  (G) Mean and standard deviation of the total number of ngn1+ cells 
in the otic epithelium and outside the otic vesicle for the genotypes indicated in the color key (counted 
from the serial sections, n=3 or 4 otic vesicles per time point).  The number of ngn1+ neuroblasts in the 
otic epithelium was normal in gsc mutants and morphants at all stages, except for a small but significant 
reduction seen in gsc morphants at 24 hpf (asterisk).  (H-J) For the genotypes indicated in the color key, 
embryos were heat shocked at the indicated times and fixed several hours later to stain for ngn1 (H, I) or 
basal relocalization of GM130 (J).  Data show the mean and standard deviation of the total number of 
stained cells in the otic epithelium or delaminated cells outside the otic vesicle (counted from the serial 
sections, n=3 otic vesicles per time point).  Asterisks (*) indicate significant differences from control 
specimens.  (K-V) EMT markers in cross sections (dorsal up, anterior left) passing through the neurogenic 
domain of control embryos, gsc mutants or hs:gsc embryos immuno-stained for p-Paxillin (K-P) or 
GM130 (red) and DAPI (blue) (Q-V).  Controls and transgenic embryos were heat shocked at 22 hpf.  
Boxed regions in K-M are magnified in N-P, and boxed regions in Q-S are magnified in T-V.  White 
arrows indicate elevated basal staining in cells undergoing EMT. 
 
 Consistent with this idea, we observed a ~12% decrease in the size of the otic vesicle at 
24 hpf following activation of hs:gsc at 22 hpf  (Fig. 4.S6A, B), likely caused by the 
increased number of cells leaving the otic vesicle.  This size reduction persisted through 
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at least 31 hpf (Fig. 4.S6), suggesting a limited capacity to compensate for earlier cell 
loss.   
 
 
Fig. 4.S5.  Effects of altering gsc function on ZO-1 and p-Paxillin.  (A-I) Cross sections through the 
neurogenic domain just posterior to the utricular macula in a control embryo (A, D, C), gsc mutant (B, E, 
H) and hs:gsc embryo (C, F, I) at 24 hpf.  These are the same sections depicted in Fig. 2K-P but showing 
co-staining for p-Paxillin (red) and ZO-1 (green) (A-C), or ZO-1 alone (D-I).  The boxed regions in (A-F) 
are enlarged in (G-I).  White arrows (A-C) indicate cells undergoing EMT with elevated basal 
accumulation of p-Paxillin, whereas double-headed arrows (D-I) span the otic epithelium to highlight 
changes in ZO-1 staining. 
 
Effects of Gsc on later stages of SAG development 
Next, we examined whether altered delamination of neuroblasts affected later 
stages of neural development.  Normally, newly delaminated neural progenitors quickly 
lose expression of ngn1 and upregulate neurod, marking the transit-amplification (TA) 
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stage of SAG development (64-66, 132, 180).  TA cells migrate towards the hindbrain as 
they proliferate and then differentiate into mature neurons, marked by Isl1 staining.   The 
number of neurod+ TA cells and mature neurons was significantly reduced in gsc 
mutants and morphants at every time point examined (Fig. 4.3B, E, G, H).   This is 
consistent with impairment of neuroblast delamination seen in these embryos.  
Conversely, activation of hs:gsc at 22 hpf led to a ~30% increase in the number of 
neurod+ TA cells and mature neurons (Fig. 4.3C, F, G, H).  
 
 
Fig. 4.S6.  The size of the otic vesicle declines following activation of hs:gsc.  (A-F) Whole mount live 
specimens show dorsolateral views of the otic vesicle in controls (A-C) and hs:gsc embryos (D-F).  (G) 
Mean and standard deviation of surface area of the otic vesicle, normalized to control embryos, are 
indicated for hs:gsc embryos at the indicated time points 
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Fig. 4.3.  Effects of Gsc on later stages of SAG development. (A-F) Cross sections passing through the 
utricular sensory epithelium (dorsal up, medial left) in controls, gsc mutants and hs:gsc embryos showing 
expression of nrd (A-C) or Isl1 (outlined in orange, D-F).  The otic epithelium is outlined in all images.  
(G-J) Mean and standard deviation of the total number of nrd+ (G, I) or Isl1+ (H, J) cells for the genotypes 
indicated in the color key at times presented on the X-axes. nrd+ cells were counted on serial sections 
(n=3-5), Isl1+ cells were counted on whole mounts for time points between 30-48 hpf (n=10-17) and on 
serial sections for 53 and 78 hpf (n=2-3).  (K) Mean and standard deviation of the total number of 
Phospho-Histone H3 (Ph3)+ cells within the nrd:Gfp+ domain (which marks TA cells) at the indicated 
times in control and hs:gsc embryos.  Embryos were heat shocked at the indicated times.  Asterisks (*) 
indicate statistically significant differences compared to control embryos.  
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Furthermore, the number of mature SAG neurons remained elevated in these embryos 
through at least 50 hpf before returning to control levels (Fig. 4.3H).  Overexpression of 
gsc during earlier placodal stages also increased accumulation of Isl1+ neurons at 30 
hpf, though to a lesser degree than activation at 22 hpf (Fig. 4.S7C).  Activation of 
hs:gsc at 30 hpf gave results similar to activation at 22 hpf (Fig. 4.3I, J; Fig.  
4.S7A, B).  Interestingly, activation of hs:gsc at 36 or 42 hpf caused a disproportionately 
greater increase in the number of neurod+ TA cells compared to earlier activation (Fig. 
4.3I).  This was unexpected because rates of neuroblast specification are very low at 
these later stages, suggesting another source of supernumerary neurod+ cells.  Analysis 
of the cell proliferation revealed that activation of hs:gsc at 36 or 42 hpf dramatically 
increased the rate of mitosis in TA cells (Fig. 4.3K), likely accounting for increased 
numbers of TA cells expression ngn1 and neurod (Figs. 4.2F and 4.3I).  In contrast, 
activation of hs:gsc at 22 hpf reduced the rate of proliferation amongst TA cells (Fig. 
4.3K).  Thus, activation of hs:gsc increases the number of TA cells by different 
mechanisms at different stages: Gsc increases the rate of neuroblast delamination during 
early stages of neurogenesis, whereas it increases the rate of proliferation in TA cells 
during later stages of neurogenesis.  Activation of hs:gsc did not alter the rate of 
proliferation in the otic epithelium (Fig. 4.S7D).  gsc mutants showed normal 
proliferation in the otic epithelium and in TA cells at all stages (Fig. 4.S7E). 
 Despite the initial surge in neurod+ cells following activation of hs:gsc at 36 or 
42 hpf, the number of neurod+ TA cells subsequently returned to the level seen in 
control embryos by 78 hpf (Fig. 4.S7A).  The decline in TA cells occurred 
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concomitantly with a corresponding increase in the number of mature Isl1+ neurons 
(Fig. 4.S7B).   
   
 
Fig. 4.S7.  Effects of Gsc on development of SAG neurons and sensory epithelia.  (A-C) Mean and 
standard deviation of the total number of nrd+ TA cells (A) or Isl1+ (B, C) SAG neurons for the genotypes 
indicated in the color key.  Nrd+ cells were counted on serial sections, Isl1+ cells were counted on 
wholemounts for time points between 30-48 hpf (n=10-17) and on serial sections for 53 and 78 hpf (n=2-
3).  (D, E) Mean and standard deviation for the number of pH3+ cells in the otic epithelium of hs:gsc 
embryos (D) or in the otic epithelium or TA cells in gsc mutants (E) at the indicated times.  (F) Mean and 
standard deviation of the total number of TUNEL+ hair cells or SAG neurons at the indicated times in 
controls, gsc mutants or hs:gsc embryos.  TUNEL+ cells were counted from serial sections (n=3 or 4 otic 
vesicles per time point) except at 42 and 48 hpf when counts were performed on whole mounts for hs:gsc 
and control embryos (n=10-15).  Asterisks (*) indicate significant differences compared to control 
embryos. 
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gsc loss of function and overexpression led to a modest increase in the rate of apoptosis 
amongst hair cells and mature neurons (Fig. 4.S7F).  The elevated cell death possibly 
reflects the detrimental effects of altering epithelial integrity or non-autonomous effects 
of gsc function (See discussion). 
 
 Cooperation between Gsc and Ngn1 in regulating EMT 
We noted that the ability of Gsc to promote EMT appeared to be restricted to the 
otic floor near the domain of ngn1 expression.   This prompted us to examine the role of 
ngn1 in EMT.  In ngn1 morphants, the number of ngn1+ cells that accumulated outside 
the otic vesicle was severely reduced (Fig. 4.S8A), although a small number of 
delaminated cells was still observed.  The fate of these cells is unclear, but they are 
unable to continue SAG development since ngn1 morphants produce no TA cells or 
mature SAG neurons.  The number of delaminated cells nearly doubled in ngn1 
morphants following activation of hs:gsc, but remained far below normal (Fig. 4.S8B, 
C).  These data suggest that Gsc provides otic cells with a limited capacity for 
undergoing EMT in the absence of proper fate specification, but the capacity for 
delamination is strongly enhanced by ngn1.  To test this further, we tested the effects of 
simultaneous overexpression of gsc and ngn1.  Co-activation of hs:ngn1 and hs:gsc 
resulted in additive increases in the number of neurod+ TA cells and mature SAG 
neurons by 30 hpf, and these increases persisted through at least 48 hpf ( Fig. 4.S8D-I).  
Interestingly, activation of hs:ngn1 induced ectopic neurod+ neuroblasts in the medial 
wall of the otic vesicle, but these neuroblasts were not observed to undergo delamination  
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Fig.  4.S8.  Ngn1 and Gsc work in concert during otic neurogenesis.  Transgenic embryos were heat 
shocked at 22 hpf.  (A, B) Cross sections passing through the neurogenic domain of the otic vesicle just 
posterior to the utricular macula show ngn1 expression in the indicated genotypes.  Black arrows indicate 
delaminated cells outside the otic vesicle.  (C) Mean and standard deviation for the total number of ngn1+ 
cells outside the otic vesicle.  Genotype of the embryos is indicated in the color key.  (D-G) Cross sections 
show nrd+ cells in embryos with indicated phenotypes. Black arrows point to the ectopic expression of 
nrd in the medial otic vesicle (F, G) including delamination from the medial wall of the otic vesicle in 
hs:gsc embryos (G).  (H, I) Mean and standard deviation for the total number of nrd+ cells (H) and Isl1+ 
mature SAG neurons (I) in embryos with genotypes indicated in the color key.  Asterisks (*) indicate 
statistically significant differences between groups indicated by brackets or compared to control embryos. 
 
(Fig. 4.S8F).  In contrast, co-activation of hs:ngn1 and hs:gsc appeared to promote 
delamination of ectopic neurod+ neuroblasts from the medial wall (Fig. 4.S8G).  Thus, 
ngn1 and gsc synergize to promote EMT in the otic floor and to a lesser degree the 
medial wall.  However, the ability to promote neurogenesis and delamination from  
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Fig. 4.4.  Pax2a opposes the function of Gsc in the otic epithelium.  (A-F) Cross sections (dorsal up, 
medial left) passing through the widest part of the neurogenic domain of the otic vesicle just posterior to 
the utricular macula showing expression of pax2a or gsc at 24 hpf (outlined in red) in embryos with 
indicated genotypes.  Control and transgenic embryos were heat shocked at 22 hpf.  The otic epithelium is 
outlined black in each image.  (G, H) Mean and standard deviation of the percentage of cells expressing 
pax2a or gsc in successive sections through the otic floor in the embryos with indicated genotypes. Data 
were obtained by counting the number of stained and unstained cells in each section (n=3-4 specimens).  
Illustrations of typical domains of pax2a and gsc (medial up, anterior left) are provided above each graph 
to help clarify spatial patterns within each section of the otic floor.  (I-M) Expression of ngn1 at 24 hpf in 
embryos with indicated genotypes.  Transgenic embryos were heat shocked at 22 hpf.  (N-Q) Expression 
of ngn1 (N, O) and gsc (P, Q) in controls and pax2a mutants at 30 hpf.  (R-U) Mean and standard 
deviation of the total number of ngn1+ cells inside the otic epithelium or outside the otic vesicle (R, S; 
counted on serial sections, n=3-4), nrd+ TA cells (T; counted on serial sections, n=3-4) and Isl1+ cells (U; 
counted on whole mounts, n=6-12).  Control (hs) and transgenic embryos were heat shocked at 22 hpf and 
fixed at time points indicated.  Asterisks (*) indicate significant differences compared to control embryos.  
Hs:gsc+hs:pax2a embryos were significantly different than hs:gsc embryos at all time points but showed 
no statistical difference compared to hs:pax2a embryos.  
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ectopic sites was quite limited, suggesting that other regional factors act to oppose these 
functions in non-neurogenic regions. 
 
Pax2a opposes Gsc function in the otic vesicle   
We hypothesized that pax2a, which is expressed in the medial half of the otic 
vesicle, acts to oppose gsc function and block EMT.  Pax2 has been shown to stabilize 
the otic epithelium during placodal stages in zebrafish, chick and mouse (110, 184, 185, 
204),  raising the possibility that this function persists after expression becomes 
restricted to the medial wall of the otic vesicle (Fig. 4.4A).  We therefore examined the 
functional relationship between pax2a and gsc in the otic vesicle.  Normally, pax2a 
expression abuts but does not overlap the neurogenic domain in the otic floor.  In gsc 
mutants, pax2a expression expanded laterally into the neurogenic domain, albeit at a 
relatively low level (Fig. 4.4B, G), whereas activation of hs:gsc caused the domain of 
pax2a to recede slightly from the otic floor in regions near the sensory maculae (Fig. 
4.4C, G).  Conversely, in pax2a mutants the domain of gsc expression showed a weak 
medial expansion whereas activation of hs:pax2a completely eliminated gsc expression 
within 2 hours (Fig. 4.4D-F, H).  These data suggest that gsc and pax2a mutually repress 
each other’s expression in the otic floor, with a especially prominent role of pax2a in 
repressing gsc.  Next we examined whether pax2a function affects neurogenesis or EMT 
in the otic vesicle.  Loss of pax2a function did not alter ngn1 expression in the otic 
epithelium yet transiently increased the number of delaminated ngn1+ neuroblasts at 24 
hpf (Fig. 4.4J, R), consistent with the observed expansion of gsc expression in these 
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embryos (Fig. 4.4E, H).  However, the number of delaminating cells in pax2a mutants 
subsequently fell to less than half of normal at 27 and 30 hpf (Fig. 4.4R).  Consistent 
with dynamic changes in delamination, accumulation of TA cells and mature neurons 
was initially elevated in pax2a mutants but subsequently returned to normal after 30 hpf 
(Fig. 4.4T, U).  The later decline probably reflects sporadic cell death in otic neurons and 
epithelia as previously noted in zebrafish and mouse mutants lacking Pax2 (204-206).  In 
contrast to the effects of disrupting pax2a, activation of hs:pax2a at 22 hpf strongly 
suppressed delamination of ngn1+ neuroblasts by 23-24 hpf (Fig. 4.4K, S), consistent 
with loss of gsc expression (Fig. 4.4F).  Accumulation of TA cells and mature SAG 
neurons was also severely impaired following activation of hs:pax2a, and these 
deficiencies persisted through at least 48 hpf (Fig. 4.4T, U).   Importantly, co-activation 
of hs:gsc and hs:pax2a at 22 hpf completely masked the effects of hs:gsc, causing a 
phenotype similar to activation of hs:pax2a alone: Specifically, neuroblast delamination 
was strongly suppressed (Fig. 4.4S), and there was a lasting deficit in accumulation of 
TA cells and mature SAG neurons (Fig. 4.4T, U).  Thus, in addition to repressing gsc 
transcription, Pax2a antagonizes transgenic Gsc activity. 
 EMT is typically induced by repression of genes encoding Cadherins.  We 
therefore surveyed expression of various cadherin genes in relation to gsc and pax2a 
function in the otic vesicle.  During normal development the E-cadherin gene cdh1 is 
expressed throughout the otic vesicle, but expression levels varied markedly in the otic 
floor, with low-expressing cells potentially corresponding to cells undergoing EMT (Fig. 
4.5A).  In gsc mutants, cdh1 was expressed at uniformly high levels throughout the otic  
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Fig. 4.5.  Gsc and Pax2a differentially regulate cdh1.  (A-F) Cross sections passing through the 
neurogenic domain of the otic vesicle just posterior to the utricular macula showing cdh1 expression at 23 
hpf in embryos with indicated genotypes.  The otic epithelium is outlined in each image.  Arrows in (A) 
indicate cells with very low cdh1 expression interspersed with cells showing high cdh1 expression.  (G) 
Mean and standard deviation of the percentage of cells in the otic floor expressing cdh1 in the embryos 
with indicated genotypes.  Data were obtained by counting the number of stained and unstained cells in 
serial sections (n=3-4).  Transgenic embryos were heat shocked at 22 hpf.  Asterisks (*) indicate 
significant differences between groups indicated by brackets or compared to control embryos.  (H) A 
model for regulation of epithelial tissue dynamics during otic neurogenesis.  See text for details. 
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floor (Fig. 4.5B), whereas activation of hs:gsc at 22 hpf caused global downregulation of 
cdh1 in the otic epithelium (Fig. 4.5C).  The opposite relationship was seen with regard 
to Pax2a function: pax2a mutants showed little change in cdh1 expression, although 
levels appeared slightly reduced in the otic floor (Fig. 4.5D).  Activation of hs:pax2a 
caused substantial upregulation of cdh1 throughout the otic vesicle, including uniformly 
high expression in the otic floor (Fig. 4.5E).  Co-activation of hs:pax2a and hs:gsc led to 
uniformly high expression of cdh1 throughout the otic vesicle, similar to activation of 
hs:pax2a alone (Fig. 4.5E, F).  Changes in the percentage of cells in the otic floor 
expressing cdh1+ cells, determined by counting cells in serial sections, confirmed the 
above trends (Fig. 4.5G).  Overall these results suggest that Gsc and Pax2a have 
opposing effects on tissue architecture mediated in part by differential regulation of cdh1 
transcription. 
 Global loss of E-cadherin transcription does not lead to widespread cell dispersal 
in hs:gsc embryos.  This prompted us to analyze the expression of other cadherin genes 
that might have redundant functions in the otic vesicle.  Indeed, expression of cdh2 
remained unaffected in the otic vesicle upon loss of function or overexpression of gsc 
and/or pax2a (Fig. 4.S9A-F).  Cdh11 is expressed in the non-neurogenic regions of the 
otic vesicle such as the medial and lateral walls (Fig. 4.S9G) and did not show any 
changes in gsc mutants or hs:gsc embryos (Fig. 4.S9H, I).  However, cdh11 transcript 
was lost from part of the medial wall in pax2a mutants whereas activation of hs:pax2a 
induced cdh11 expression in ectopic locations including the otic floor (Fig. 4.S9J-L).  
Conceivably, cdh11 also helps to mediate Pax2a’s role in stabilizing epithelial integrity.  
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Cdh6 is predominantly expressed in the delaminated otic neuroblasts in the TA pool 
(Fig. 4.S9M).  In keeping with the effects of gsc on delamination, gsc mutants had fewer 
cdh6+ cells outside the otic vesicle and gsc overexpression increased accumulation of 
cdh6+ cells in the TA pool (Fig. 4.S9N, O, S).  In contrast, overexpression of pax2a 
reduced the number of cdh6+ otic neuroblasts outside the ear and suppressed the effects 
of activating hs:gsc (Fig. 4.S9P, Q, S ).  pax2a mutants showed a statistically normal 
number of cdh6+ neuroblasts at 24 hpf (Fig. 4.S9P, S), possibly because elevated cell 
death counterbalances the transient spike in neuroblast delamination seen at 24 hpf in 
these embryos (Fig. 4.4R). 
 
 
Fig. 4.S9.  Expression of cadherin genes in relation to Pax2a or Gsc function in the otic vesicle. 
Transgenic embryos were heat shocked at the indicated times.  (A-R) Cross sections (dorsal up, medial 
left) passing through the middle of the neurogenic domain showing expression of cdh2 (A-F), cdh11 (G-L) 
and cdh6 (M-R) in embryos with indicated phenotypes.  (S) Mean and standard deviation of the total 
number of cdh6 expressing cells outside the otic vesicle.  Asterisks (*) indicate significant differences 
between groups indicated by brackets or compared to control embryos. 
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DISCUSSION 
Delamination from the otic vesicle is a vital step in otic neurogenesis that has 
heretofore been described only at the morphological level.  Here we elucidate for the 
first time a molecular mechanism for this process (Fig. 4.5H).  First, we describe a novel 
role for the organizer gene gsc in promoting delamination of neuroblasts from the otic 
vesicle.  Loss of gsc function impairs delamination of SAG neuroblasts and leads to a 
significant loss of mature SAG neurons whereas misexpression of gsc enhances 
neuroblast delamination and increases the size of the mature SAG.  Second, Gsc’s ability 
to promote EMT requires coexpression of ngn1 as a parallel output of Fgf signaling.  
Co-misexpression of gsc and ngn1 stimulates neuroblast delamination from ectopic sites 
within the otic vesicle.  Third, we document a new role for Pax2a in stabilizing the otic 
epithelium in opposition to Gsc.  Pax2a not only represses gsc transcription, but it also 
suppresses Gsc protein function and blocks EMT.  The opposing activities of Pax2a and 
Gsc correlate with their differential regulation of the cdh1, which is downregulated in 
delaminating neuroblasts in zebrafish as well as mouse (207). 
 In this model, distinct regulation of ngn1 and gsc assures orderly delamination 
coupled with ongoing renewal of neuroblasts within the otic epithelium: As gsc+ 
neuroblasts delaminate, adjacent neuroblasts presumably move into the gsc domain in 
preparation for their own EMT.  In early stages of neurogenesis, the domain of ngn1 
expands, allowing replacement of cells lost through EMT.  Eventually Fgf levels rise to 
block further ngn1 induction (132), terminating the ability to replenish neuroblasts as 
they delaminate.  This mechanism is reminiscent of Gsc’s role in driving cellular 
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dynamics and replenishment in the vertebrate organizer (186-189).  An important goal of 
future research will be to conduct detailed cell-labeling experiments to elucidate patterns 
of epithelial rearrangement implied in our current study. 
 In addition to promoting EMT, overexpression of gsc had unexpected stage-
specific effects on proliferation of TA cells.  When activated at 22 hpf, hs:gsc caused a 
slight decrease in proliferation in the TA pool.  This is understandable since hs:gsc 
causes virtually all ngn1+ neuroblasts to delaminate at once, temporarily disrupting the 
normal steady flow of cycling progenitors into the TA pool.  The sudden bolus of TA 
cells would then continue to develop synchronously and shift the population mean 
towards a post-mitotic state, reducing the overall rate of proliferation.  In contrast, 
activation of hs:gsc at 36 hpf or later caused a dramatic increase in proliferation of TA 
cells (Fig. 4.3K).  The mechanistic basis for this is unclear but could reflect the changing 
status of Fgf signaling during successive stages of SAG neurogenesis (132, 181).  
During early stages of otic vesicle development, the level of Fgf signaling is relatively 
low, which stimulates specification of neuroblasts in the otic epithelium but is not 
sufficient to affect development of TA cells.  As development proceeds, mature SAG 
neurons begin to accumulate and express fgf5, which eventually exceeds an upper 
threshold to terminate specification of neuroblasts in the otic epithelium.  Elevated Fgf5 
also delays terminal differentiation and promotes proliferation of TA cells.  We 
speculate that forced expression of gsc in TA cells reinforces this effect of Fgf5, thereby 
increasing the TA pool disproportionately at later stages.  This does not reflect a normal 
function of gsc since it is not normally expressed in TA cells.  Indeed, proliferation of 
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TA cells was normal at all stages in gsc mutants (Fig. 4.S7E).  Further studies will be 
required to rigorously test the relationship between gsc and fgf5 during later stages of 
otic development. 
 
Conservation and diversity of Gsc function 
The function of gsc in the zebrafish inner ear is likely to be conserved in other 
vertebrates.  In mouse, Gsc is expressed in the developing otocyst in a pattern similar to 
that in zebrafish (190, 196), although its function has not been investigated.  Loss of Gsc 
function in humans causes SAMS syndrome, characterized by mandibular hypoplasia 
similar to that seen in zebrafish gsc mutants, as well as loss of the auditory canal.  These 
defects reflect deficiencies in neural crest-derived pharyngeal arches 1 and 2, known 
sites of Gsc expression, but it is unknown whether auditory neurons are also affected.  
Although a recently reported human chromosomal deficiency spanning Gsc causes 
auditory neuropathy, the deficiency also removes other genes that potentially affect the 
trait (208).  Thus, additional studies are needed to clarify the role of Gsc in otic 
neurogenesis in mammals.   
 Interestingly, the role of Gsc in otic neurogenesis in zebrafish appears similar to 
the role of Gsc in regulating the stomatogastric nervous system (SNS) in Drosophila.  
SNS neuroblasts in fly initially form in the foregut epithelium and subsequently 
delaminate and migrate significant distances to form the equivalent of vertebrate enteric 
neurons.  Epithelial SNS neuroblasts express Gsc, and delamination is strongly impaired 
in Gsc mutants (209, 210).  Additionally, delamination requires Egfr and the RAS-
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MAPK pathway (211, 212).  Together, these findings suggest that a broadly conserved 
pathway, acting through RAS-MAPK and Gsc, functions to localize neuroblast 
delamination in these widely divergent species. 
 In addition to gsc, it is likely that additional factors regulate EMT in the otic 
vesicle.  We note that neuroblasts normally begin to delaminate from the otic epithelium 
by 17 hpf, several hours before the onset of gsc expression (Fig. 4.1), and delamination 
is not completely lost in gsc mutants (Fig. 4.2G).  A number of transcription factors 
known to regulate EMT in other tissues, including Snail and Zeb proteins, are also 
expressed in the otic vesicle at appropriate stages (213-215).  These might help promote 
delamination from the otic vesicle, but functional studies are yet to be reported.  
 
Pax2 as an epithelial stabilizer   
Pax2 appears to coordinate cell fate specification and epithelial integrity in 
several contexts.  In zebrafish, combinatorial knockdown of redundant genes pax2a, 
pax2b and pax8 leads to progressive dispersal of otic cells soon after formation of the 
otic vesicle (185).  Similarly, loss of both Pax2 and Pax8 in mouse impairs placode 
invagination and severely reduces otic vesicle size, apparently due to abnormal cell 
migration (204).  Studies in chick show that Pax2 is required for proper expression of 
NCAM and N-cadherin to stabilize epithelial integrity during placode invagination 
(184).  A continuing role in epithelial maintenance at later stages of otic development 
might explain why mouse and zebrafish embryos lacking Pax2 or Pax5 function show 
elevated cell death in the otic vesicle, especially in sensory epithelia (205, 206).  
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Similarly, Pax2 plays a role in epithelial maintenance during kidney development.  
Mouse Pax2 mutants display severe renal defects resulting from loss of epithelial 
structure in the nephric duct, accompanied by formation of irregular outgrowths and 
increased cell motility (216, 217).   
 
Regulation of Cadherin dynamics   
The functions of Gsc and Pax2a counter each other in regulating the level of E-
cadherin (cdh1) transcription (Fig.4.5A-F).  E-cadherin is classically associated with 
epithelia and its downregulation is a common signature of EMT.  Hence the ability of 
Pax2a to totally suppress the effects of Gsc can be explained partly through its ability to 
maintain cdh1 expression.  However, this mechanism is likely not sufficient.  Activation 
of hs:gsc downregulates cdh1 throughout the otic vesicle yet does not induce widespread 
dispersal of the otic epithelium.  This is probably because other cell adhesion molecules 
like cdh2 and cdh11 are coexpressed in the otic epithelium and are not affected by Gsc 
activity.  The physical arrangement and functional relationships between coexpressed 
CAMs remain poorly understood aspects of epithelial structure, but partial redundancy 
likely explains the limited effects of Gsc activity.   
 Another factor limiting Gsc’s ability to promote EMT is the requirement for co-
expression of Ngn1.  These factors probably regulate different subsets of genes to 
facilitate EMT.  Gsc acts as a transcriptional repressor (218-221) likely explaining its 
ability to downregulate cdh1 in the otic vesicle (Fig. 4.5C) as well as in a diverse array 
of aggressive metastatic cancers in which Gsc promotes EMT (194, 195, 222).  In 
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contrast, Ngn1 acts predominantly as a transcriptional activator.  Relevant targets of 
Ngn1 might include factors that regulate f-actin dynamics, or proteases that degrade 
basement membrane.  All of these processes are potentially coordinated under the 
combinatorial control of Gsc and Ngn1 to ensure a robust EMT response.   
 EMT is typically associated with Cadherin switching.  For example, cdh6 is 
upregulated in neuroblasts after delamination, with weak expression first appearing in 
scattered cells within the otic epithelium (Fig. 4.S9).  Such switching may help weaken 
epithelial junctions and/or inhibit re-epithelialization of neuroblasts after delamination 
while facilitating collective migration.  Interestingly, the role of specific Cadherins often 
differs according to context.  For example, cdh11 is often associated with mesenchymal 
cells (223, 224) yet is expressed in the most stable parts of the otic epithelium in 
zebrafish (Fig. 4.S9).  Conversely, cdh6 is expressed in migrating otic neuroblasts in 
zebrafish, whereas it marks premigratory neural crest in chick ectoderm and must be 
downregulated to allow neural crest delamination (225, 226).  The otic vesicle promises 
to be a useful model for future functional studies to determine how diverse cell adhesion 
molecules interact and contribute to tissue architecture and dynamics. 
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CHAPTER V 
 
 
GLYCOLYSIS MEETS FGF SIGNALING: THE GLYCOLYTIC ENZYME PGK1 IS 
REQUIRED NON-AUTONOMOUSLY FOR FGF-DEPENDENT SPECIFICATION 
OF OTIC NEURONS IN ZEBRAFISH 
 
 
INTRODUCTION 
In all vertebrates; hearing and balance related information is transmitted from the 
inner ear to the brain via the neurons of the Stato-Acustic Ganglion (SAG). SAG 
neurons are formed by a complex, stepwise program that starts in the otic vesicle, the 
progenitor of the mature vertebrate ear. At the first step, SAG neural progenitors are 
specified in the otic epithelium and marked by the expression of the proneural gene 
neurogenin1 (ngn1).  Ngn1 is a basic helix-loop-helix transcription factor, crucial for the 
cell-fate specification of the otic neuroblasts such that ngn1 loss of function causes 
complete loss of SAG neurons and other cranial neurons (60).  Next, a subset of 
specified otic neuroblasts undergoes epithelial-mesenchymal transition and delaminates 
from the otic vesicle (14). Soon after leaving the otic epithelium, neuroblasts turn of 
ngn1 expression and upregulate a related proneural factor called neurod.  Neurod 
expressing cells migrate towards the hindbrain as they continue to proliferate and form a 
stable transit-amplifying (TA) progenitor pool (132). TA cells differentiate into mature 
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SAG neurons upon reaching their final destination and turn on the expression of mature 
neuronal markers such as Isl1/Isl2b (133, 227).  The mature SAG segregates into two 
functional subunits: the anterior patch of the SAG sends projections to the utricular 
macula and semicircular canals to mediate balance related information, whereas the 
posterior subunit of the SAG transmits auditory information from the saccule and lagena 
to the hearing centers in the hindbrain. Very little is the known about the mechanisms 
that govern functional segregation and axonal navigation of the distinct SAG subunits.    
Significant progress has been made to identify and characterize the signaling pathways 
and genes that regulate distinct steps of SAG development. First, we showed that a 
threshold level of Fgf signaling is paramount for the specification of SAG progenitors in 
the otic vesicle, hence the conditions that completely block Fgf signaling impair otic 
neurogenesis and reduce the size of the mature SAG (132).  However, a high level of Fgf 
signaling is also detrimental to otic neurogenesis, such that, high level overexpression of 
the Fgf ligands blocks ngn1 expression in the otic vesicle and leads to production of 
fewer SAG neurons (132). Accordingly, during the normal progression of SAG 
development, the rise of Fgf signaling originating from the local sources and mature 
SAG neurons shuts down otic neurogenesis at around 42 hpf (132).  The level of Fgf 
signaling in the otic vesicle is partially regulated via the action of the transcription factor 
Tfap2a which dampens Fgf signaling through upregulation of Bmp7 to promote 
specification of SAG neuroblasts.   Thus, the mechanism of SAG development is highly 
sensitive and tuned to the rise of the level of Fgf signaling in the otic vesicle, yet, how a 
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threshold level of Fgf signaling is initially set and maintained during the early stages of 
SAG progenitor specification is very poorly understood. 
We conducted an ENU mutagenesis screen in zebrafish to identify novel genes 
that regulate SAG development. We identified two lethal mutations, named sagd1 and 
sagd2, that showed no gross morphological defects but both strongly reduced a subset of 
SAG neurons. Sagd1 mutants showed a specific reduction in the number of vestibular 
neurons required for balance, whereas auditory neurons developed normally. Further 
characterization of sagd1 mutants revealed that the otic neurogenesis was impaired due 
to defective Fgf signaling during early SAG development.  Fgf signaling recovers as 
development proceeds and otic neurogenesis resumes to normal, enabling auditory 
neurons to develop as usual.  
Whole genome sequencing revealed the affected locus in sagd1 mutants as pgk1 
(Phospho-glycerate kinase1). The best known role for Pgk1 is to catalyze the transfer of 
high energy phosphate from the 1, 3-diphospoglycerate to ADP and to generate 3-
phosphoglycerate and ATP during glycolysis. Interestingly, Pgk1 also has an mRNA 
stabilization function such that the translation of the sequences in the first two thirds of 
the pgk1 transcript has been shown to stabilize pgk1 mRNA (228-230). 
Here we describe a novel role for Pgk1 during SAG neurogenesis. First we show that 
pgk1 is strongly upregulated in the sensory epithelium and vestibular neurons which are 
the tissues affected by the sagd1 mutation. Targeted knockdown of the pgk1 gene using 
CRISPR technology phenocopies sagd1 mutants. Further analysis with the use of the 
genetic mosaics showed that Pgk1 non-autonomously regulates Fgf signaling in the otic 
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vesicle. Furthermore, the impairment of the Fgf signaling in pgk1 mutants were not 
rescued by overexpression of Fgf ligands, indicating that Pgk1 affects Fgf signaling at a 
step downstream of the ligand production. Further experiments show a novel role for 
Pgk1 and glycolysis in regulation of MAPK signaling independently from Fgf ligands 
and through lactate production.    
 
MATERIALS AND METHODS 
 
Fish strains and developmental conditions 
Wild-type embryos were derived from the AB line (Eugene,OR). The following 
transgenic lines were used in this study: Tg(hsp70:fgf8a)
x17
(19),  Tg(Brn3c:GAP43-
GFP)
s356t
(159), Tg(-17.6isl2b:GFP)
zc7
(99), Tg(hsp70:pgk1.1)
x57
.Mutant lines sagd1
x40
 
and pgk1.1
x54
 were used for loss of function analysis. Homozygous mutants were 
identified by a characteristic decrease in the expression of Isl2b-GFP in SAG.  Embryos 
were maintained at 28.5°C except after a heat-shock regimen embryos were placed at 
33°C.  Embryos were staged according to standard protocols (100). PTU (1-phenyl 2-
thiourea, 0.3 mg/ml, Sigma) was included in the fish water to inhibit pigment formation.  
 
Gene misexpression and morpholino injections 
Heat-shock regimens were carried in a water bath at indicated temperatures and 
durations. Embryos were kept in a 33°C incubator after the heat-shock. Transgenic 
carriers were identified by morphological characteristics. Knockdown of Plasminogen 
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was performed by injecting morpholinos (5 ng/ul) at one cell stage using the following 
MO sequence: 5’-AACTGCTTTGTGTACCTCCATGTCG.   
 
Statistics 
Student’s t-test was used for pairwise comparisons. Analysis of 3 or more 
samples was carried by one way ANOVA and Tukey post-hoc HSD test.   
 
In situ hybridization and immunohistochemistry 
Whole mount in situ hybridization and immunohistochemistry protocols used in 
this study were previously described (72, 102). Whole mount stained embryos were cut 
into 10 μm thick sections using a cryostat (132).  The following antibodies were used in 
this study: Anti-Islet1/2 (Developmental Studies Hybridoma Bank 39.4D5, 1:100), Anti-
GFP (Invitrogen A11122, 1:250), Alexa 546 goat anti-mouse or anti-rabbit IgG 
(ThermoFisher Scientific A-11003/A-11010, 1:50). Promega terminal deoxynucleotidyl 
transferase (M1871) was used according to manufacturer’s protocol to perform the 
TUNEL assay.  
 
Pharmacological treatments 
Glycolysis was blocked by treating embryos with 2-deoxy-glucose diluted from a 
10 mM stock in DMSO to a final concentration of 100 μM in fish water.  Lactate 
production from pyruvate was inhibited by galloflavin diluted from a 10 mM stock 
solution into a final concentration of 100 μM in fish water.  Lactate treatments were 
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performed with 60% stock sodium DL-lactate solution (Sigma, L1375) diluted 1 to 1000 
in fish water containing 10 mm MES. Treatments were carried in a 24-well plate with a 
maximum of 15 embryos per well in a volume of 500 μl each.   
 
RESULTS 
To identify and characterize the novel genes that regulate development of the 
SAG neurons we have conducted a mutagenesis screen with more than 50 founders in 
isl2b-GFP transgenic background. Initial screening for the 50 mutagenized founders and 
their families yielded 2 lethal mutations, termed sagd1 and sagd2. SAG neurons form 2 
functionally distinct subunits. Anteriorly located SAG neurons project to the vestibular 
apparatus of the inner ear and mediate balance related information, whereas the posterior 
subunit of the SAG is required for transmitting auditory information. sagd1 mutants 
were initially recovered for a specific defect in the vestibular neurons, whereas auditory 
neurons develop normally (Fig. 5.1A-R). Quantification of the isl2b:GFP staining on 
serial sections revealed a ~60% deficiency in the number of vestibular SAG neurons 
located in the anterior portion the otic vesicle (adjacent to the utricular macula) at 24 and 
30 hpf (Fig. 5.1A-D, Q).The number of vestibular SAG neurons remained lower 
compared to controls through at least 48 hpf. The number of auditory SAG neurons, 
located in the posterior sections of the otic vesicle abutting the saccular macula, was not 
significantly altered compared to control embryos (Fig. 5.1I- R). There were no overt 
morphological defects in sagd1 mutants, and the size and the axial patterning of the otic 
vesicle was also unaffected (Fig. 5.2A-J).  It is also noteworthy that the defect in the  
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Figure 5.1. sagd1 mutants produce fewer vestibular SAG neurons. (A-P) Cross sections passing 
through the utricle (A-H) and saccule (I-P) of the otic vesicle in isl2b-GFP expressing controls and sagd1 
mutants label the mature SAG neurons at indicated time points. Embryos were stained for GFP prior to 
cryo-sectioning. (Q,R) Mean and standard deviation for the total number of Isl2b+ SAG neurons in 
controls versus sagd1 mutants. Asterisks (*) indicate statistically significant differences compared to 
control embryos (p≤0.05).  
 
number of vestibular SAG neurons does not stem from an increased rate of apoptosis 
(Fig. 5.2K), suggesting the impairment of an early step during SAG formation in sagd1 
mutants. Next, we examined earlier stages of SAG development in sagd1 mutants. 
Normally delaminated neural progenitors lose expression of ngn1 and upregulate 
expression of the related proneural gene, neurod, which marks transit-amplification (TA) 
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stage of SAG development. TA cells migrate towards the hindbrain and subsequently 
differentiate into Isl+ neurons.   
 
 
 
Figure 5.2. Gross morphology and otic vesicle patterning is normal in sagd1 mutants.  (A, B) Live 
specimens at 32 hpf viewed from dorsolateral view reveal no gross morphological differences between 
controls and sagd1 mutants. (C-D) Whole-mount images (dorsal up, anterior left) show dorsolateral views 
of the otic vesicle (outlined) in controls and sagd1 embryos for the indicated genes at 30 hpf. (K) Mean 
and standard deviation for the total number of TUNEL+ SAG neurons in controls versus sagd1 mutants at 
indicated time points. There is no significant differences compared to control embryos (p≤0.05). 
 
Accumulation of neurod+ SAG neuroblasts in the anterior portion of the otic vesicle was 
impaired in sagd1 mutants (Fig. 5.3A-E). This deficit was more pronounced at 36 hpf 
(~60% decrease) than at 48 hpf (~20% decrease). Despite the deficiency in the number 
of anterior TA cells, accumulation of the TA neuroblasts in the posterior regions of the 
otic vesicle was normal in sagd1 mutants (Fig. 5.3F-J). We hypothesized that the 
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decrease in the size of the anterior TA pool reflects impairment of neuroblast 
specification in the otic vesicle. To test this we examined expression of ngn1, a marker 
of the specified neuroblasts.  
 
 
Figure 5.3. sagd1 mutants produce fewer TA neuroblasts. (A-D, F-I) Cross sections (dorsal up, medial 
left)  passing through the utricle (A-D) and saccule (F-I) show neurod staining in controls and sagd1 
embryos. (Q,R) Mean and standard deviation for the total number of neurod+ cells in controls versus 
sagd1 mutants in utricular (E) versus saccular (J) sections. Asterisks (*) indicate statistically significant 
differences compared to control embryos (p≤0.05). 
 
We observed that specification of neuroblasts was reduced during early SAG 
development between 20-30 hpf (Fig. 5.4A, B, E), with the most severe effect observed 
at 24 hpf, the peak stage of otic neurogenesis. Interestingly, specification of neural 
progenitors returned to normal after 30 hpf (Fig. 5.4C, D, E). The number of the  
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Figure 5.4. Specification of neuroblasts is impaired in sagd1 mutants during early neurogenesis. (A-
D) Cross sections passing through the widest part of the neurogenic domain (dorsal up, medial left) just 
posterior to the utricular sensory epithelium show ngn1 staining in controls and sagd1 embryos at 
indicated time points. (E-H) Mean and standard deviation for the total number of ngn1+ cells in controls 
versus sagd1 mutants in the inside (E), outside (F), anterior half (G) and posterior half (H) of the otic 
vesicle. Asterisks (*) indicate statistically significant differences compared to control embryos (p≤0.05). 
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delaminated neuroblasts outside the otic vesicle remained deficient at every stage 
examined, possibly reflecting the early impairment of neurogenesis (Fig. 5.4.F).  Recent 
studies from cell-tracing experiments in mice suggest that the early delaminating 
neuroblasts form the anteriorly located vestibular SAG population whereas later forming 
neuroblasts mostly contribute to the auditory portion of the SAG. We previously showed 
that conditions that enhance otic neurogenesis at early stages lead to an increase only in 
the size of the vestibular SAG population (132, 181, 231). Overall, these studies suggest 
that the subtype specification of SAG neurons is regulated temporally. This is consistent 
with the phenotype of the sagd1 mutants, where an early deficit in neuroblast 
specification affects only the vestibular SAG neurons.   
 
 
Figure 5.5. Effects of sagd1 mutation on Fgf signaling.  (A-L) Whole-mount images (dorsal up, anterior 
left) show dorsolateral views of the otic vesicle (outlined) in controls and sagd1 mutants  for the expresson 
of etv5b and pax5 at indicated time points 
 
Next, we sought to understand the reasons for the early impairment of otic neurogenesis 
in sagd1 mutants. We previously showed that specification of the otic neuroblasts 
requires a threshold level of Fgf signaling and conditions that completely block Fgf 
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signaling halt otic neurogenesis (132).  To test whether Fgf signaling was impaired in 
sagd1 mutants, we analyzed the expression of the Fgf responding gene etv5b and ear-
specific Fgf target gene pax5.   Expression of both markers was markedly reduced at 18 
hpf in sagd1 mutants (Fig. 5.5A-D), but partially recovered at later stages (Fig. 5.5E-L). 
Overall these data suggest that early impairment of Fgf signaling leads to a deficiency in 
otic neurogenesis and results in a lower number of mature vestibular SAG neurons.  
 
 
Figure 5.6.  sagd1 mutants produce fewer otic hair cells. (A,B) Whole-mount images (dorsal up, 
anterior left) show dorsolateral views of the otic vesicle (outlined) in Brn3c:GFP+ controls and sagd1 
mutants  and label the hair cells. Mean and standard deviation for the total number of Brn3c:GFP+ cells in 
control versus sagd1 mutant otic vesicles. Asterisks (*) indicate statistically significant differences 
compared to control embryos (p≤0.05). 
 
  
132 
 
However, Fgf signaling recovers and enables normal neuroblast specification at later 
stages such that formation of auditory neurons remains unaffected. Most likely due to 
the impairment of Fgf signaling, sensory hair cell development in both utricular and 
saccular macula is also deficient in sagd1 mutants (Fig. 5.6A-D).Impairment of the Fgf 
signaling could stem from the changes in the expression of Fgf ligands in sagd1 mutants. 
To test whether overexpression of an Fgf ligand could rescue the sagd1 phenotype we 
generated a sagd1 mutant line that carries a heat-shock inducible fgf8 construct.  
Interestingly, high(39 °C) or low level (35 ºC) activation of hs:fgf8 at multiple time 
points including 18 and 24 hpf did not rescue the sagd1 phenotype, development of SAG 
neurons remained deficient (Fig. 5.7A-F, data not shown). This data suggests that the 
sagd1 lesion impairs Fgf signaling at a step downstream of Fgf ligand-receptor binding, 
such that cells remain unresponsive even when the level of the fgf ligands was elevated 
with the activation of the hs: fgf8 transgene. 
               To identify the affected locus in sagd1 mutants, we analyzed the whole genome 
sequencing data with homozygosity mapping approaches (232) and revealed that the 
sagd1 mutation affects the glycolytic enzyme Pgk1 (Phosphoglycerate kinase-1).   
There are 2 predominant transcripts expressed from the zebrafish pgk1 locus (Fig. 5.8) 
(233). The primary transcript is highly conserved in vertebrates and consists of 10 exons 
(233). However, zebrafish has a unique alternative pgk1 transcript that harbors 2 novel 
exons resulted from the integration of a DNA transposon sequence into pgk1 locus 
(233). Transcribed from a unique promoter, the alternate pgk1 transcript also a seventh 
exon that includes a stop codon (233). Thus the protein product of alternate pgk1  
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Figure 5.7.  Overexpression of fgf8 does not rescue sagd1 mutants. (A-F) Whole-mount images (dorsal 
up, anterior left) show dorsolateral views of the otic vesicle (outlined) in isl2b: GFP+ controls and sagd1 
mutants, hs:fgf8 embryos  and hs:fgf8 + sagd1 mutants.  hs:fgf8 transgene was activated at 39°C or 35°C 
for indicated durations.  
 
  
134 
 
transcript is smaller compared to that of primary pgk1 transcript (Fig. 5.7). Thus, the 
alternate Pgk1 protein lacks a significant portion of the nucleotide binding and catalytic 
domains of Pgk1 such that it is unable to catalyze the glycolytic functions. 
 
 
Figure 5.8. Schematic representation of the pgk1 locus in zebrafish.  Zebrafish pgk1 has 2 different 
splice variants. sagd1 mutation affects the alternate pgk1 transcript with indicated lesions.  
 
We identified 2 linked nucleotide substitutions in the pgk1 locus of sagd1 mutants that 
affect only the alternate pgk1 transcript leading to both loss of a splice acceptor site and 
the start codon. First, we isolated the primary pgk1 cDNA and produced a RNA probe 
which could potentially detect the presence of both of the transcripts. A low level of 
pgk1 transcript was detected through the embryo, however, the expression was 
significantly upregulated in tissues that are affected in sagd1 mutants such as utricular 
and saccular hair cells, and vestibular SAG neurons (Fig. 5.9A-F). 
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Figure 5.9. Expression of pgk1 in the otic vesicle.  (A-F) Cross sections (dorsal up, lateral left) passing 
through the utricle (A, C, F) and saccule (B, D, F) show pgk1 staining in wild type embryos at indicated 
time points. Red asterisks indicate hair cells, green asterisks indicate vestibular SAG neurons.  
 
                We next tested the effects of disrupting and overexpressing the primary pgk1 
transcript on the development of SAG neurons. Using CRISPR-Cas9 targeting we 
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recovered a mutation that is predicted to eliminate only the primary pgk1 transcript, 
hereby referred as pgk1.1. Similar to sagd1 mutants, pgk1.1 mutants also showed a lower 
level of etv5b expression, reduction in neurogenesis and a deficiency in the number of 
mature SAG neurons (Fig. 5.10A-F). Thus, the pgk1.1 mutation strongly recapitulated 
all the aspects of sagd1 mutants and resulted in a strikingly similar reduction of the total 
number of SAG neurons (Fig. 5.10G). We also generated a heat-shock inducible 
transgene to overexpress pgk1.1 transcript and showed that the overexpression of pgk1.1 
rescues the number of SAG mature neurons to normal in sagd1 mutants (Fig. 5.10G). 
We next tested whether the pgk1.1 and sagd1 lesions complement each other and the 
transcripts affected by these mutations have different functions.  To examine this idea, 
we performed a complementation experiment by crossing a heterozygous sagd1 carrier 
to a heterozygous pgk1.1 carrier. To our surprise, the transheterozygous embryos 
(sagd1/pgk1.1) did not display the SAG phenotype.  This result suggests the 
employment of unique functions for the primary and alternate pgk1 transcripts in 
regulation of SAG development. Since the alternate transcript contains the segments that 
are predicted to regulate the stabilization of pgk1 mRNA, we hypothesized that the main 
role of the alternate transcript is to protect pgk1.1 mRNA from degradation.  Consistent 
with this idea, sagd1 mutants showed a decrease in the total level of pgk1 mRNA 
compared to wt embryos (data not shown). 
              We next sought out the mechanism by which Pgk1 protein regulates Fgf 
signaling during SAG development.  First, we examined whether Pgk1 regulates Fgf 
signaling cell autonomously.  To test this directly we generated genetic mosaics by 
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transplanting wild-type donor cells into pgk1.1 mutant host embryos. We reasoned that if 
Pgk1 were to act non-autonomously, wild-type donor cells would be prevented from  
 
 
Figure 5.10.  pgk1.1 mutants recapitulate the main aspects of sagd1 mutants (A,B) Whole-mount 
images (dorsal up, anterior left) show dorsolateral views of the otic vesicle (outlined) in controls and 
pgk1.1 mutants  for the indicated genes. Mean for the total number of Isl1+ SAG neurons, each dot 
represents an embryo from the indicated crosses. 9/36 and 8/31 embryos display the mutant phenotype in a 
cross between two heterozygous sagd1 and pgk1.1 carriers, respectively.  Mutant phenotype was not 
observed in other crosses.  
 
responding to Fgf sources when transplanted into pgk1.1 mutant host embryos. In 
support, the majority of the wt cells lost etv5b expression when transplanted into pgk1.1 
host embryos, indicating that Pgk1 acts non-autonomously to regulate the response to 
Fgf signaling (Fig. 5.11B, D, F, G). In contrast, wild-type cells showed a normal 
expression of etv5b when transplanted into wild-type host embryos (Fig. 5.11A, C, E, 
and G). Hence, Pgk1 non-autonomously impairs Fgf signaling in the otic vesicle.  
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The only well-studied function of the secreted Pgk1 protein is that it acts as a disulfide 
reductase and cleaves the kringle 5 domain of Plasmin to release the angiogenesis  
 
Figure 5.11. Pgk1 acts non-autonomously. (A, B) Cross sections passing through the widest part of the 
neurogenic domain (dorsal up, medial left) just posterior to the utricular sensory epithelium show etv5b 
staining in controls (A, C, C’) and pgk1.1 mutant embryos (B, D, D’) at 18 hpf. (C, D) Dextran labelled wt 
cells are transplanted into control (C) or pgk1.1 mutant (D) embryos show red fluorescence. (E) Mean and 
standard deviation for the percentage of etv5b+ cells in the otic vesicle of control or pgk1.1 embryos. (F) 
Mean and standard deviation for the percentage of etv5b+ wt cells transplanted to the otic vesicle of 
control or pgk1.1 mutant embryos. 
 
inhibitor Angiostatin (234).  Plasmin is released from the liver as an inactive zymogen 
called plasminogen which is converted to the active form by a variety of activator 
enzymes. Plasmin is a serine protease that is best known for its ability to dissolve blood  
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Figure 5.12. A possible mechanism for the otic function of Pgk1. A schematic respresenting the 
predicted role of Pgk1 in regulation of Fgf signaling during otic vesicle neurogenesis. Mean for the total 
number of Isl1+ SAG neurons, each dot representing an embryo from the indicated crosses. The number 
of embryos displaying the mutant phenotype in indicated crosses are shown in red.  
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clots by cleaving fibrin and remodeling extracellular matrix through its proteolytic 
activity. Interestingly, plasmin has also been shown to digest the active heparin sulfate 
proteoglycan (HSPG)-Fgf complexes in vitro (235).  We suspected that the accumulation 
of plasmin in the pgk1.1 mutants could result in the degradation of   Fgf ligands and 
thereby lead to the deficiency of Fgf signaling observed in these mutants (Fig. 5.5). To 
test this, we block translation of the plasminogen (PLG) gene in sagd1 and pgk1.1 
mutants with morpholinos to block formation and accumulation of Plasmin in these 
embryos. However, injection of the PLG morpholino did not rescue the number of 
mature SAG neurons to normal in sad1 or pgk1.1 mutants (Fig. 5.12). 
We next investigated whether the glycolytic function of the Pgk1 plays a role in 
SAG development. Pgk1 activity is required for glycolysis which is a major mechanism 
by which cells produce ATP from degradation of glucose into pyruvate.  When oxygen 
is available, pyruvate is shuttled into mitochondria to be further broken down for cellular 
ATP needs. In the absence of oxygen pyruvate is converted into lactate, in a process 
called fermentation.  First described in cancer cells, cells with high proliferative needs 
undergo fermentation and produce lactate despite the abundant levels of available 
oxygen in a process called “aerobic glycolysis” or the “Warburg effect”. It is thought 
that the Warburg effect serves to generate the building blocks required for biosynthesis 
of the materials needed for proliferation in rapidly dividing tumor cells. However, a 
growing body of studies suggests that increased glycolytic activity can be a feature of 
normal cells and have important developmental roles (236-238).  
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Figure 5.13.  Role of Glycolysis in SAG development.  Mean and standard deviation for the total number 
of Isl1+ SAG neurons, each dot represents an embryo from the indicated crosses or treatments. Asterisks 
(*) indicate statistically significant differences compared to control embryos (p≤0.05). 
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To test if glycolytic activity is required for normal SAG development, we used 
an inhibitor of glycolysis called 2-deoxy-glucose (2DG). Treatment with 2DG at 14 hpf 
reduced the number of mature SAG neurons (Fig. 5.13). The number of the mature SAG 
neurons in 2DG treated embryos was similar to that of pgk1 or sagd1 mutants (Figure  
13).  This result suggests that impairment of glycolysis can be the causative for the SAG 
phenotype observed in pgk1 or sagd1 mutants.  Glycolysis could be utilized in otic cells 
to produce ATP or lactate. Both deficiencies in lactate or ATP levels have been shown to 
affect MAPK signaling, despite each molecule regulate the pathway via different 
mechanisms (239, 240). Interestingly, addition of either ATP or lactate rescued the 
number of SAG neurons to normal in sagd1 or pgk1 mutants (Fig. 5.13). Furthermore, 
lactate or ATP treatments of wild type embryos displayed a significant increase in the 
number of mature SAG neurons. To test whether production of lactate is required for 
normal SAG development we used galloflavin, an inhibitor of the enzyme Lactate 
Dehydrogenase which converts pyruvate into lactate. Galloflavin treatment is predicted 
to inhibit lactate formation without affecting glycolytic production of ATP through 
glycolysis. Intriguingly, galloflavin treated embryos displayed a reduction in SAG 
neurons similar to pgk1 or sagd1 mutants (Fig. 5.13).  
Because pgk1 and sagd1 mutants show a deficiency in accumulation of mature 
SAG neurons due to impaired MAPK signaling, we tested whether MAPK signaling was 
impaired in galloflavin treated embryos and investigate the role of lactate in potentiating 
MAPK signaling. Indeed, galloflavin treated embryos displayed a reduction in etv5b 
expression (data not shown). To further test the role of lactate in MAPK signaling we 
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treated wild type embryos with lactate and observed a significant upregulation of etv5b 
expression (Fig. 5.14A, B). Next we tested whether lactate can activate MAPK signaling 
in the absence of Fgf signals. We inhibited the Fgf pathway by overexpression of a 
dominant negative Fgf receptor construct (hs: dnfgfr1), which strongly decreased etv5b 
expression in the otic vesicle (Fig. 5.14C).  Importantly, lactate treatment enhanced 
etv5b expression in hs:dnfgfr1 embryos, showing that lactate can activate the MAPK 
pathway (Fig. 5.14D).  Treatments with ATP fail to produce similar results (data not 
shown) suggesting that ATP affects SAG development through mechanisms independent 
of MAPK signaling.  
 
 
 
Figure 5.14.  Lactate treatment enhances MAPK signaling. (A-D) Whole-mount images (dorsal up, 
anterior left) show dorsolateral views of the otic vesicle (outlined) in indicated phenotypes and treatments 
for the expression of etv5b at 18 hpf.  
 
Overall, our results suggest that glycolytic activity and lactate production is upregulated 
in the otic vesicle and potentiates MAPK signaling during SAG neurogenesis. 
 
DISCUSSION 
Here we report the results from an ENU mutagenesis screen in zebrafish 
conducted to identify novel regulatory genes of SAG development. First, we describe a 
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novel mutation, sagd1, which impairs development of the vestibular SAG neurons but 
does not affect auditory neurons. Characterization of the sagd1 mutants showed a 
temporary impairment of Fgf signaling during early SAG neurogenesis, yielding a 
deficiency in the early-forming vestibular neurons. Fgf signaling returns to normal at 
subsequent stages, allowing normal development of auditory neurons. The sagd1 
mutation is mapped to pgk1 locus and CRISPR mediated targeted knock down of Pgk1 
phenocopies our sagd1 mutants. Furthermore, overexpression of pgk1 rescues sagd1 
mutants. Third, we showed that Pgk1 impairs Fgf signaling non-autonomously. Wild-
type cells lose expression of the Fgf target gene, etv5b, when transplanted into pgk1.1 
mutant host embryos. Moreover, overexpression of fgf8 fails to rescue SAG neurons to 
normal in sagd1 mutants, suggesting that Pgk1 impairs Fgf signaling independently from 
the amount of the Fgf ligand. The mechanism by which Pgk1 regulates Fgf signaling 
involves lactate production through a modified form of glycolysis.   
 
Segregation of Auditory and Vestibular Neurons 
Fate mapping studies in mouse and chick embryos show that early delaminating 
ngn1-positive neuroblasts contribute almost exclusively to the vestibular ganglion 
whereas later forming otic neuroblasts generate auditory SAG population (113, 114). It 
is likely that the signaling environment in the otic vesicle changes from the early to late 
neurogenesis, inducing transcription factors that condition the otic neuroblasts to 
generate the auditory SAG lineages. In this regard, inhibition of the Sonic Hedgehog 
(Shh) pathway has been shown to specifically reduce the auditory SAG population (107, 
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241). For example, the transcription factor Gata3 has been shown to regulate 
specification, wiring and maintenance of auditory SAG neurons in mouse and chick 
embryos (142, 145, 146, 242, 243). Interestingly, ear specific known down of Shh 
signaling strongly reduces Gata3 expression in the mouse otocyst (241). Future studies 
might shed light on how Hh signaling regulates segregation of SAG neural lineages in 
zebrafish and the role of gata3 in this process.  
Many studies also suggest spatial segregation of otic neuroblasts into vestibular 
and auditory locales in the otic vesicle during SAG formation (114, 242). In this regard, 
it is suggested that neuroblasts that contribute to the vestibular lineage delaminate from 
anterior-lateral parts of the otic vesicle whereas auditory precursors delaminate from 
posterior-medial locations (114, 242).  It is important to note that, in zebrafish ngn1-
positive cells are mostly found in anterior-lateral portions in the otic vesicle early on, 
however, as the development precedes ngn1 domain shifts to posterior-medial otic 
vesicle. This is most likely due to the changes in the level of Fgf signaling in the otic 
vesicle. Early on, neurogenesis is most active in the regions adjacent to the anterior 
macula. As development progresses, the macula grows in size and produces a higher 
level of ligands which increases Fgf levels in the adjacent regions. Since high levels of 
Fgf signaling inhibits otic neurogenesis, the growth of the macula and the subsequent 
rise in Fgf signaling most likely pushes the ngn1 domain to further posterior and medial 
locations in the otic vesicle. This temporal shift in the ngn1 domain likely accounts for 
the proposed segregation of auditory and vestibular precursors in the otic epithelium. It 
is also noteworthy that sagd1 mutants show a deficiency in the ngn1-positive cells at 
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both the anterior and posterior half of the otic vesicle in the early stages, suggesting that 
both of these regions contribute to the vestibular ganglion during early neurogenesis. 
Moreover, during late neurogenesis sagd1 mutants show a recovery in the number of 
both anterior and posterior ngn1-positive neuroblasts which are assumed to contribute to 
the auditory SAG population.    
 
Evolution of the Pgk1 Locus 
Evolution of new genetic traits by transposon mediated integration into the gene 
regulatory sequences or coding regions was suggested more than 40 years ago.  In this 
regard, DNA repeat elements were commonly found in the DNA binding regions of 
many transcription factors, expanding the regulatory repertoire of these elements (244-
246). Moreover, integration of transposable elements into cis regulatory regions has been 
shown to induce new expression patterns for the afflicted genes and contribute to the 
neofunctionalization and evolution of new characteristics (244-246). Integration of the 
DNA repeat elements into mRNAs is also commonly seen in mammalian genomes 
enhancing the versatility and variability of the resulting proteins (244-246). In many 
cases these integration events are represented in alternate splice variants due to selection 
against disruption of the intact coding regions (244-246). Here we describe the insertion 
of a DNA repeat element into pgk1 locus which resulted in the transcription of an 
abundant alternative transcript, possibly with an enhancing functionality in the mRNA 
binding function of Pgk1. The loss of the nucleotide binding domain in the alternate 
pgk1 transcript most likely disables glycolytic functions of the resulting peptide, availing 
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this protein for other functions, such as regulation of mRNA stability (228-230). This 
described transcription event is unique to the zebrafish genome and is not found in the 
even closely related fish species (233). Conceivably, other genomes coopted different 
methods to enhance Pgk1 protein levels such as the modification of the cis regulatory 
regions or coding sequences. Accordingly, 5’ upstream sequences greatly diverge 
between zebrafish and mammalians and even between some of the closely related fish 
species (233).  
 
Functions of Pgk1 
Pgk1 is characterized as a “moonlighting protein” due to its many diverse, 
mechanistically different functions. For example, mitochondrial Pgk1 has been shown to 
inhibit mitochondrial pyruvate metabolism by acting as a protein kinase during 
tumorigenesis when cellular energy is predominantly produced by a high rate of 
glycolysis rather than oxidative respiration (Warburg effect) (247). Pgk1 is also 
identified as a primer recognition protein that participates in the lagging strand DNA 
replication (248). Pgk1 is secreted from cancer cells as a free soluble protein through 
oncotic pores in response to a decrease in the extracellular protein concentrations (249). 
Extracellular Pgk1 cleaves the serine protease plasmin and generates the angiogenesis 
inhibitor angiostatin (234). Plasmin is a protease and is known to digest Fgf-HSPG 
complexes in vitro (234, 235). We investigated whether plasmin is involved in the 
mechanism by which Pgk1 regulates MAPK signaling. This model predicts 
accumulation of plasmin in sagd1 and pgk1.1 mutants which could lead to excess 
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removal of Fgf-HSPG complexes. To test this model, we injected plasminogen MOs into 
sagd1 and pgk1.1 mutants and examined SAG phenotypes for a possible rescue. 
However, injection of plasminogen MOs fails to rescue these mutants, suggesting a 
different mechanism for regulation of otic development by Pgk1 function.  
Pgk1 is best known for oxidizing 1, 3-diphosphoglycerate to 3-phosphoglycerate 
during glycolysis. Increased glycolytic activity is a hallmark of cancer cells (Warburg 
effect) and cells with high proliferative needs (aerobic glycolysis) and usually attributed 
to the need for generation of the required building blocks for molecules. However, recent 
studies suggest that upregulation of glycolysis is observed in normal cells as a part of the 
normal developmental program (236-239, 250, 251).  Here we discovered a novel 
mechanism in which otic cells engage in upregulated aerobic glycolysis to boost MAPK 
levels and enable neuroblast and hair cell formation. We show that pgk1 is upregulated 
in the sensory epithelium and mature vestibular neurons. Other glycolytic enzymes also 
display increased levels in the otic epithelium (252).  We investigated role of the two 
important products of aerobic glycolysis: ATP and lactate and we showed that lactate 
can enhance MAPK signaling in the otic vesicle, even in the absence of signaling 
through Fgf ligands. Overall, our results suggest a novel role for glycolysis and lactate in 
potentiation of MAPK signaling in otic development.   
A threshold level of Fgf signaling specifies neural fates in the otic vesicle; 
however, expression of ngn1 precedes expression of Fgf ligands in the otic vesicle (132). 
It is likely that MAPK pathway is activated prior to the onset of Fgf ligand expression in 
the otic vesicle. In this regard, MAPK activation through lactate signaling could be vital 
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for accumulation of the Fgf responding genes etv5b and pea3 which also serve as 
downstream effectors of Fgf signaling. We have shown that lactate can stimulate MAPK 
pathway following overexpression of hs:dnfgfr1, a condition that strongly downregulates 
signaling through Fgf ligands. It is likely that early accumulation of Etv5b and Pea3 
proteins in the otic vesicle through lactate induced MAPK pathway is important for 
generating a quick and robust signal after Fgf ligands begin to be expressed in the otic 
vesicle.     
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CHAPTER VI 
 
 
CONCLUSIONS AND DISCUSSION 
 
 
In all vertebrates, SAG neurons connect the ear to the brain and transmit hearing 
and balance related information. SAG neurons originate in the otic vesicle (the precursor 
of the vertebrate inner ear) and follow a complex stepwise progression. At the first step 
neuroblasts turn on expression of the proneural gene neurogenin1 (ngn1) which is 
necessary and sufficient for specification of the neural fate in the otic vesicle.  
Accordingly, ngn1 loss of function leads to loss of all cranial neurons, including those of 
the SAG, in zebrafish. We first showed that a low level of Fgf signaling is necessary for 
induction of neurogenesis in the otic vesicle. Inhibition of Fgf signals by a 
pharmacological inhibitor or by overexpression of a dominant-negative Fgf receptor 
severely inhibits ngn1 expression in the otic vesicle and decreases the number of mature 
SAG neurons. In similar experiments, we showed that misexpression of Fgf signaling at 
a low level enhances otic neurogenesis at early stages. 
 
FGFS AS A MORPHOGEN IN OTIC SENSORY AND NEURAL DEVELOPMENT 
In zebrafish, the sensory epithelium and neurogenic domains develop in adjacent 
regions. The sensory epithelium is the closest source of Fgf ligands (Fgf3/fgf8) to the 
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otic vesicle and likely provides the necessary level of Fgf signals for neurogenic 
development. Expression of Fgf responding genes in the otic vesicle follows a predicted 
pattern, where highest levels of etv5b, pea3 and sprty4 expression are observed in the 
sensory epithelium, lower levels of etv5b, pea3 and sprty4 are observed in the 
neurogenic domain (132, 181).  It is likely that Fgf ligands act as morphogens in otic 
development, since a high level of the signal is required for sensory development and a 
low level of the signal initiates formation of the neurogenic domain. However, whether a 
high level of Fgf signaling is required for development of hair or support cells has not 
been thoroughly investigated.  
Fgf ligands act as morphogens in several contexts; they diffuse over long 
distances and encode positional information in target tissues. Injection of Fgf8 
recombinant protein into zebrafish embryos at the 30% epiboly stage results in 
accumulation of the recombinant protein 12 cell diameters away and leads to induction 
of the Fgf responding gene, sprty4, up to 16 cell diameter away from the source (253). In 
the blastoderm margin, at the stage when fgf8 is expressed in 8 rows of cells, the Fgf 
response genes etv5b, pea3 and sprty4 are detected in 17, 15 and 13 cell diameters away, 
respectively, showing that Fgf ligands can induce expression of different genes based on  
concentration (253).  
Fgf signaling is required for proper development and patterning of the sensory 
epithelium (254-256). Previous studies have shown that high level overexpression of 
fgf3 or fgf8 is insufficient to expand the sensory epithelium (198). Moreover, a mild 
treatment of Fgf inhibitor SU5402 enhances sensory development and increases the 
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number of hair cells (255). In addition,  increasing the level of Fgf signals is shown to 
inhibit differentiation of sensory progenitor cells or support cells into hair cells 
(transdifferentiation) (254). Conceivably, a high level of Fgf signaling is necessary to 
allow proper patterning of the sensory epithelium such that the correct number and 
spacing of hair and support cells are established. Fgf signaling likely plays a similar role 
in the neurogenic otic domain. Lowering the level of Fgf signaling by a pharmacological 
inhibitor increases the specification events by increasing the number of ngn1+ cells in 
the otic vesicle and also stimulates differentiation of neurod+ transit-amplifying cells 
into mature SAG neurons. Also, high level overexpression of Fgf ligands slows down 
both production and differentiation of SAG neuroblasts. Regardless, it is unclear whether 
the amount of Fgf signaling required to correctly pattern sensory epithelium versus 
neurogenic domain is different. Future studies to examine both sensory and neural 
development following treatments that lower or rise Fgf signaling could determine 
whether Fgf ligands act as a morphagen in the otic vesicle.    
 
THE ROLE OF PAX GENES 
Differences in Fgf level requirements likely stems from the need for distinct sets 
of transcription factors for sensory versus neural development in the otic vesicle.  For 
instance, pax2a and pax5 genes are both important for sensory development and respond 
to a high level of Fgf signaling. Epithelial integrity of the sensory cells is possibly 
jeopardized in pax5 or pax2a mutants, since sensory cells are either lost from the otic 
epithelium or undergo apoptosis (205, 206). This could stem from the EMT-inducing 
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roles of Fgf signaling. Fgf signaling is shown to induce cell migration in several 
instances and increased Fgf levels are correlated with metastatic properties of tumor 
cells (257-259). In the third chapter we show that Fgf signaling induces expression of 
gsc, a key player in EMT during otic neurogenesis (231).  It is likely that high levels of 
Fgf signaling become detrimental to epithelial integrity of the sensory cells in the 
absence of the pax2 and pax5 genes. In this regard, examination of the otic epithelial 
architecture in pax2/pax5 mutants following misexpression of Fgf signals could be 
informative.  We also show that overexpression of pax2a stabilizes otic epithelia and 
inhibits EMT during otic neurogenesis (231). This role of Pax2a is likely indispensable 
for the development of the sensory cells under high Fgf conditions. The spatial domain 
of pax genes is completely excluded from the neurogenic domain in the otic vesicle and 
overexpression of pax2a in the neurogenic domain has deleterious effects.      
Overexpression of pax2a strongly blocks EMT of SAG neruoblasts and leads to 
formation of a much smaller SAG (231).  We also showed that overexpression of pax2a 
strongly represses gsc expression in the otic vesicle and thereby reduces EMT events in 
the otic epithelium (231).  It is likely that pax genes are not expressed in the neurogenic 
domain due to the lack of a high level of Fgf signaling that is required for activation of 
pax genes. Accordingly, in a recent study using microarrays, it was shown that Fgf 
treated chick otic ectoderm samples display a 7.3 fold upregulation in pax2a expression 
(260).   
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FORMING AN FGF GRADIENT IN THE OTIC EPITHELIUM 
As mentioned earlier, Fgf ligands form a sharp gradient in the otic vesicle; a 
strong etv5b expression is detected in the sensory epithelium whereas etv5b level drops 
dramatically in the neighboring neurogenic domain. Diffusion of the Fgf ligands is 
controlled at multiple levels. Spreading of the Fgf ligands is shown to be restricted by 
endocytosis (253). Conditions that block endocytosis increase the extent of the Fgf 
responding genes whereas conditions that stimulate endocytosis clear Fgf protein from 
the extracellular space and restrict its spreading (253). Thus, endocytosis determines the 
concentration of Fgf ligands in the extracellular space and affects the width of the target 
tissue responding to Fgf signaling. Small GTPases of the Rab family label the clathrin-
coated endocytosis vesicles and play a role in the tethering and fusion of the vesicles 
(261). Accordingly, Rab5a is shown to regulate endocytosis of Fgf ligands and is 
strongly expressed in the otic vesicle (252, 253). Futures studies to analyze detailed 
expression of rab5 and other endocytosis regulators in the otic vesicle could aid in 
understanding how a sharp Fgf gradient is formed. Additionally, diffusion of Fgf ligands 
in the extracellular matrix is regulated by heparin sulfate proteoglycans (HSPGs) and the 
length or sulfation level of heparin sulfate structures associated with Fgf ligands can 
greatly affect the level of Fgf signaling (262).  
 
IMPORTANCE OF FGF LIGAND SPECIFICITY 
Several different Fgf ligands regulate SAG development. A low threshold of Fgf 
signaling is necessary to initiate neurogenesis. Most likely, fgf3 and fgf8 expressed in the 
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utricular macula meet this requirement as the closest Fgf source. However, Fgf signals 
from the tissues surrounding the otic vesicle could also contribute to SAG development. 
Overexpression of fgf3 or fgf8 results in similar SAG phenotypes and suggests that Fgf 
ligand specificity is not critical in SAG development (132). At later stages of SAG 
development, mature SAG neurons express fgf5, which contributes to the increasing 
levels of Fgf signaling and shuts down neurogenesis in the otic vesicle (132). Similarly, 
overexpression of fgf3 or fgf8 at later stages inhibits neurogenesis, suggesting that the 
level of Fgf signaling, rather than the specificity of the Fgf ligands, regulates SAG 
neurogenesis. To shed light on the importance of Fgf ligand specificity in SAG 
development, gene replacements to swap fgf5 with fgf3 or fgf8 using homologous 
recombination mediated TALEN or CRISPR-CAS9 editing could be utilized and effects 
on SAG neurogenesis can be examined. In this regard, it is interesting that mutations in 
fgfr2 versus fgfr3 result in different inner ear phenotypes in mouse (82, 83). 
Accordingly, ligand specificity of the Fgf receptors and their expression levels has been 
studied extensively in the mouse inner ear to explain the resulting phenotypes of 
mutations in different Fgf receptors (81, 82). However, in zebrafish all Fgf receptors are 
expressed in the developing otic vesicle and it is currently unknown if the ligand 
specificity of each receptor plays a role in otic development (263-266).  
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REGULATION OF THE TRANSIT-AMPLIFYING STAGE DURING SAG 
DEVELOPMENT 
Specification of neuroblasts takes place in a very short time window in the otic 
vesicle. Specified neuroblasts leave the otic vesicle and slowly cycle as they mature and 
differentiate into SAG neurons. The number of cells in the transit-amplifying pool stays 
constant throughout early development and the rate of proliferative renewal matches the 
rate of loss from the TA pool as cells differentiate (132). Thus, once a stable number of 
TA cells are formed, specification of neuroblasts in the otic vesicle is no longer required 
and TA cells can serve as a continuous supply for new SAG neurons. Mature SAG 
neurons help maintain this homeostatic state by expressing fgf5 which both regulates the 
rate of differentiation in the TA pool and specification of neuroblasts in the otic vesicle 
(132). In fgf5 morphants, the number of specified neuroblasts increases and termination 
of SAG neuroblast specification is delayed (132). The same phenotype is observed when 
Fgf signaling levels are lowered by a pharmacological inhibitor of the pathway or 
overexpression of a dominant-negative Fgf receptor (132).   Overall, these data indicate 
that increasing Fgf levels during SAG neurogenesis regulates termination of the 
specification events in the otic vesicle. Importantly, laser ablation of the mature neurons 
also delays termination of neurogenesis in the otic vesicle (132). This confirms that 
mature neurons play a significant role in regulation of the SAG tissue size.  
 Fgf signaling also regulates the differentiation rate of the transit amplifying cells: 
conditions that block Fgf signaling increases the number of mature neurons at the 
expense of TA cells (132, 181). At later stages, a high level Fgf signaling provided by 
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mature neurons is likely required to prevent premature differentiation of TA cells to the 
mature neurons and maintain sufficient cycling progenitors in the TA pool. In fgf5 
morphants, initially a larger TA pool is formed due to failure of termination of 
neuroblast specification in the otic vesicle (132). However, it is predicted that this 
condition will result in depletion of TA cells in the long term, since the TA cells will 
quickly differentiate into mature neurons in the absence of high Fgf signaling and 
deplete the cycling TA neuroblasts. Future studies to generate fgf5 mutants or time 
specific knock down of fgf5 will likely show the indispensable role of mature neurons in 
regulating the size of the TA pool.  
Notch signaling also plays an important role in regulation of the SAG tissue size. 
Inhibition of Notch signaling enhances neurogenesis in the otic vesicle and also 
stimulates differentiation of TA cells into mature neurons (181). Proneural genes 
expressed by the SAG neuroblasts, ngn1 and neurod, activate expression of Delta 
ligands to aid in temporal control of the pace of SAG development (181).  
We have shown that otic neuroblasts leave the otic epithelium and form a stable 
stem cell pool to provide new SAG neurons at a constant rate until at least 5 dpf (132). It 
is currently unknown how long new SAG neurons are produced in zebrafish. Zebrafish 
forms new hair cells until adulthood and can regenerate lost hair cells (19, 267). 
Possibly, the ability to produce new SAG neurons to connect newly forming hair cells to 
the information processing centers also exists in adult zebrafish. Conceivably, TA cells 
also exist in larval or adult stages of zebrafish to maintain the ability to produce new 
SAG neurons. Maintenance of the TA cells is regulated by Fgf and Notch signals. We 
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showed that overexpression of both Fgf and Notch pathways increases the number of 
proliferating SAG progenitors in the TA pool and delays further differentiation, whereas 
downregulation of both signals induces premature differentiation of these progenitors 
into mature neurons and depletion of the TA pool (181). Future studies to examine adult 
zebrafish SAG neurons could determine whether Fgf and Notch signals are maintained 
through development to conserve a self-preserving TA pool where the number of 
proliferating progenitors matches the number of newly forming neurons. However, in 
fish species of similar size, only a few hundred SAG neurons have been detected in 
adulthood. It is also likely that the differentiation rate of SAG neuroblasts declines with 
age and stops when sufficient neurons are produced.  High Fgf5 levels provided by 
mature neurons could also signal for the final tissue size of SAG and regulate the size of 
the TA pool or differentiation of the TA progenitors accordingly. It is currently unknown 
whether fgf5 expression is maintained in mature SAG neurons through larval stages. 
Future studies to examine the genes expressed in adult SAG neurons and whether the TA 
precursors exist in mature zebrafish could aid in answering these questions.  
 
 NOVEL ROLE OF TFAP2A AND BMP SIGNALING IN OTIC NEUROGENESIS 
We show that additional factors aid in regulation of Fgf and Notch signaling 
during SAG development. For instance, ventral otic cells express tfap2a, which 
indirectly modulates Fgf and Notch pathways by activating the expression of bmp7a 
(181). In tfap2a mutants, loss of bmp7a expression from the otic epithelium leads to an 
increase in Fgf and Notch levels that stalls SAG development.  Furthermore, 
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overexpression of tfap2a activates bmp7a expression and stimulates SAG development 
through lowering Fgf and Notch levels. It is likely that the level of Fgf and Notch signals 
quickly rises during development and regulation by bmp7a is necessary to avoid 
premature termination of specification in the otic vesicle or prolonged cycling of the TA 
precursors.  Simultaneous activation of Fgf and Notch pathways at high levels increases 
the number of the proliferating TA neuroblasts. However, this severely disrupts their 
differentiation into mature neurons (181).  This phenotype is consistent with the increase 
in the size of the TA pool observed in tfap2a mutants, due to the increased level of Fgf 
and Notch signaling observed (181). Treatment with dorsomorphin, a pharmacological 
inhibitor of the BMP pathway, blocks the effects of tfap2a overexpression suggesting 
that Tfap2a regulates SAG development through activating BMP pathway. However, a 
direct analysis of Bmp7a function is currently lacking from our analysis. Future studies 
to induce time specific knock down or overexpression of bmp7a could show a direct 
function for this gene in regulation of the pace of SAG neurogenesis.  
The interplay between the Fgf and Bmp pathways has been shown in several 
instances. In the otic vesicle, expression of the Fgf ligands does not change in tfap2a 
mutants although bmp7a expression is lost and there is a significant increase in the 
expression level and domain of the Fgf responding gene sprty4.  This result is consistent 
with other studies showing that Bmp signaling antagonizes Fgf signaling. In Xenopus 
animal cap cells, overexpression of the Bmp inhibitor Noggin, results in increased levels 
of phosphorylated MAPK (ERK), a downstream effector of Fgf signaling (268). 
Moreover, overexpression of Bmp ligands inhibits expression of Fgf-induced 
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downstream neural markers (268).  The BMP pathway regulates Fgf signaling during 
early neural patterning by suppressing flrt3 expression, a positive regulator of the 
pathway. flrt3 knockdown inhibits Fgf induced ERK phosphorylation and flrt3 
overexpression recovers inhibition of Fgf pathway by BMP signals (268). Flrt3 is a 
transmembrane protein that interacts with Fgf receptors and positively modulates MAPK 
response and expressed in the otic vesicle in zebrafish (265). The temporal and spatial 
modulation of Fltr3 could serve as the basis for inhibition of Fgf signaling by BMP 
pathway during SAG development. Functional studies to knock down or overexpress 
flrt3 could shed light on the mechanism by which BMP lowers Fgf signal transduction in 
the otic vesicle.  
Even though the crosstalk between the Fgf and Bmp pathways has been studied 
intensively during early embryonic development and later in tissue modeling,  an 
interaction between the Notch and Bmp pathways has not been studied in detail prior to 
our study (231). We show that overexpression of tfap2a downregulates expression of 
delta ligands deltaA and deltaB via regulating BMP pathway (231). Inhibition of Bmp 
pathway by a pharmacological inhibitor rescues this inhibitory effect of tfap2a on Notch 
signaling. Possibly, deltaA and deltaB genes share common enhancer element that could 
be bound by activated BMP effectors. 
 
 ROLE OF GSC IN OTIC NEUROGENESIS 
We have identified Spemann organizer gene Gsc as a major regulator of 
epithelial-mesenchymal transition (EMT) during SAG neurogenesis (231). 
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Overexpression of gsc enhances the number of delaminated SAG neuroblasts whereas 
gsc knockdown diminishes the ability of SAG neuroblasts to leave the otic epithelium 
(231). Most likely, the mechanism by which gsc enhances EMT involves repression of 
cadherin1 (E-cadherin), however, the direct functional link between cadherin1 
downregulation and increase in EMT events is currently lacking from our analysis. 
Future studies to generate transgenic lines to temporally overexpress or knockdown 
cadherin1 could provide additional support for this hypothesis. It is also likely that gsc 
regulates expression of additional genes that are important for EMT during otic 
neurogenesis. We showed that the tight junction protein ZO1 immunoflourescence is 
decreases following overexpression of gsc (231). This difference in ZO1 protein levels 
could stem from repression of zo1 transcription by Gsc. Similarly, other genes that 
regulate formation and maintenance of the tight or adherens junctions could be regulated 
by Gsc function in the otic vesicle. Chromatin immunoprecipitation assays could 
identify potential targets of Gsc in the otic vesicle and help to determine the mechanism 
by which Gsc enhances EMT.  
 
THE FUNCTION OF PGK1 AND GLYCOLYSIS IN SAG DEVELOPMENT 
We identified the glycolytic enzyme Pgk1 as a regulator of neurogenesis in the 
otic vesicle. pgk1 mutants produce too few SAG neurons. This effect stems from a 
transient deficiency in early MAPK signaling.  For example, pgk1 mutants show a lower 
level of etv5b expression between 18-24 hpf in the otic vesicle. With mosaic analysis, 
we observed that wild type cells lose expression of the Fgf responding gene, etv5b, when 
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transplanted into pgk1 mutants. This finding suggests that Pgk1 non-autonomously 
regulates Fgf signaling in the otic vesicle. This finding raised the possibility that a 
moonlighting function of the secreted Pgk1 could potentiate downregulation of Fgf 
signaling.  The only known role of the secreted Pgk1 protein is the cleavage of the 
kringle 5 domain of the Plasmin protein, a protease that is known to digest (HSPG)-Fgf 
complexes in vitro (234, 235). We have examined the possibility of regulation of Fgf 
signaling by Pgk1 through modulation of Plasmin protein levels. This model predicts 
that Plasmin protein accumulates in pgk1 mutants thereby causing the excess removal of 
active Fgf-HSPG complexes. However, injection of morpholinos against plasmin failed 
to rescue pgk1 mutants suggesting a different mechanism of action for Pgk1 during otic 
neurogenesis.  
 
GLYCOLYTIC FUNCTION OF PGK1  
  The main function of Pgk1 is oxidation of 1, 3-diphosphoglycerate to 3-
phosphoglycerate during glycolysis. Pgk1 activity is indispensable for glycolytic 
activity, which is a major mechanism in cells to produce ATP from degradation of 
glucose to pyruvate. When oxygen is available, pyruvate is transported into 
mitochondria and converted into acetyl-coA, which is then further oxidized to generate 
ATP. In the absence of oxygen, pyruvate is converted to lactate in a process called 
fermentation.  
Through investigation of Pgk1 function , we discovered a novel mechanism in 
which otic cells engage in a modified form of glycolysis called the “Warburg effect” 
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(269). First described in metastatic tumors, the Warburg effect describes a metabolic 
shift into fermentation where pyruvate is converted into lactate instead of being shuttled 
to mitochondria for ATP production, despite the presence of abundant oxygen (269).  
Glycolysis can serve to generate the building blocks required for biosynthesis such as 
acetyl-coA for making fatty acids or ribose for making nucleotides. That is why it is 
thought that glycolysis is mainly used in cells with high proliferative needs to produce 
the glycolytic intermediates required for proliferation. However, many recent studies 
suggest novel roles for glycolysis during the developmental course of normal cells (250, 
251). For example,  during early development of the mouse embryo a major metabolic 
shift takes place during implantation when the embryos begin to increase the glycolytic 
activity and lactate production (270). As development proceeds, this intense glycolytic 
activity is replaced during organogenesis with oxidative phosphorylation (271). High 
glycolytic activity is thought to coincide with high proliferative activity during early 
mouse embryogenesis, however, a high rate of proliferation is also observed during 
organogenesis when glycolytic activity begins to decrease, thus suggesting another role 
for this high glycolytic activity.  
Growing evidence suggests that the Warburg effect can be a feature of normal 
cells during embryogenesis and have important developmental roles. For instance, 
inhibition of the aerobic glycolysis in the Xenopus retina by a pharmacological inhibitor 
reduces proliferation and differentiation of the retinal progenitors even though ATP 
levels are maintained normal with oxidative phosphorylation (272). Moreover, Wnt 
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proteins are shown to regulate glycolytic activity and induce the Warburg effect during 
bone formation and thereby regulate osteoblast differentiation (250).  
 
ROLE OF GLYCOLYSIS IN OTIC NEUROGENESIS 
These studies suggest that the glycolytic function of Pgk1 might have a 
regulatory role during otic development. Accordingly, expression of many other 
glycolytic enzymes also increases in the otic epithelium at neurogenic stages suggesting 
the presence of high glycolytic activity during the development of SAG neurons (252). 
The enzymes with increased otic expression include central glycolysis regulators such as 
pgk1 (Chapter V), hexokinase 1, hexokinase 2 and phosphofructose kinase (252).  Future 
studies will aim to test whether knockdown of these genes would also give rise to similar 
SAG phenotypes as pgk1 mutants.  
A temporal decrease in early Fgf levels in pgk1 and sagd1 mutants causes 
formation of too few SAG neurons. Several recent studies suggest a functional link 
between upregulation of glycolytic activity and Fgf signaling during development. For 
instance, in the presomitic mesoderm (PSM) a gradient of glycolytic activity regulates 
Fgf signaling and plays an indispensable role in posterior elongation of the embryonic 
axis in an ATP independent manner (251).  
A possible link between glycolysis and Fgf signaling is provided by studies of 
hypoxia induced responses. Hypoxia responses enable cells to adapt to harsh 
environmental conditions such as low oxygen availability and mainly regulated by 
hypoxia inducible factors (HIFs) (273). Many of the functions of HIF factors include 
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regulation of metabolic pathways, oxygen delivery and pH and impact cell proliferation 
and survival (273). One of the immediate responses to hypoxia, upregulation of 
glycolysis and inhibition of Kreb’s cycle, is mediated by HIFs (273). Many downstream 
effectors of Fgf signaling is activated in response to hypoxia such as PI3K, AKT and 
ERK, although, there is no evidence linking activation of these factors to HIFs (274). 
Thus, the mechanism by which these elements are activated in response to hypoxia 
remains elusive. However, a recent study shows that a hypoxia induced gene, NDRG3, is 
expressed independently of HIF levels and binds to lactate to activate the MAPK 
pathway through Raf-c and Erk1/2 phosphorylation (239). This study provides a novel 
link between glycolysis and MAPK activation and suggests a novel role for lactate in 
regulation of hypoxia induced responses (239). Both depletion of NDRG3 and inhibition 
of lactate production suppress hypoxia induced activation of MAPK pathway (239). It is 
also shown that lactate can form complexes with NDRG3;  however, the mechanism by 
which these complexes activate phosphorylation of Raf or Erk proteins remains 
unknown (239).  
Lactate was once considered a metabolic waste, an end product of glycolysis. 
However, growing evidence suggests that it can have critical roles in maintenance of 
tumor growth and metastasis. Lactate also can act as a signaling molecule and enhance 
angiogenesis during tumor growth. Elevated levels of Lactate Dehydrogenase A, the 
enzyme that converts pyruvate to lactate, is a hallmark of many tumors and inhibition of 
this enzyme can block tumor growth in cell lines in vitro (275) and in transplanted breast 
tumors in vivo (276). A pharmacological inhibitor of the lactate dehydrogenase 
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enzymes, galloflavin, also suppresses proliferation of breast cancer cells at high 
concentrations (277).  Lactate can also be secreted into extra cellular matrix and taken up 
by the cells to be used as a substrate in oxidative phosphorylation. For instance, 
astrocytes undergoing aerobic glycolysis secrete lactate to be used as a food source by 
the neurons (278).  Furthermore, cancer cells can induce neighboring cells to produce 
and shuttle lactate to fuel their oxidative metabolism (279). Secreted lactate can also act 
as a signaling molecule to induce migration, tube formation and angiogenesis (280). 
Studies show that secreted lactate can lead to acidification of extracellular matrix and 
activate metalloproteases which modify the extracellular environment and to promote 
cell motility (281). Overall, these studies emphasize many diverse roles for glycolysis in 
regulation of signaling pathways during normal development and tumor growth. Our 
analysis of the role of pgk1 and lactate in otic development adds to this growing body of 
literature and provides a concise mechanistic framework for how these studies might be 
generally related.  
To address the role of increased glycolytic activity and lactate production during 
SAG neurogenesis we used an inhibitor of glycolysis, 2-deoxy-glucose (2DG) and an 
inhibitor of lactate synthesis, galloflavin. Both pharmacological treatments lead to a 
decrease in the number of mature SAG neurons, similar to the phenotypes observed in 
pgk1 or sagd1 mutants.  Additionally, treatment of pgk1 or sagd1 embryos with lactate 
rescued the observed SAG phenotypes in these embryos. Importantly, multiple 
homologs of NDRG3 are expressed in the otic vesicle in zebrafish (252), providing 
further support for a possible interaction between lactate and NDRG3 to induce MAPK 
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signaling. Future studies to knockdown or overexpress ndrg3 could further implicate the 
role of lactate-NDRG3 complexes on neurogenesis and MAPK signaling in the otic 
vesicle.  
A low threshold level of Fgf signaling is required to specify neural fates in the 
otic vesicle. However, the onset of ngn1 expression precedes expression of Fgf ligands 
in the otic epihelium. ngn1 expression is first detected at ~16 hpf in the otic cells 
whereas fgf3 and fgf8 begin to be expressed at ~18 hpf. It is likely that Fgf signaling 
from the tissues surrounding the otic placode initiate otic neurogenesis. However, it is 
also likely that other ligands or signaling molecules activate MAPK pathway prior to the 
beginning of Fgf ligand expression in the utricle. In this regard, activation of the MAPK 
pathway by aerobic glycolysis through lactate production could be vital to boost this 
signal and activate neurogenesis in the otic vesicle. MAPK responding genes such as 
etv5b and pea3 also serve as the downstream effectors of Fgf signaling. Early 
accumulation of these transcripts in the otic vesicle is likely important for generating a 
quick and robust signal following the onset of Fgf ligand expression in the otic vesicle. 
In this regard, we tested whether lactate can activate expression of etv5b in the absence 
of Fgf signaling and showed that lactate can increase etv5b expression following 
activation of hs:dnfgfr1 construct. This result suggests a novel role for lactate signaling 
in activation of MAPK pathway during otic development.  
To conclude, we have discovered many new regulatory mechanisms important 
for SAG development. First we show that a threshold level of Fgf signaling is required 
to initiate otic neurogenesis in the otic vesicle, however high levels inhibits specification 
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of otic neuroblasts. In this regard, fgf5 expressed by the mature SAG neurons aid in 
termination of otic neurogenesis at late stages and regulate the overall size of the 
ganglion. In further studies we showed that Tfap2a has an important role in regulating 
the pace of SAG development such that regimens to overexpress tfap2a lower Fgf and 
Notch signaling and doubles the size of the mature SAG. We also show novel roles for 
Notch signaling in modulating differentiation of TA neuroblasts. We investigated the 
mechanism by which SAG neuroblasts leave the otic vesicle and discovered Gsc as a 
major regulator of the EMT events in the otic epithelium. We also showed that non-
neurogenic regions of the otic vesicle are resistant to the EMT promoting function of 
Gsc due to the presence of the epithelializing factor Pax2a. Gsc and Pax2a have 
opposing roles in the otic vesicle, partially through modulation of cadherin1 expression. 
Also, we conducted a mutagenesis screen and identified 2 novel genes that affect SAG 
development in unique ways. We identified the first mutated locus to affect the 
glycolytic enzyme pgk1. This finding suggests a novel role for aerobic glycolysis during 
otic development and emphasizes that Warburg affect can also modulate development of 
normal cells in addition to its role in promoting tumor growth and metastasis. Our 
analyses have filled many gaps in our understanding of SAG development through 
identification of novel roles for the transcription factors such as Tfap2a , Gsc and Pax2a; 
and through characterizing diverse functions of main signaling pathways such as BMP, 
Notch and Fgf .   
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